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ABSTRACT. 
Binding of the calcium channel antagonist [ 3H] 
verapan-til has been detected in crude and solubilised 
membrane fractions from maize coleoptiles. Binding was 
saturable and reversible. The dissociation constants for 
specific binding of [3H] verapamil to crude and 
solubilised membrane fractions were 72 nM and 158 nM 
respectively, with respective binding-site concentrations 
of 135 prnol/ing protein and 78 pmol/ing protein. In both 
cases the Scatchard plots were linear indicating a single 
class of non-interacting binding sites. 
[3H] veraparnil binding to crude maize coleoptile 
membrane fractions could not be displaced by unlabelled 
desinethoxyverapamil or nifedipine, but could be displaced 
by methoxyverapamil. These results suggest that there may 
be alternative specific binding sites for the different 
channel antagonists in plant membranes, possibly within 
the same channel. Preliminary investigations suggest that 
the number of calcium channels varies according to tissue 
type and that there is subcellular localisation of 
verapainil binding calcium channels on the plasma 
membrane. 
Partial purification of a verapainil binding protein 
was achieved using detergent solubilisation of the 
membrane bound protein(s), followed by ion exchange, gel 
filtration and hydrophobic interaction chromatography. 
This resulted in an average purification of 36 ± 16 fold 
(n=7) . Analysis of the polypeptides from the final 
purified fraction, by SDS polyacrylarnide gel 
electrophoresis, indicated that a protein of 169 kDa may 
contain the verapamil binding site. However the verapamil 
binding protein could not be further accurately 
identified either by photoaffinity labelling or by [3H] 
verapamil overlay techniques. Preliminary experiments 
also suggested that the putative verapamil binding 
protein and possible associated channel proteins, were 
not glycosylated, did not bind calcium and were not 
phosphorylated by endogenous protein kinase. 
CHAPTER 1. 
INTRODUCTION. 
The aim of this introduction is to describe what is 
known about the role of calcium in the regulation of 
plant physiology and how cytoplasmic calcium levels are 
maintained in plant cells. This will be followed by an 
outline of our knowledge to date about calcium channels 
in both plants and animals and their importance in the 
regulation of intracellular calcium levels. 
1.1. Calcium as a second messenger. 
Animal and plant cells need to convert extracellular 
signals into an intracellular message that can be 
understood by the cells to achieve the correct 
biochemical or physiological response. In animal cells, 
calcium ions, together with cyclic AMP, act as second 
messengers to translate primary signals, such as light 
and hormones, into a final response. Cyclic AMP, although 
present in higher plant cells (Brown & Newton, 1981) 
does not appear to have a role as a second messenger; the 
only known primary receptor for cyclic AMP, a cAMP-
dependent protein kinase has never been found and cAMP 
has not been shown to be required for any physiological 
response (Saliainath & Marmé, 1983) . Calcium ions alone, 
therefore, may be the main second messenger in plant 
cells, coupling stimulus to response and co-ordinating 
plant processes. There is also some evidence to suggest 
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that, as in animal systems, there is interaction between 
calcium and the inositol phospholipids to create an 
intracellular messenger system (Elliot & Skinner, 1986; 
Reddy et al., 1987; Ranjeva et al., 1988). 
The following sections will focus on calcium as an 
intracellular regulator of plant processes and how the 
plant cell can achieve this regulation. 
1.2. Calcium regulation of physiological processes in 
plants. 
Calcium has long been known to be an important 
macronutrient in the growth and development of plants 
(Kirkby & Pilbeam, 1984) . Recently it has become 
increasingly apparent that calcium ions are also .a major 
intracellular regulator of numerous biochemical and 
physiological processes. Such processes include polarised 
growth (Nobling & Reiss, 1987; Brownlee & Wood,1986; 
Hepler & Wayne, 1985) , cytoplasmic streaming (Hayarna et 
al., 1979; Williamson & Ashley, 1982) and mitosis (Keith 
et al., 1985; Hepler & Callaham, 1987). 
The involvment of calcium has been shown by altering 
cytoplasmic calcium with either calcium ionophores, by 
application of calcium antagonists or by chelation of 
extracellular calcium. A number of workers have also 
demonstrated that calcium ions mediate a variety of 
events elicited by extracellular signals, including 
light, hormones and gravity (Wayne & Hepler, 1985; Roux 
et al., 1986; Elliot, 1986; DeSilva et al., 1985; 
?oovaiah et al., 1987). A change in cytosolic calcium 
concentration caused by the extracellular signal is 
considered to be the primary event in triggering a 
cellular response. It is proposed that the signal causes 
a rise in cytosolic calcium concentration which then 
elicits the response. 
One of the difficulties involved in determining the 
role of calcium in signal-response coupling, is the 
measurement of cytoplasmic calcium levels. There are 
various methods available for such measurement, for 
example, calcium-binding dyes, calcium-activated 
photoproteins and calcium-sensitive electrodes. However, 
technical problems arise when applying them to plants. 
Despite this, some measurements have been made, which set 
cytosolic calcium concentration at approximately iO 	M 
in plant cells (Gilroy et al., 1986; Williamson & Ashley, 
1982; Brownlee & Wood, 1986) . The change in internal 
calcium concentration in response to an extracellular 
signal e.g.light, has also been demonstrated (Miller & 
Sanders, 198). 
Calcium then, appears to regulate a number of 
physiological processes in plants. The next sections show 
that plant cells have the means to sense and respond to 
external stimuli and so elicit these processes and that 
calcium as an ion is ideally suited to this role. 
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1.3. Plant calmodulin and Ca2+-calmodulin dependent 
enzymes in plants. 
Calmodulin consists of a single polypeptide chain of 
148 amino acids with four calcium binding domains which 
bind calcium with high affinity. When cytosolic calcium 
concentration rises, calmodulin becomes functionally 
active and binds calcium. It then undergoes a 
conformational change which allows it to interact with 
target proteins and modulate their functions (Klee & 
Vanainan, 1982) 
Calmodulin has been found in plant tissues (Anderson. 
et al., 1980) and is very similar to animal calmodulin. 
The amino acid sequence of spinach calmodulin has only 13 
different amino acids to that of bovine brain calmodulin. 
This difference does not appear to cause any functional 
changes and the affinities of plant and vertebrate 
calmodulin for calcium appear to be of the same order of 
magnitude (Marmé et al., 1984) 
The Ca2+_calmodulin complex, once formed, plays an 
important role in the messenger system by directly 
regulating certain enzymes or by activating a protein 
kinase for example, which can regulate other 
enzymes/proteins by phosphorylation. These two modes of 
action allow fast and slow responses to be mediated by 
calcium and calmodulin. The first calmodulin-dependent 
enzyme to be discovered in plants was NAD kinase from 
peas (Anderson & Cormier, 1979). Other enzymes have since 
been shown to be Ca2+_calmodulin dependent. These include 
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other NAD kinases localised in the cytoplasm, 
mitochondrial membranes and chloroplast envelope (Dieter 
& Marine, 1980), Ca2 and Mg2 ATPases (Fukuinoto & Venis, 
1986), protein kinases (Blowers et al., 1985) and Quinate 
NAD oxidoreductase (Graziana et al., 1983) 
The existence of calmodulin and Ca2 F calmodulin  
dependent enzymes in plant cells suggests that plants 
have the biochemistry to use calcium as a second 
messenger. Fig.1.1. illustrates a possible scheme for 
calcium as a second messenger in plants. 
1.4.The suitability of calcium. 
Calcium itself has various properties which make it 
a suitable ion to regulate intracellular processes, 
compared to other ions such as magnesium, sodium or 
potassium. 
At elevated levels (approaching millimolar) , calcium 
will react with inorganic phosphate forming an insoluble 
precipitate which inhibits the normal phosphate based 
energy metabolism of the cell. Therefore it is important 
that the cell maintains a low (0.1 pM - 1.0 pM) 
intracellular concentration of calcium. 
By having a low concentration of cytosolic calcium, 
a small change in the absolute amount of calcium in the 
cytosol can result in a 10 - 100 fold rise (0.1 pM - 1.0 
pM/la pM) which can trigger a physiological response 
without greatly disturbing the ionic environment of the 
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EXTRACELLULAR STIMULUS 
Hormones. Light. Gravity. 
4, 
Ca2+ Channels open in response 
to a depolarisation of the membrane 
and allow Ca2+  to move into the cell. 
1 
Rise in cytoplasmic Ca2+  concentration. 
10-7 010-5 M. 
Ca2+  bound by Calmodulin. 
i 
Ca2+/Calmodulin complex binds 
to target enzymes. 
Activation of target enzymes either 
a. Directly 
b. By phosphorylation via a Ca2+  Calmodulin 
dependent protein kinase. 
1 
RESPONSE. 
Fig.1.1. The possible role of calcium as a second 
messenger in plant cells. 
r;1 
cell. The influx of a relatively small number of ions is 
not an osmotic burden to the cell, as they can be pumped 
out, bound or sequestered, to return the cell to its 
resting calcium levels with very little energy 
expenditure. The rapid removal of ions allows both 
spatial and temporal calcium gradients to form which can 
carry a message from the initial signal. In the case of 
the more abundant ions like Mg2+ or K+,  the cell would 
have to increase the concentration of these ions from 
io 	-10 Mto achieve the same effect. This would upset 
the osmotic balance of the cell and require a lot of 
energy to restore the cell to its resting level. 
Calcium also has a low free energy of hydration 
which allows a more rapid exchange of water molecules, 
(approximately iO times faster than Mg2+),  when binding 
to target sites. Interaction with a receptor is therefore 
faster and requires less energy. The variable 
coordination number and bond length of the calcium ion 
also allows greater flexibility of interaction with 
receptor sites compared to ions like Mg2+  which have 
fixed coordination and bond lengths. 
1.5. Regulation of cytosolic calcium. 
Due to the low internal concentration of calcium 
there is a large difference, (1000-10,000 fold), in 
calcium concentration between the cytoplasm and cell 
exterior. This results in a large potential driving force 
for inward calcium movement. However, the permeability of 
the membrane for calcium ions is low and so calcium 
movement into the cell is slow. Only when the calcium 
channels are open does the calcium move rapidly down its 
electrochemical gradient into the cell, so causing a rise 
in cytosolic calcium levels. To return the cytosolic 
calcium concentration to its low level requires that the 
ion be actively pumped out of the cytosol to the apoplast 
or sequestered into other cell organelles including 
vacuoles, endoplasmic reticulum, chioroplasts and 
mitochondria (Evans, 1988) . A number of calcium pumps 
that can do this have been identified in the various 
membrane fractions including plasma membrane (Dieter & 
Marine, 1981), endoplasmic reticulum (Schumaker & Sze, 
1986) and mitochondria (Hodges & Hanson, 1965; Dieter & 
Marmé, 1980) . Chloroplasts have also been shown to 
sequester calcium when illuminated (Kreirner et al., 1985; 
Miller & Sanders, 1987). The plasma membrane calcium pump 
is probably the major pump regulator of cytosolic 
calcium, although in daylight, chioroplasts in 
photosynthesising tissue may play an important regulatory 
role. The calcium pumps themselves appear to be regulated 
by a number of factors including plant growth substances 
(Kubowicz et al., 1982), phytochrome (Roux et al., 1986) 
light (Miller & Sanders, 1987) and calmodulin (Dieter & 
Marmé, 1983; Moore & Akerman, 1984; Fukumoto & Venis, 
1986). Calinodulin probably has a homeostatic effect by 
stimulating the plasma membrane pump as the cytosolic 
calcium rises, resulting in the restoration of lower 
calcium concentrations in the cytoplasm. Calmodulin also 
plays another role in maintaining a low internal calcium 
concentration by binding calcium ions when they enter the 
cell. These functions, although important to regulation 
of cytosolic calcium, are minor compared to the function 
of calmodulin in processing the extracellular signal. 
An outline of intracellular calcium regulation is 
summarised in Fig. 1.2. 
1.6. Calcium entry into the cytoplasm. 
This introduction has so far considered the 
mechanisms involved in the maintenance of low cytosolic 
calcium concentration and the role of calcium as a second 
messenger in plants. Central to this role of 
intracellular messenger is the rise in cytoplasmic 
calcium triggered by the primary stimulus. In animal 
cells the stimulus causes the release of calcium from 
intracellular organelles and/or causes plasma membrane 
sited calcium channels to open, through which calcium 
ions move into the cell. 
There are two main types of calcium channels; the 
voltage-dependent calcium channel and the receptor-
operated channel, (Benham & Tsien, 19867; Neher, 1987) 
The receptor-operated channels, which appear to be 
independent of voltage and are linked to phospholipid 
metabolism, appear to be the type responsible for calcium 
release from intracellular organelles such as endoplasinic 
reticulum in animal cells (Michell, 1982; Berridge, 
IP ? 
sequestered 
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1986) . It is possible that receptor operated channels may 
exist in plants to allow release of calcium from 
organelles, but there is no firm evidence for them, as 
indeed there is no firm evidence for the involvement of 
phospholipid metabolism in the second messenger system in 
plants. 
Calcium entry through the plasma membrane sited 
voltage-dependent calcium channels, is probably the most 
important route whereby cytosolic calcium is increased. 
In the remaining sections of this introduction some 
information about voltage-dependent calcium channels in 
animal cells will be presented, followed by what is known 
about calcium channels in plant cells. 
1.7. Calcium channels. 
Calcium channels are membrane proteins which form 
pores that are capable of transferring millions of 
calcium ions per second from the cell exterior into the 
cytoplasm (Tsien, 1983). The channels open in response to 
a change in membrane potential (usually a 
depolarisation), and allow calcium ions to move down 
their electrochemical gradient into the cytoplasm 
(Hagiwara & Byerly, 1983; Tsien, 1983; Reuter, 1983) . The 
calcium flux creates a net inward, depolarising current 
and results in the accumulation of calcium in the 
cytoplasm. In the case of animal cells, the rise in 
cytosolic calcium effects such processes as muscle 
contraction, secretion of hormones and neurotransmitters, 
the regulation of enzyme activities and other calcium 
sensitive events (Reuter, 1983) . The calcium channels 
play a crucial role in coupling membrane excitation to 
cellular responses and are a major way of controlling 
internal calcium. 
1.8. Methods of studying calcium channels. 
Calcium channels have been studied using a 
combination of electrophysiological, pharmacological and 
biochemical techniques. Using the electrophysiological 
technique of patch clamping, a very small area of 
membrane can be electrically isolated from its 
surroundings. The patch of membrane may contain one or 
more functional calcium channels, which can open and 
close as the membrane potential is changed. The current 
flow across the membrane patch (i.e. through the 
channels) into the pipette can be collected and recorded. 
From this channel activity can be identified. Patch 
clamping can be applied to whole cells or to single 
channels (Hammil et al., 1981; Lee et al., 1980). 
Patch clamp recordings have allowed the study of the 
mechanism of ion permeation and selectivity of calcium 
channels (Hess & Tsien,1984), the identification and 
characterisation of multiple channel types in various 
tissues eg; sensory neurons and ventricular heart cells 
(Reuter, 1986; MCClesky  et al., 1986) and the mechanisms 
of calcium channel modulation by hormones, 
neurotransmitters and drugs which alter calcium entry 
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into cells by increasing or decreasing channel activity 
(Lee & Tsien, 1983; Reuter, 1983). 
Pharmacology has also been employed to study calcium 
channels. Different calcium channel types have different 
sensitivities to various pharmacological agents and can 
be distinguished between on that basis (Reuter, 1986) 
Such agents include various neurotransmitters, hormones, 
toxins and a group of drugs known as calcium antagonists 
and agonists. As well as modulating calcium entry, these 
drugs have been used biochemically in the purification of 
voltage dependent calcium channels and to elucidate their 
structure (Glossmann & Streissnig, 1988) 
1.9. Mechanism of ion permeation. 
In excitable membranes of animal cells, calcium 
channels are controlled by voltage-dependent gating, i.e. 
the opening and closing kinetics are a result of changes 
in membrane potential. Evidence suggests that a 'voltage 
sensor' within the membrane, possibly a protein with 
dipole properties, that is an integral part of the 
channel, reacts to the electric field. Any change in 
membrane potential will cause a reorientation of the 
charged 'sensor' within the field and thus a change in 
the ion flow through the channel (Reuter, 1983). 
The probabilty that a channel will be open depends 
on membrane potential, as does the current that flows 
while the channel is open. Studies employing patch 
clamping of single calcium channels from cardiac cells 
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show that as depolarisation occurs the probability of the 
channel being open increases. A steady level of 
activation is usually reached in a few milliseconds 
(Reuter et al., 1982) . During long depolarizing steps 
calcium channels can show inactivation i.e. a decline in 
calcium conductance through the channel. This is 20-30 
times slower than activation and maybe caused by membrane 
potential (which may decrease the probability of the 
channel being available to open) or increased 
intracellular calcium. Some excitable cells show little 
inactivation, while others display voltage and/or calcium 
dependent inactivation to different degrees (Tsien, 1983; 
Reuter et al., 1982). Ca1ciumchannel types can be 
distinguished between on the basis of activation and 
inactivation properties (see below) 
The observed distribution of channel open and closed 
times (from patch clamp recordings of single channels), 
have been interpreted in terms of 2 closed states (C11C2) 
and 1 open state (0) , with adjustable rate constants 
(Fenwick et al., 1982; Tsien, 1983). The following 
equation describes these states. 
k1 	 k2  
c1 ' c2 	'0 
k_1 	 k_2  
Hess et al. (1984) have postulated that there are 
multiple modes of channel gating and that the channel 
switches between them. Each mode has characteristic open 
and closing kinetics, shown in the above equation. Mode 1 
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is characterised by brief openings (ims) occuring in 
rapid bursts and probability of openess increases at 
stronger depolarisations. Mode 2 can be distinguished by 
relatively long lasting channel openings (20ms) and 
typically brief closings with the probability of openess 
being high. The rate constants between C1 - C2 - 0 for 
mode 1 and 2 are very different. Another mode, mode 0 
refers to a condition where the channel is unavailable 
for opening; no recording of channel opening can be made. 
Voltage-dependent inactivation is thought to increase 
the proportion of time a channel spends in mode 0. The 
transitions between the different modes is thought to be 
slower than the open/close reactions within the mode, but 
the exact intermode connections e.g. are they all 
voltage-dependent or do proteins require covalent 
modification/phosphorylation before transition can occur 
(Reuter, 1987) , are not known. It is likely that channel 
gating mechanisms are highly complex, more so than 
indicated here. 
1.10. Selectivity of the calcium channel. 
The calcium channel is highly selective for calcium 
ions despite the fact that in the medium outside the 
channel, calcium ions are greatly outnumbered by other 
ions. It has been postulated that the selectivity of the 
calcium channel is due to the presence of ion binding 
sites which preferentially bind calcium over any other 
ions. The channel is therefore occupied almost 
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continually by one or more calcium ions which, by 
electrostatic repulsion, guard the channel against the 
permeation by other ions. The repulsion between calcium 
ions also allows high throughput rates (Hess & Tsien, 
1984; McClesky & Almers, 1985) . Recently the binding of 
the permeant ion to its binding site in the channel and 
the subsequent change in conformation of the protein, has 
been shown to effect ion permeation through calcium 
channels (Pietrobon et al., 1988). 
1.11. Calcium channel antagonists. 
Calcium channel antagonists and agonists 
specifically interfere with calcium entry through open 
channels. Using a structural classification, four main 
groups of these drugs can be identified. These are the 
phenylalkylainines e.g. verapamil, desmethoxyverapamil 
(D888), methoxyverapamil (D600); the dihydropyridines 
e.g. nifedipine, nitrendipine; the benzothiazipines e.g. 
diltiazem and the diphenylpiperazines e.g.cinnarizine and 
flunarizine. Other antagonists include bepridil, 
fendiline and papaverine. Verapamil, nifedipine and 
diltiazem are used clinically to treat cardiovascular 
disorders including angina and hypertension (Triggle et 
al., 1986). Fig. 1.3. shows the structures of some of 
these compounds. Inorganic cations such as Mn2+, Cd2+ and 
La3+ are non-specific antagonists and also interfere with 
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Fig.1.3. The structures of various calcium channel 
antagonists. 
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Calcium antagonists exert their primary action on the 
voltage-dependent channel. Contractions in smooth muscle, 
(caused by depolarisation of the membrane which opens the 
calcium channels) , are almost completely abolished in the 
presence of high concentrations of antagonists. 45Ca2+ 
influx induced by depolarisation is also inhibited 
(Godfraind & Miller, 1986) . On repetitive depolarisation 
the binding site for the compounds becomes more 
accessible or there is a increase in affinity of the site 
for the drugs with changes in membrane polarity. This 
leads to an increase in inhibition of contraction over 
time which is termed 'use-dependence', a general property 
of most calcium channel antagonists. This is more 
pronounced for D600 type drugs than for dihydropyridine 
antagonists. Diltiazem is intermediate between the two 
(Lee & Tsien, 1983). 
Inhibition of calcium flux may not happen in all 
situations as calcium channels are heterogeneous 
(Hagiwara & Byerly, 1983), and may not always be 
sensitive to the drugs. The differing potency of 
different drugs to inhibit depolarised induced 
contractions in different tissues, gave rise to the idea 
of tissue selectivity of calcium antagonists (Godfraind & 
Miller, 1986) . The selectivity maybe a property of the 
compound or maybe a consequence of variation in 
physiological responses of tissues to stimuli e.g. 
dihydropyridines may not distinguish between calcium 
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channel types in the absence of depolarisation of the 
membrane. 
Specific and high affinity binding sites for 
dihydropyridines and phenylalkylamines have been 
identified in smooth muscle, cardiac muscle and brain 
with radioligand binding studies (Glossmann et al., 
1982) . The binding sites differentiate between the 
enantiomers of the dihydropyridines and between the 
stereoisomers of verapainil and D600. Calcium antagonists 
from one structural group could displace calcium 
antagonists from another group, but not as well as those 
from the same series (Glossmann et al., 1982). From these 
type of results, it is suggested that there are separate 
binding sites for the different drug types and that these 
sites may be linked. (Triggle et al., 1986). 
Results from binding studies and electrophysiology 
suggest that the drug binding sites are localised in 
different parts of the channel. Verapamil and D600 are 
thought to act on the inner mouth of the calcium channel 
to inhibit calcium entry, having entered the channel 
while it was in the open state (Hescheler et al., 1982) 
The dihydropyridine site of action has not been properly 
resolved. It is thought to be situated on the outer mouth 
of the channel, as the effect of the dihydropyridines 
increases with their lipophilicity (Kokubun & Reuter, 
1984) . However the divalent cation dependence of 
dihydropyridine binding (Glossmann et al., 1982) 
suggests an association between ligand and metal ion 
I.  
binding sites which indicates a more intracellular 
binding site for the drug (Hess & Tsien, 1984) . Blockade 
of channels by dihydropyridine type antagonists reduces 
peak inward current and speeds its decay, which has been 
interpreted as the drug effecting open channels (Lee & 
Tsien, 1983) . However, other work suggests that calcium 
channel antagonists may show preferential binding to 
inactivated channels (Peizer et al., 1982) 
The dihydropyridines and phenylalkylamines are 
thought to have their antagonistic or agonistic effect by 
modulating the gating mechanism of the channels. It is 
thought that the binding of the drugs does not simply 
plug the the pore, but favours one or more of the modes 
of gating outlined previously. A dihydropyridine 
antagonist would promote mode 0 and a dihydropyridine 
agonist would favour mode 2. Using nimodipine 
(antagonist) and Bay K 8644 (agonist) , this has been 
shown to be the case (Hess et al., 1984). D600 (a 
phenylalkylainine antagonist), also appears to favour mode 
0 and also tends to shorten individual openings within 
mode 1 (Fox et al., 1986). 
The inhibitory effect of the drugs is reinforced by 
inactivation of the calcium current. For example, 
prolonged depolarisations, which cause inactivation of 
channels, strongly promotes the inhibitory effect of 
nisoldipine. Other dihydropyridines act to slow recovery 
from inactivation following a depolarising pulse (Hess et 
al., 1984). 
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1.12. Different types of calcium channels. 
It has recently become apparent that there are 
several types of voltage-dependent calcium channels, each 
one with different properties. Multiple channel types 
have been identified in various neuronal tissues and 
muscle tissue (Nilius et al., 1985; Nowycky et al., 1985) 
and have been distinguished between by measuring the 
calcium current through several or single patch clamped 
calcium channels. From differences in conductance, three 
types, termed the L,T and N type calcium channels have 
been identified. The L-type channel has repeated openings 
which produce currents of relatively long duration (20 
m3). The T-type channel, which can be activated by 
smaller depolarisations than L-type channels, produce 
transient inward currents (1 ms). N-type channels need 
very strong depolarisations to activate them and have 
neither of the inward current patterns seen for L and T-
type channels. All three types of channels are found in 
neuronal cells, but only the L and T-type are found in 
cardiac and skeletal muscle (Reuter, 1986) 
Apart from differences in activation and 
inactivation properties, the channel types can be 
distinguished on their sensitivity to various 
pharmacological agents. 3-adrenoreceptor agonists seem 
only to effect L-type channels. The L-type channel is 
also more sensitive to organic drugs (dihydropyridines, 
phenylalkylamines, benzothiazipines and 
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diphenylbutylpiperidines) (Galizzi et al., 1986; 
Glossmann & Striessnig, 1988) than the T-type, although 
the T-type can be inhibited by gallopamil and 
cinnarizine. N, L and T-type channels in neurons can be 
blocked by omega-conotoxjn. The toxin revesibly inhibits 
the T channel from heart but has no effect on smooth or 
skeletal muscle channels (Miller, 1987; M'Cleskey et al., 
1987) . As the dihydropyridines have more of an effect on 
heart and smooth muscle than in the nervous system and 
because only the L-type channels are sensitve to these 
drugs, it is suggested that the L-type channel is more 
abundant in heart and smooth muscle. 
Each of the channel types may serve a particular 
function. It has been hypothesised that T-type channels 
could be involved in the rhythmic firing of neurons and 
specialised cardiac cells (Nowycky et al., 1985; Bean, 
1985) . L-type channels may be important in contractile 
activation of cardiac and smooth muscle (Reuter, 1986) 
N-type channels are probably involved in neuronal calcium 
uptake and neurotransmitter release (Reynolds et al., 
1986; Dooley et al., 1987) 
1.13. The structure of voltage-dependent calcium 
channels. 
Calcium channel antagonists have been used to 
structurally characterise voltage-dependent L-type 
calcium channels. (N-type channels have recently begun to 
be characterised using omega-conotoxin but as yet, no 
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stuctural information is available on T-type channels). 
Most of the information about the stuctural composition 
of the L-type channel comes from purification studies 
with either guinea-pig or rabbit skeletal muscle, using 
labelled dihydropyridines as a probe for the purified 
channel proteins either by direct binding assays or 
irreversible photoincorporation (Curtis & Catterall, 
1984; Borsotto et al., 1985; Striessnig et al., 1986b, 
1987) . Some data is available on L-type channels in 
cadiac tissue (Cooper et al., 1987). Skeletal muscle was 
used to purify the L-type channel as it was found to be 
the richest man-alian source of dihydropyridine and 
phenylalkylamine sensitive calcium channels, with binding 
site densities of 50-80 pinol/mg protein (Ferry & 
Glossmann, 1982a) . The drug receptor sites are located on 
the transverse tubule membranes (Fosset et al., 1983; 
Glosmann et al., 1983). 
After detergent solubilisation and purification, the 
skeletal muscle calcium antagonist receptor was shown to 
be composed of 5 subunits; a, a2, 	, . This has been 
shown to be a functional calcium channel by 
reconstituting the purified calcium antagonist receptor 
into phophatidylcholine vesicles and measuring uptake of 
45Ca2 or 133Ba2 . In the presence of the dihydropyridine 
(+)-PN200-110 and phenylalkylamine verapamil, uptake was 
blocked and Bay K 8644, (a dihydropyridine agonist), 
increased channel activity (Curtis & Catterall, 1986) 
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The a subunit has an apparent molecular mass of 
155-200 kDa (under reducing and non-reducing SDS PAGE 
conditions) and binds monoclonal and polyclonal 
antibodies that do not recognise the a.2 subunit 
(Takahashi et al., 1987; Sharp et al., 1987). 
Photoaffinity labelling with [3H] azidopine (a DHP) and 
[3H] LU 49888, (an analog of D888) , indicate that the al  
subunit contains the receptor sites for dihydropyridines 
and phenylalkylamines (Ferry et al., 1984b,1986; 
Striessnig et al., 1986a,1987; Vaghy et al., 1987) . The 
subunit has N-glycosylation sites but little or no 
carbohydrate attached and a hydrophobic affinity probe 
indicates that it has multiple transmembrane segments 
(Tanabe et al., 1987; Takahashi et al., 1987; Sharp et 
al., 1987) . The a1 subunit is thought to be the main 
functional subunit of the dihydropyridine sensitive L-
type channel and may act as both the voltage-activated 
calcium channel and the voltage sensor (Tanabe et al., 
1987; Agnew, 1987) 
The a2 subunit has an apparent molecular mass of 
135-150 kDa after reduction of disulfide bonds. It 
appears to be glycosylated (Leung et al., 1987) and has 
no significant transmembrane hydrophobic domains. The 
subunit is linked to a glycoprotein of molecular mass 24-
29 kDa called the 5 subunit, which increases the apparent 
size of the a2 subunit to 175 kDa when disulfide bonds 
are intact. Since the a25 complex is heavily glycosylated 
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and has few transmembrane segments, it may be exposed at 
the extracellular surface. 
The j3 and y subunits are peripherally associated 
with the a1 subunit. The 3 subunit is neither 
glycosylated, nor labelled by hydrophobic probes 
(Takahashi et al., 1987) and so may be attached to the 
intracellular surface of the calcium channel complex. The 
subunit is both labelled by hydrophobic probes and is 
glycosylated and so may be a intracellular and/or 
extracellular component of the channel. Fig.1.4. shows a 
model of dihydropyridine sensitive calcium channel 
subunit structure as proposed by Takahashi et al., 
(1987) 
Despite the fact that the a1 subunit contains much 
of the functional actvity of the channel, the other 
subunits do appear to be a vital part of the calcium 
channel complex, although this has been questioned. One 
piece of evidence that all the subunits are needed for a 
functional channel is shown by attempts to break the non-
covalent bonds that hold the subunits together. If 
broken, reversible dihydropyridine binding is lost, which 
suggests that the non-a1 components stabilise the channel 
in a high affinity conformation. 
The a1 subunit from rabbit skeletal calcium channels 
has been cloned (Tanabe et al., 1987) and has some 
homology with the voltage-dependent sodium channel. In 
particular there is homology between transmembrane 
segments which are thought to play an important role in 
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Fig.1.4. Model of the subunit structure of the voltage-
dependent L-type calcium channel (after 
Takahashi et al., 1987). 
The model shows the proposed structure of the voltage-
dependent (dihydropyridine-sensitive) calcium channel 
from rabbit transverse tubule membranes. P indicates the 
sites of cAMP-dependent phosphorylation. and vindicate 
sites of glycosylation. SS denotes the disulphide bonds 
linking 5 to a2. 
ion transport and voltage-dependent gating in the sodium 
channel. These regions are highly conserved in the 
calcium channel structure, suggesting that the a, subunit 
is important in ion transfer and voltage sensing. Also 
seen are regions resembling parts of calcium binding 
proteins, which fits in with electrophysiological and 
biochemical data postulating two divalent cation binding 
sites within the channel pore (Hess & Tsien, 1984) 
1.14. Regulation of voltage-dependent calcium channels. 
Voltage-dependent calcium channels are thought to be 
regulated by neurotransmitter-mediated phosphorylation 
and dephosphorylation events. Electrophysiological and 
45ca2+ studies have shown that cAMP and cAMP dependent 
protein kinase can influence the opening of calcium 
channels in cardiac and skeletal muscle (Schmid et al., 
1985; Flockerzi et al., 1986a,b). Regulation of the 
dihydropyridine sensitive channel by cAMP-dependent 
phosphorylation may involve phosphorylation of the 
calcium channel itself or associated proteins which 
regulate channel activity. Experimental evidence suggests 
that two components of the channel itself i.e. the al and 
subunits are sites of cAMP-dependent phosphorylation 
(Curtis & Catterall, 1985; Irnagawa et al., 1986). Other 
studies have shown that the a, subunit in skeletal muscle 
is the major substrate for cAMP-dependent protein kinases 
(Hosey et al., 1986,1987; Takahashi et al., 1987) and 
calcium/calmodulin-dependent protein kinase. Evidence 
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suggests that the a subunit appears to be multiply 
phosphorylated at distinct sites by both kinases 
(O'Callahan, 1988) . Therefore as well as being capable of 
forming an ion channel and acting as a voltage sensor, 
the a1 subunit also contains sites necessary for 
neurotransmitter regulation via phosphorylation. Other 
studies have suggested that calcium channels may be 
regulated by phosphorylation of the 3 subunit by protein 
kinase C (Nastainczyk et al., 1987; Galizzi et al., 
1987) 
Electrophysiological work indicates that G proteins 
can also modulate T,L and N-type channel function in 
neuronal cells (Scott & Dolphin, 1987; Hescheler eta1., 
1987). G-proteins and their subunits are also thought to 
regulate L-type channels in muscle by mediating 
neurotransmitter and hormone action (Yatani et al., 
1987) . However these observations have not been confirmed 
using purified calcium channel preparations. 
1.15. Calcium channels in plants. 
If plant cells are to use calcium ions as a second 
messenger, the entry of these ions into the cell needs to 
be rapid and regulated. The plasma membrane is fairly 
impermeable to calcium and so movement of calcium ions 
into the cell is slow. To take advantage of the steep 
electrochemical gradient that exists for calcium suggests 
that plant cells have calcium channels as these would 
allow the controlled but fast entry of calcium ions into 
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the cell. This would cause a rise in cytosolic calcium 
which could then act as a signal. However, evidence for 
the existence of calcium channels in plant membranes is 
limited. - 
Various pieces of experimental evidence point to the 
existence of calcium channels in plants. Chioroplast 
movement in the alga Mougeotia is a light-dependent, 
calcium-mediated response, which occurs fairly rapidly. 
The speed of the response may be explained by calcium 
channels which would allow rapid inflow of ions to 
initiate chioroplast movement (Wagner et al., 1984) . This 
suggestion has been supported by electrophysiological 
experiments with Chara, that indicate a calcium action 
potential-dependent increase of cytoplasmic calcium which 
inhibits cytoplasmic streaming (Hayama et al., 1979; 
Williamson & Ashley, 1982; Kikuyama & Tazawa, 1983) 
Electrophysiological studies on growing rhizoid 
cells of Fucus serratus also suggest the presence of 
calcium channels. Experiments on this system demonstrate 
the presence of a longitudinal gradient of cytosolic 
calcium in the rhizoid cell, which appears to be 
maintained by preferential calcium influx in the region 
of the growing tip (Brownlee & Wood, 1986). From this 
work it was postulated that the calcium influx is via 
calcium channels and the gradient the influx supports may 
be involved in cell polarity. 
Data from experiments using 45Ca2+  flux measurements 
also point to the presence of voltage controlled calcium 
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channels in plant membranes. Results from such 
experiments indicated that influx of 45Ca2+ into non-
growing corn root tissue was increased as a result of 
actions such as cutting, chilling and heating or 
chemicals such as cyanide, which are known to depolarise 
the cell membrane. Calcium flux was decreased by actions 
such as washing or chemicals such as fussicoccin which 
hyperpolarise the membrane. (Rincon & Hanson, 1986) 
Other studies using calcium antagonists also suggest 
that calcium channels exist in plant cells. As already 
mentioned, labelled antagonists such as nifedipine and 
verapamil, have been used to identify binding sites in 
various animal tissues, so indicating the presence of a 
calcium channel (Glossmann et al., 1982; Galizzi et al., 
1984a,b) . The same approach has been used for various 
plant tissues. Hetherington & Trewavas (1984) 
demonstrated [3H] nitrendipine binding to pea shoot 
membranes and Andrejauskas et al. (1985) have 
demonstrated specific binding of [3H] verapamil to 
zucchini membranes. More recently specific binding of 
[3H] verapamil to membrane fractions of Chlarnydomonas 
reinhardtjj has been identified (Dolle & Nultsch, 1988) 
Polar growth of lily pollen tubes has been shown to 
be affected by nifedipine, causing irregular growth 
patterns, which suggests the presence of nifedipine 
sensitive calcium channels in pollen tubes (Reiss & 
Herth, 1985) . Similarly verapamil and Lad 2 have been 
found to effect inorphogenesis in Micrasterias (Lehtonen, 
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1984) and calcium antagonists have also been shown to 
block cytokinin induced bud formation in Funaria 
(Saunders & Hepler, 1983) 
Although plant membranes have binding sites for 
antagonists and cell functions known to be mediated by 
calcium are effected by antagonists, it has only recently 
been demonstrated that calcium antagonists can block 
calcium entry into a plant cell (Graziana et al., 1987). 
In these experiments 45Ca2+  uptake into carrot 
protoplasts in the presence of calcium channel inhibitors 
was studied. The results indicated that antagonists of 
the phenylalkylamine and diphenylbutylpiperidine series, 
as well as bepridil, could inhibit 45Ca2 flux into 
carrot protoplasts. The dihydropyridines did not have an 
inhibitory effect and specific binding sites for the 
dihydropyridine [3H] (+)PN 200-110 could not be 
identified. A high density of [3H)(-)D888 binding sites 
were found. The results from this work strongly suggest 
that the D888 binding site does represent the calcium 
channel in plant membranes and provides further evidence 
for the existence of calcium channels in plant cells. 
1.16. Summary. 
Calcium channels appear to be present in plant 
membranes. Apart from knowledge of their possible 
existence, very little else is known about them in 
plants. Up until now there have been no reported attempts 
to purify the plant calcium channel and so nothing about 
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its stucture has been elucidated. Any similarities 
between plant and animal channels in terms of structure, 
have so far been speculative, but it is known that the 
protein structures of antagonist receptors in plant and 
animal membranes must have some differences, as 
monoclonal and polyclonal antibodies (Schmid et al., 
1986a,b; Vandaele et al., 1987; Cooper et al., 1987), 
developed for dihydropyridine and phenylalkylamine 
receptors in skeletal muscle, do not cross react with 
plant membranes (personal communication from M. 
Lazdunski) 
In order to increase our understanding of calcium 
channels in plant cells and to obtain some information 
about the stucture and possible regulation of plant 
calcium channels, an investigation was carried out using 
the channel antagonist [3H] verapamil. Binding studies 
were performed and a method developed to solubilise and 
partially purify the veraparnil binding protein, (and 
possibly therefore the whole calcium channel) , from maize 
coleoptile membranes. The following sections of this 
thesis presents the results of this investigation. 
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CHAPTER 2. 
MATERIALS AND METHODS. 
2.1. Plant material. 
Maize seeds, (Zea mays cv. Leader) , were a generous 
gift from the National Institute of Agricultural Botany, 
Cambridge, U.K. Zucchini seeds, (Cucurbita pepo) were a 
kind gift from Dr. M.A.Venis. All seeds were stored in 
the dark at 200C until required for use. 
2.2. Radiochemicals. 
[N-methyl-3H] verapamil hydrochloride, with a 
specific activity of 68.8 Ci/mmol was obtained from New 
England Nuclear, Boston, Massachusetts, U.S.A. (-)-[N-
methyl-3H] desmethoxyverapamil hydrochloride, with a 
specific activity of 85 Ci/mmol, was obtained from 
Amersham International Plc, Amersham, Buckinghamshire, 
U.K. (3H] LU 49888 (Azidopainil) , with a specifc activity 
of 79.65 Ci/mmol, was a generous gift from Knoll AG, West 
Germany. ['-32P] Adenosine triphosphate was obtained from 
Amersham International Plc at a specific activity of 4995 
Ci/mmol. 45Calc±um chloride in aqueous solution with a 
specific activity of 10-40 mCi/mg calcium, was obtained 
from Amersham International Plc. All radiochernicals were 
stored at -200C. 
2.3. Chemicals. 
Unlabelled (+) or (-)-verapamil hydrochloride was 
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obtained from Sigma, Poole, Dorset. Unlabelled (-)-
desmethoxyverapamil hydrochloride was from Amersharn 
International Plc. Unlabelled methoxyverapamil was a 
generous gift from Dr. M.A. Venis. Nifedipine was 
obtained from Bayer U.K. Haywards Heath, Sussex. U.K. All 
other chemicals were of the higest grade available and 
were obtained from either Sigma, Poole, Dorset, U.K. or 
BDH Chemical Company, Poole, Dorset, U.K. 
2.4. Centrifuges. 
Superspeed-65 ultracentrifuge and Micro-Centaur 
microfuge were from MSE Scientific Instruments, Manor 
Royal, Crawley, U.K. The Sorvall RC-5B was from the Du 
Pont Company, Biomedical products division, Newton, 
Conneticut, U.S.A. 
2.5. Liquid Scintillation Counting. 
The scintillation counter was a Kontron 
Intertechnique from Kontron Instruments Ltd, 
Hertfordshire, U.K. Scintilation fluid for aqueous 
samples was prepared from Toluene UL), Triton x-100 
(O.SL), Butyl-PBD (7g). Scintillation fluid for non-
aqueous samples was prepared from Toluene (1L) and Butyl-
PBD (4g). 
2.6. pH Meter. 
The pH meter, EIL model 7010 was from Mackay and 
Lynn Ltd, Edinburgh, U.K. 
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2.7. Preparation of Plant Tissue. 
Maize seeds were first washed to remove fungicide 
and then imbibed in fresh water for two three hours. The 
seeds were then sown in trays of moist vermiculite and 
allowed to grow in the dark at 250C. After 5 days the 
coleoptiles, including the leaf rolls, (unless indicated 
otherwise), were harvested and collected on ice. When 
maize root tissue was required, maize seeds were sown on 
wet tissue and grown under the same conditions. Roots 
were harvested after 5 days. Zucchini seeds were grown in 
vermiculite as above and the hypocotyls harvested after 5 
days. 
2.8. Preparation of Crude Membrane Fractions. 
All preparative procedures were carried out at 40C, 
unless stated otherwise. Freshly harvested tissue was 
chopped with a razor blade on a perspex sheet and then 
homogenised in 2 ml per gram fresh weight of 50 mM Tris, 
3 mM EDTA buffer, pH 7.5 with HC1, in a pestle and 
mortar. The homogenate was then filtered through one 
layer of nylon cloth (pore size 100 inn) and the resulting 
suspension centrifuged at 4000 g for 20 min in a Sorvall 
SS 34 rotor using a Sorvall RC-5B centrifuge. The pellet 
was discarded and the supernatant re-centrifuged at 
50,000 g for 45 min as above. This yielded the crude 
membrane pellet which was resuspended in 50 mM Tris, 50 
mM Mops buffer, pH 7.5 with HC1, using a glass-Teflon 
homogeniser. The resuspension was termed as the the crude 
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membrane fraction or preparation. 
2.9. Solubilisation of the Crude Membrane Fractions. 
The crude membrane preparations was solubilised in a 
solubilisation buffer containing 50 mM Tris, 50 mM Mops, 
pH 7.5 with HC1, ± 20% sucrose or glycerol, plus varying 
concentrations of one of the following detergents:-
CHAPS, octyl glucoside and Triton x-100. After a 30 mm 
incubation at 40C, the mixture was centrifuged at 
100,000g for 1 hour in a MSE Superspeed-65 
ultracentrifuge, using a 10 x 10mLMSE aluminium fixed 
angle rotor. The resulting supernatant contained the 
solubilised proteins. 
In the final solubilisation procedure the crude 
membrane preparation was incubated at a protein:detergent 
ratio of 1:14 (w/w) in 0.5% CHAPS, 20% sucrose, 50 mM 
Tris, 50 mM Mops buffer, pH 7.5 with HC1, for 30 min at 
40C and then centrifuged for 1 hour at 100,000 g as 
above. The solubilised crude membrane was termed as the 
solubilised membrane fraction or CHAPS extract. 
2.10. Phase Partitioning of Crude Membrane. 
The method employed for plasma membrane isolation 
was based on that by Yoshida et al. (1983). Crude 
membrane was prepared as described previously and the 
crude membrane pellet resuspended in +NaC1 buffer 
containing 0.5 M sorbitol, 15 mM Tris/maleate, 30 mM 
NaCl, pH 7.3 with KOH. Aliquots (500 il) of the 
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resuspension were layered onto polyethyleneglycol/Dextran 
phases to produce 4g phases with a final composition of 
5.6% (w/w) each of polyethyleneglycoi (approximate 
molecular weight of 3,350 Da) and Dextran (average 
molecular weight of 472,000 Da) in +NaC1 buffer.The 
phases were mixed thoroughly by 30 inversions and left to 
settle for 30 min at 0°C. Brief centrifugation in a bench 
centrifuge was used to aid phase separation. Upper and 
lower phases were separated and diluted with 30 ml of 
-NaCl buffer, containing 0.5 M sorbitol, 15 mM 
Tris/maleate, pH 7.3 with KOH and centrifuged at 50,000 g 
for 1 hour in a Sorvall SS 34 rotor using a Sorvall RC-5B 
centrifuge. The resulting upper phase pellet is referred 
to as the plasma membrane enriched fraction and the lower 
phase as the residual membrane fraction. 
2.11. Verapamil Binding Assays. 
2.11.1. Centrifugatiuu MeLhod. 
[3H] verapamil was added to the crude membrane 
resuspension (approximately 0.4 mg protein/i ml) , to give 
a final concentration of 0.3 nFl. The resuspension was 
then divided into 1 ml cellulose acetate butyrate tubes, 
(Sorvall, Du Pont Biomedical Division, Newtown, 
Conneticut U.S.A.), which contained unlabelled verapamil 
at a range of concentrations. To determine total binding 
of [3H] verapamil, membrane resuspension was added to a 
tube containing an equivalent volume of distilled H20 or 
methanol. The solutions were then incubated for 2 hours 
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at 200C. The resuspensions were then centrifuged at 
50,000 g for 30 min in Sorvall 1 ml tube adaptors in a 
Sorvall SS 34 rotor using a Sorvall RC-5B centrifuge. The 
supernatants were decanted and the tubes left to drain. 
The pellets were then washed carefully with distilled 
H20, left to drain and any adhering drops of liquid 
blotted with tissue. Bound radioactivity in the pellet 
was then recovered by resuspending the pellets in a total 
volume of 1.3 ml of distilled H20. The resuspension was 
placed in scintillation vials with 10 ml of aqueous 
scintillation fluid and counted in a scintillation 
counter. Non-specific binding was determined by 
incubating parallel samples with 100 jiM unlabelled 
verapamil. The value obtained from these samples was 
subtracted from the total binding to give the specific 
binding of (3H) verapamil. 
2.11.2. Filter Method. 
In the final assay, referred to as the standard 
filter assay, [3H] verapamil was added to the crude 
membrane resuspension (0.5 mg/500 jil), solubilised 
membrane fraction (0.5-1.0 mg/500 jil) or column fraction 
to give a final concentration of 2.24 nM. Unlabelled 
verapamil or other compounds, at a range of 
concentrations, were then added to the final assay volume 
of 500 iii, as indicated in the figure legends. After 
incubation for 120 min at 200C, the reaction was stopped 
by the addition of 3 ml of ice-cold wash buffer 
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containing 10% PEG 8000, 50 mM Tris, at pH 7.5 with HC1. 
The mixture was immediately filtered under vacuum through 
a GF/C filter (Whatman, Maidstone, Kent, U.K.), using a 
Millipore multifilter unit (Millipore, Bedford, Mass. 
U.S.A.). When solubilised fractions were assayed the 
filters were pre-treated with 0.3% polyethyleneiinine 
(PEI) solution for at least 2 hours before use (Bruns et 
al., 1983). The filters were then washed once with 3 ml 
of ice-cold wash buffer to remove any unbound label. The 
radioactivity retained on the filter was determined by 
liquid scintillation counting in 5 ml of aqueous 
scintillant for 10 min using a liquid scintillation 
counter. As described previously, non-specific binding 
was determined by incubating parallel samples with 100 .mM 
unlabelled verapamil and was subtracted from total 
binding, (obtained from assays containing [3H] verapamil 
only) , to give the specific binding of [3H] verapamil. 
All assays were carried out in duplicate or triplicate 
and the results expressed as an average for each set of 
replicates. This assay method was also used in binding 
studies with [3H] desmethoxyverapamil. 
2.12. [3H] LU 49888 Binding Assay. 
In the standard binding assay, [3H] LU 49888 was 
added to the crude membrane resuspension to give a final 
concentration between 0.1 aM - 18 nM as indicated in the 
figure legends. Unlabelled desmethoxyverapamil was added 
to an assay volume of 500 i.i1 to give a final 
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concentration of 100 pM. Total binding was determined in 
parallel samples containing labelled antagonist only. 
After incubation for 120 min at 200C in the dark, the 
reaction was stopped by addition of ice-cold wash buffer 
as before and bound radioactivity determined by the 
standard filter assay. 
2.13. Column Chromatography. 
All chromatography columns were prepared at 40C and 
packed according to the manufacturers'  recommended 
instructions. Unless indicated all column chromatography 
was carried out at 40C. Where appropriate, fractions were 
collected using a 2070 Ultrorac 2 fraction collector (LKB 
instruments Ltd, Croydon, Surrey, U.K.). A single path 
UV-1 column monitor (Pharmacia) , was also used in some of 
the column chromatography experiments. The following 
table (Table 2.1.), outlines the columns and column 
matrices used, plus their suppliers. 
The standard column buffer, used for all the column 
chromatography experiments, contained 50 mM Tris, 50 mM 
Mops, 0.1% CHAPS, 20% Sucrose, pH 7.5 with HC1, unless 
stated otherwise. 
[3H] verapainil binding in each column fraction was 
determined using the standard filter assay. 
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Method. 	 Matrix. 	Column support. 
Anion exchange. 	DEAE 	 Pharmacia K9 
Bio-Gel A)- 	I.D. 9 mm. Length 15 cm 
Sephacryl 	Bio-Rad Econocolumn 








I.D. 10 mm. Length 10 cm 
CL-4B.3  





Table 2.1. Chromatographic materials. 
Column matrices and column supports were supplied by 
either:- 1. Bio-Rad, Watford, Herts, UK. 
Pharmacia, Milton Keynes, Bucks, UK. 
Sigma Chemical Company, Poole, Dorset, UK. 
2.14. DEAE Ion Exchange Chromatography. 
2.14.1. Linear NaC1 gradient elution. 
A 4 x 1 cm DEAE Bio-Gel A column was prepared and 
equilibrated with at least 10 bed volumes of column 
buffer. The bed volume of the column, determined using 
rir2h, was 3.14 ml. Approximately 10 ml of the solubilised 
membrane fraction, from approximately 50-100 g fresh 
weight of tissue, was loaded onto the pre-equilibrated 
column. After loading was complete, the column was washed 
with 10 ml of column buffer. The veraparnil binding 
activity was then eluted using a linear gradient of 
0-0.5 M NaCl in column buffer. The gradient was formed in 
gradient maker, (Botny Dept, Workshop). 2 ml fractions 
were collected, at a flow rate of 1 ml/1.5 min and 
assayed for (3HJ verapamil binding. In a parallel 
experiment the elution gradient was applied to the DEAE 
column alone. 2 ml fractions were collected, placed in 
aluminium coated cuvettes, (Bio-Rad, Watford , Herts, 
U.K.), and a conductivity reading taken for each fraction 
using a M-102BZ conductivity meter, (Maplin electronic 
supplies, Rayleigh, Essex, U.K.). Conductivity readings 
were also taken for samples containing 0.1 M, 0.2 H, 0.4 
H & 0.5 H NaCl only. 
2.14.2. Step NaC1 gradient elution. 
A 4 x 1 cm DEAE Bio-Gel A column was prepared as 
described previously. Approximately 10 ml of solubilised 
membrane fraction was loaded onto the column and the 
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column then washed with 10 ml of column buffer. The 
verapamil binding activity was eluted from the column 
using 10 ml of 0.1 M and 10 ml of 0.2M NaCl in column 
buffer. Fractions of 1 ml were collected and assayed for 
[3H] verapamil binding. 
2.14.3. Final DEAE elution protocol. 
In the final purification procedure, the DEAE ion 
exchange step was carried out as follows. Solubilised 
membrane fraction from approximately 100 g fresh weight 
of tissue was loaded onto a 4 x 1 cm DEAE Bio-Gel A 
column, which had been pre-equilibrated with column 
buffer. The ratio of sample to matrix was 5:1 (v/v). 
After loading the sample, the column was washed with an 
equal volume of column buffer. Elution with 0.15 M in 
column buffer yielded the verapamil binding activity in 
the first 8 ml of the eluate . This was collected, 
aliquots assayed directly for verapamil binding and the 
eluate then quick-frozen in liquid nitrogen and stored at 
-800C until required for further purification. A fresh 
DEAE column was prepared at the start of each new 
purification procedure. 
2.15. Gel Filtration Chromatography. 
2.15.1. Sephacryl S300 column. 
A Sephacryl S300 column, (fractionation range 1 x 
104 - 1.5 x 106  Daltons) , was prepared and equilibrated 
with 5 bed volumes of column buffer. The bed volume of 
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the column, determined using nr2h, was 9.62 ml. 0.5 ml of 
peak DEAE fraction was then loaded onto the column and 
eluted with column buffer. 1 ml fractions were collected, 
at a flow rate of 1 ml/min. Each fraction was assayed for 
[3H] veraparnil binding using the standard filter assay. 
The effects of including 0.2 M NaCl, 1.0 M NaCl or 1 mM 
DTT in the column buffer were also investigated. 
The void volume of the column was determined 
separately using Blue Dextran 2000 monitored at A280  
using a UV Spectrophotometer (Pye Unicarn, Cambridge, 
U.K.). 
2.15.2.. Sephacryl S400 column. 
In the final purification procedure a Sephacryl S400 
column, (fractionation range 2 x iO - 8 x 106) , with a 
bed volume of 38.8 ml, was prepared and equilibrated with 
column buffer at a flow rate of 0.5 ml/min. 2 ml of 
pooled peak verapamil binding fraction from the DEAE 
column, was loaded onto the wet bed surface of the column 
and eluted with column buffer. Fractions of 1 ml were 
collected and aliquots assayed for verapamil binding 
activity. Fractions with the highest binding activity 
were pooled prior to further purification. As above, the 
void volume of the column was determined using Blue 
Dextran 2000. 
At the end of each column run, the S300 or S400 
columns were washed with 2 bed volumes of column buffer 
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and the column then stored in 0.02% sodium azide until 
required. 
2.16. Hydrophobic Interaction Chromatography. 
2.16.1. Phenyl Sepharose column buffers. 
Three main buffers, plus variations of these, were 
used in a series of experiments in order to find the 
optimum phenyl Sepharose column elution protocol; 
Low salt Buffer. 50 mM Tris, 50 mM Mops, 20% sucrose, 
0.1% CHAPS, 0.1 mM CaC12, pH 7.5 with 
HC1. 
High Salt Buffer. 50 mM Tris, 50 mM Mops, 20% sucrose, 
0.1% CHAPS, 1 M (NH4)2S04
1 
0.1 mM 
CaC12, pH 7.5 with HC1. 
Low Detergent/Sucrose Buffer. 
50 mM Tris, 50 mM Mops, 8.5% (0.25 M) 
sucrose,0.01% CHAPS, 0.1 mM CaC12, 
1 M (NH4)2SO4, pH 7.5 with HCl. 
2.16.2. Phenyl Sepharose column elution protocol. Basic 
Method. 
A 4 x 1 cm phenyl Sepharose C1-4B column, connected 
to a UV.1 column monitor, was prepared and equilibrated 
with 10 bed volumes of one of the three basic buffers. 
Approximately 4 ml of pooled peak verapamil binding 
fractions from the DEAE column were either adjusted to 
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1 M (NH4)2SO4 and 1 mM CaC12 or 1 mM Cad 2 only and 
loaded onto the column. The column was then washed with 
the same equilibration buffer, until the A280 trace 
returned near to baseline. After washing, the column was 
eluted by the removal of salt, calcium or Tris/Mops from 
one of the three basic buffers, as indicated in the 
figures. The A280 trace was allowed to return near to 
baseline in between subsequent elution steps. Fractions 
of 4 ml were collected and 2 ml was assayed for [3H] 
verapainil binding activity using the standard filter 
assay. 
Using this basic method a number of elution 
protocols were experimented with in order to find the 
optimum elution procedure for the phenyl Sepharose 
column. The details of the different protocols are shown 
in Table 2.2. 
2.16.3. Final phenyl Sepharose column elution protocol. 
In the final purification procedure, pooled peak 
verapamil binding fractions from the Sephacryl S400 
column were adjusted to 1 M (NH4)2SO4, 1 mM CaCl2. These 
were then loaded onto a 2 x 1 cm column of phenyl 
Sepharose CL-4B which had been equilibrated with 10 bed 
volumes of high salt buffer. After washing the column 
with up to 18 ml of high salt buffer, the column was 
eluted with 18 ml each of the following series of 
buffers: low salt buffer, low calcium buffer and minus 
Tris/Mops buffer. Fractions of 2 ml were collected and 
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PROTOCOL SA?Fft COLUMN LOAD & ELUTION STEPS. 
MJER. ADJUSTMENT. WASH CONDITIONS. 
1. 2. 3. 4. 5.  
 1 mM CaC12 Low salt Low Ca Minus Tris/Mcps Minus Ca2 H20 - 
 1 mM CaC12 
High salt Low salt Low Ca2 Minus Iris/Mops Minus Ca2 H20 
1M (NH4 ) 2504 
 1 mM CaC12 
Low detergent! Low salt Minus Iris/Mops Minus Iris/Mops - - 
Low sucrose (low detergent/sucrose) (high detergent/sucrose) 
1 m (NH4 ) 2504 
 1 mM CaC12  
High salt Low salt Minus Iris/Mops Minus Iris/Mops - - 
1 M (NH4 ) 2SO4 (low detergent/sucrose) (high detergent/sucrose) 
 1 mM CaCl2 High salt Low salt Low Ca2 Minus Iris/Mops - - 
1 M 	)NH4 ) 7504 
Table.2.2. Phenyl Sepharose column elution protocols. 
the first four 2 ml fractions of each elution step were 
assayed for [3H] verapamil binding. 
2.17. Lectin Affinity Chromatography. 
2.17.1. Con-A Sepharose elution protocol. 
Approximately 1 ml of solubilised membrane fraction 
was applied to 300 p1 of Con-A Sepharose contained in an 
eppendorf tube. The Con-A had previously been washed with 
5 ml of Con-A column buffer containing 0.02 H Tris-HC1, 
0.5 H NaCl, 0.5 mM CaCl2,  0.5 mM MnC12, 0.19g CHAPS, 20% 
sucrose, pH 7.5. The Con-A plus the sample were then 
incubated for 2 hours at 40C and then centrifuged at 
11,600 g for 5 mm. The supernatant, referred to as the 
load supernatant (LSN) was removed and assayed for £3HJ 
verapamil binding. The Con-A was then washed three times 
with 1 ml of Con-A column buffer and centrifuged after 
each wash. The wash supernatants (WSN) were pooled and 
assayed for E3H] verapamil binding. The Con-A was then 
sequentially eluted with with 1 ml each of 0.1 M, 0.2 M, 
0.3 H, 0.4 M and 0.5 M -methyl mnannoside in Con-A column 
buffer. Each concentration of elution buffer was applied 
to the Con-A in turn and the mixture then centrifuged. 
The supernatants from each elution step (ESN) were 
assayed for [3H] verapamil binding. The standard filter 
assay for [3H] verapamil binding was used throughout. 
2.17.2. Wheat Germ Agarose column elution protocol. 
Approximately 1 ml of solubilised membrane fraction 
was applied to 300 i.il of wheat germ agarose (WGA) 
contained in an eppendorf tube. The WGA had previously 
been equilibrated with 5 ml of standard column buffer. 
The WGA plus the sample were then incubated for 2 hours 
at 40C and then centrifuged at 11,600 g for 5 mm. The 
LSN was then assayed for [3H] verapamil binding. The WGA 
was then washed with standard column buffer as described 
above and the pooled WSN assayed for [3H] verapamil 
binding. Elution of the WGA was carried out using 1 ml of 
100 mM n-acetyl-D-glucosamine in standard column buffer. 
This was applied to the WGA and the mixture then 
centrifuged as before. The ESN was assayed for [ii] 
verapamil binding. The standard filter assay for [3H] 
verapamil binding was used throughout. 
2..18. SDS Polyacrylamide Gel Electrophoresis. 
2.18.1. Equipment. 
Sodium-dodecyl--sulphate (SDS) polyacrylamide gel 
electrophoresis was carried out using vertical slab gels. 
Electrophoresis equipment was obtained from the Botany 
Dept. workshop or Dual vertical slab gel electrophoresis 
equipment from Bio-Rad, Watford, Herts, U.K. was 
employed. The Mighty Small vertical slab gel unit was 
obtained from Hoeffer Scientific instruments, San 
Francisco, California, U.S.A.. 
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2.18.2. Gel Preparation. 
Slab gels with dimensions of 16 x 16 cm or 8 x 6 cm 
and 1.5 mm thickness, were prepared from stock solutions 
which were made up as follows: 
30% Acrylamide solution: 29.2% (w/v) acrylamide, 0.8% 
(w/v) bis-acrylamide. Stored at 40C. 
Resolving gel buffer (RGBx4) : 1.5 M Tris-HC1 pH 8.8, 0.4% 
SDS. Stored at 40C. 
Stacking gel buffer (SGBx4): 0.5 M Tris-HCL pH 6.8, 0.4% 
SDS. Stored at 40C. 
10% AMPS. Stored at 40C and made up fresh for each gel. 
TEMED, obtained from Sigma, Poole, Dorset. 
The stacking gel contained 5% (w/v) acrylamide, 
0.13% (w/v) bis-acrylamide, 125 mM Tris-HC1 pH 6.8, 0.1% 
(w/v) SDS. This was degassed under vacuum and then 0.03% 
(w/v) AMPS and 0.1% (v/v) TEMED were added to polymerise 
the gel. 
The resolving gel contained 12% (w/v) acrylamide, 
0.32% (w/v) bis-acrylamide, 375 mM Tris-HC1 pH 8.8, 0.1% 
(w/v) SDS, degassed under vacuum and then 0.015% (w/v) 
AMPS and 0.05% (v/v) TEMED were added to polymerise the 
gel. Where necessary, volumes were adjusted to create 
resolving gels containing 10% or 7% acrylamide. 
2.18.3. Sample Preparation. 
Samples for SDS-PAGE were denatured in an equal 
volume of sample buffer containing 4.7 % (w/v) SDS, 10% 
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(v/v) 2-Mercaptoethanol, 20% (w/v) glycerol, 125 mM Tris 
pH 6.8. Brornophenol blue (0.02%) at 15 p.1/100l sample 
was added as a tracking dye. The samples were then heated 
in a Tecarn DB-3 dri-block (Techne, Cambridge, U.K.), for 
10 min at 1000C and allowed to cool. The samples of 100 
1.11 were loaded into the gel slots using a Hamilton 
syringe. 
Phenyl Sepharose fractions were concentrated using a 
Speed-Vac centrifugal evaporator (Hicksville, New York, 
U.S.A.), before samples for gel electrophoresis were 
prepared. This was done because the amount of protein in 
column fractions from the phenyl Sepharose column was 
very low and could not be detected on a gel by silver 
staining, unless concentrated first. 
2.18.4. Running Conditions. 
The gels were run at 200C in electrode buffer 
containing 25 mM Tris, 192 iriM glycine, 0.1% (w/v) SDS, at 
300 Volts, 20 mA (constant current) for large gels or 150 
Volts, 18 mA (constant current) for Mighty Small gels. 
2.18.5. Molecular Weight Markers. 
Myosin (205 kDa) , B-galactosidase (116 kDa) 
Phosphorylase B (97.4 kDa), Bovine Serum Albumin (66 
kDa), Ovalbumin (45 kDa) and Carbonic Anhydrase (29 kDa) 
were used as molecular weight markers. All markers were 
obtained from Sigma, Poole, Dorset, U.K.. A stock 
solution containing the molecular weight markers at 1-2 
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mg/ml, plus an equal volume of sample buffer and 
Bromophenol blue was prepared as described previously. 
When required approximately 10 '.il of the stock was 
diluted 1:1 with sample buffer, heated at 1000C for 10 
mm, allowed to cool and then loaded into the gel slots 
as before. 
2.19. Visualisation of proteins in polyacrylamide gels. 
2.19.1. Coomassie blue staining. 
Polyacrylamide gels were fixed and stained for 30 
min in 0.2% (w/v) Coomassie Brilliant Blue R in 50% (v/v) 
methanol and 7% (v/v) acetic acid. The gel was then 
destained in 25% (v/v) ethanol, 8% (v/v) acetic acid for 
1 hour. Background staining was removed by an overnight 
wash in storage solution containing 5% (v/v) methanol, 7% 
(v/v) acetic acid. Gels were then dried down under vacu;m 
and mild heat onto Whatmann 3MM chromatography paper. 
2.19.2. Silver Staining. 
Silver staining was carried out essentially 
according to the method of Morrisey (1981), using a 
silver staining kit from Sigma, Poole, Dorset, U.K.. 
Deionised distilled water (d.d.H20) was used for all 
silver staining solutions. After electrophoresis the gel 
was fixed in 3 stages. 1. 50% (v/v) methanol, 10% (v/v) 
acetic acid for 30 mm, followed by, 2. 30 min in 5% 
(v/v) methanol, 7% (v/v) acetic acid followed by, 3. 10% 
(v/v) glutaraidehyde for 30 mm. The gel was then washed 
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in several changes of d.d.H20 over a period of 2 hours, 
followed by a 30 min wash in 5 1g/in]. DTT. The gel was 
then transferred to the silver equilibration solution and 
gently agitated for 30 mm, followed a rapid wash in 
d.d.H20. The water was then replaced by developer 
solution for 5-8 min and left until the bands began to 
appear on the gel. After sufficient development time, (5 
mm), the developer solution was replaced by a stop 
solution of 1% (v/v) acetic acid. The gel was then rinsed 
3 times for 10 min each time with a large volume of 
d.d.H20. If necessary, reducer solution was added to 
remove background staining. The gel was then left in 
d.d.H20 and a small amount of glycerol overnight and 
dried down as described previously. 
2.20. Photography. 
Gels were photographed using Kodak Technical Pan 
film 2415, (Eastman Kodak Company, Rochester, N.Y. 
U.S.A.). Films were developed in Kodak HC-110 developer 
for 5 mm, the development stopped in 1% acetic acid for 
2-3 min and the film then fixed for - 5-10 min in Ilford 
Mypam fixer (Ilford Ltd. Moberly, Cheshire, U.K.). Prints 
were made on Ilford Ilfospeed photographic paper No.3. 
and developed in Ilford Ilfospeed paper developer, the 
development stopped in 1% acetic acid for 1-2 min and the 
print then fixed in Ilford Hypam fixer and washed in 
running water for a few minutes. All the solutions were 
made up according to the manufacturers instructions. 
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2.21. Protein Determination. 
The method of Bearden, (1978) was employed to 
estimate protein content. Bearden reagent was prepared as 
follows. Coomassie Brilliant Blue G-250 was dissolved in 
85% (w/v) phosphoric acid at a concentration of of 1 
mg/ml and stirred for 1 hour. This was diluted 5 fold 
with d.H20 and filtered through Whatman filter paper to 
remove undissolved solids. The reagent was stored at room 
temperature in the dark. Assays contained 0.5 ml Bearden 
reagent plus 0.5 ml of a suitably diluted protein sample. 
Absorbance measurements were made at 595 nm using a Pye 
Unicam SP8-100 ultraviolet spectrophotometer (Cambridge 
U.K.). The amount of protein in the sample was determined 
by comparison to a calibration curve constructed using 
BSA as a standard. 
2.22. Protein Western Blotting. 
Proteins separated by SDS-PAGE were transferred to 
nitrocellulose (pore size 0.2 jim, Schleicher and Schull, 
Dassel, FRG), using a Bio-Rad Transblot cell (Bio-Rad, 
Watford, Herts, U.K.). The gel and nitrocellulose were 
equilibrated separately for at least 30 min in 200 ml of 
transfer buffer containing 25 mM Tris, 192 inN glycine, pH 
8.3, 20% (v/v) methanol. The equilibrated gel was then 
overlaid on the nitrocellulose, air bubbles were removed 
and the gel and nitrocellulose were then sandwiched 
between two pieces of Whatman 3MM filter paper which had 
54 
been pre-soaked in transfer buffer. This sandwich was 
then placed in between 2 sponges and 2 plastic grids and 
then inserted into the transfer cell containing transfer 
buffer. The proteins from the gel were then transferred 
to the nitrocellulose, with the nitrocellulose on the 
anode side of the gel, at 30 Volts, 0.1 mA at 200C, or 
200 mA, constant current when using the mini-blot system, 
(TE series transphor electrophoresis unit. Hoeffer 
Scientific Instruments, Biotech, Luton, Bedfordshire, 
U.K..) 
2.23. Visualisation of Proteins Blotted onto 
Nitrocellulose. 
Nitrocellulose blots were stained for less than a 
minute in 0.1% (w/v) Coomassie Brilliant Blue R, 50% 
(v/v) methanol and 10% (v/v) acetic acid and then 
destained in 50% (v/v) methanol and 10% (v/v) acetic acid 
until bands were visible. Background staining was removed 
by overnight washing in storage solution containing 5% 
(v/v) methanol, 7% (v/v) acetic acid. Blots were allowed 
to air dry. 
2.24. Binding of (3H] Verapamil to Proteins Immobilised 
on Nitrocellulose. 
The following procedures were carried out at 200C. 
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2.24.1. Method 1. 
The nitrocellulose blots were washed in 2 x 200 ml 
of incubation buffer (50 mM Tris, 50 mM Mops, pH 7.5 with 
HC1) , plus 0.05% Tween 20 (to site saturate the blot) 
for 20 mm. The blots were then placed in plastic bags 
with 10 ml of incubation buffer containing 2.5 nM [3H] 
verapamil. The bags were sealed and the blots left to 
incubate for at least 2 hours with agitation. The blots 
were then washed for 1 hour in 500 ml of incubation 
buffer. The blots were allowed to dry in a fume cupboard 
and then sprayed evenly with 3 light coats of EN3HANCE 
(New England Nuclear, Stevenage, Hertfordshire, U.K.). 
The blots were allowed to dry and then prepared for 
autoradiography. After covering the blots with cling 
film, they were placed face down on a sheet of Hyperfilm, 
(Amersham, Bucks, U.K.), which had been pre-flashed at a 
height of 15-20 cm using a flash gun covered by an Ilford 
S902 filter covered with Whatman No.1 filter paper to 
diffuse the light (Laskey, 1980) . The blot, plus film, 
were then placed in a cassette at -700C and developed 
after 3 weeks using a Gevamatic 60 autoradiograph 
developer, (Agfa-Geveart, W.Germany). 
2.24.2. Method 2. 
The nitrocellulose blot was washed in incubation 
buffer containing 10 	M nifedipine for 2 hours in a foil 
covered container. This was performed in order to site 
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saturate the blot. Darkness was required as nifedipine is 
light sensitive. The blot was then washed rapidly in 
several changes of incubation buffer, to remove any 
excess nifedipine, and then transferred to a plastic bag 
containing 10 ml of incubation buffer containing 2.5 nM 
[3H] verapamil. After incubation of 2 hours the blot was 
washed twice for 30 min in 250 ml of incubation buffer. 
The blot was dried and prepared for autoradiography as 
described above. 
2.24.3. Method 3. 
The western blotting procedure was modified in the 
following ways: 
The gel was equilibrated for 30 min in transfer 
buffer containing 0.1% (w/v) CHAPS, (in order to remove 
SDS in the gel and renature the proteins) . The gel was 
then laid in between 2 pieces of nylon membrane, 
(Amersharn, Bucks, U.K.), which had been pre-soaked in 
transfer buffer also, and the sandwich assembled as 
described previously. The proteins were then transferred 
from the gel to the nylon membrane at 200 mA, constant 
current, for 2 hours at 200C, using the mini-blot system. 
After transfer, the blots were treated as described in 
method 2, except that the incubation buffer contained 
0.1% CHAPS throughout. 
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2.25. Binding of Con-A to Proteins Immobilised on 
Nitrocellulose. 
Nitrocellulose blots were incubated for 30 nun in 3% 
BSA or 0.05% Tween 20, in Tris buffered saline, (TBS) 
containing 20 mM Tris, 0.5 M NaCl, pH 7.5 with H2SO4,  in 
order to site saturate the blot. The nitrocellulose was 
then washed rapidly in several changes of TBS, and then 
incubated for 1 hour in a plastic bag containing 10 ml 
TBS, 100 pl Con-A peroxidase (stock batch L4010) , 1 mM 
Cad 2 and 1 mM MnC12. The blot was then washed for 10 mm 
in 2 changes of TBS, (including 1 mM Cad 2 and NnC12) 
and developed with Horse Radish Peroxidase (HRP) 
substrate, (Bio-Rad, Watford, Herts, U.K.). HRP was 
prepared as follows: At 200C, 60 mg of HRP reagent was 
mixed with 20 ml of ice-cold pure methanol. This was 
added to 100 ml of TBS, (including 1 mM CaCl2 and MnC12) 
plus 60 i.il of ice-cold 30% hydrogen peroxide. After 
several minutes purple bands developed and the blot was 
then placed in a large volume of distilled H20 to stop 
the development reaction. The blot was kept in darkness 
to prevent fading of the bands. 
2.26. Binding of 45Ca2 to Proteins Immobilised on 
Nitrocellulose. 
The nitrocellulose blot was equilibrated in 4 x 200 
ml washes of 60 mM KC1, 5 mM MgC12, 10 mM imidazole, pH 
6.8 with HC1. The blot was then incubated in 200 ml of 
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the above buffer plus 100 p1 of 45Ca2 , (approximately 1 
pM) , for 10 mm. After washing the blot in 500 ml of 
distilled H20 for 5 mm, the blot was left to air dry, 
then exposed to Hyperfilm for 2-3 weeks in a cassette at 
-70°C. 
2.27. Photoaffinity Labelling of the Phenylalkylainine 
Binding Protein from Maize Coleoptile Membranes. 
2.27.1. Method 1. 
100-200 p1 of crude maize coleoptile membrane, 
(0.5-1.0 mg protein), solubilised maize coleoptile 
membrane, (0.5 mg protein), in binding buffer (50 mM 
Tris, 50 mM Mops, pH7.5 with HC1) or DEAE and Sephacryl 
S400 purified fractions, (0.1-0.5 mg protein) , in column 
buffer, were incubated with a final concentration of 18 
nM [3H] LU 49888 (total binding) or 18 nM C3H] LU 49888 
in the presence of 10 4M (final concentration) of 
unlabelled D888 (non-specific binding) . After incubation 
for 2 hours in the dark at room temperature, the 
suspensions were placed in disposable microtitre plates 
and irradiated at a distance of 4 cm with a Blak-Ray long 
wave ultraviolet lamp, (model B-100A. Ultraviolet 
products, San Gabriel, California, U.S.A.), for 10 min on 
ice. Samples for gels were then prepared as described 
previously and subjected to electrophoresis on 10% 
polyacrylarnide gels. Molecular weight markers (see 
section 2.18.5.) were separated by SDS-PAGE at the same 
time. 
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Following electrophoresis, gel slabs were either: 
Fixed and stained with Coomassie blue and then dried 
down onto Whatxnan filter paper under vaccumm and cut into 
2 mm slices. The slices were solubilised for 48 hours in 
Protosol, (New England Nuclear, Stevenage, Herts.), or 
0.1 M NaOH and the radioactivity in each slice determined 
in aqueous scintillation fluid using a scintillation 
counter. 
Fixed and stained with Coomassie blue and then 
incubated in EN3HANCE, (New England Nuclear, Stevenage, 
Hertfordshire, U.K.), for 1 hour, followed by incubation 
for 30 min in distilled H20. The gel slab was then dried 
down under vaccum and exposed to pre-flashed Hyperfilm-3H 
for 2-3 weeks at -700C, as described previously. 
2.27.2. Method 2. 
100 p1 of crude membrane resuspension was incubated 
in binding buffer, (50 mM Tris, 50 mM Mops, pH 7.5 with 
HC1) , with a final concentration of 18 nM [3H] LU 49888, 
(total binding) , or 18 nM [3H] LU 49888 plus iO 	(final 
concentration) of unlabelled D888, (non-specific 
binding) , in a total volume of 1 ml. All assays were 
carried out in duplicate. The suspension was incubated 
for 2 hours in the dark at 200C. After incubation, 3 ml 
of ice-cold wash buffer, (10% PEG 8000, 50 mM Tris, pH 
7.5 with HC1), was added to the suspension, which was 
then filtered through a Whatrnan GF/C filter under vaccurn. 
The filter was then washed once with 3 ml of ice-cold 
wash buffer and then placed on ice and irradiated for 10 
min with ultraviolet light at a distance of 4 cm. One set 
of filters were placed directly into scintillation vials 
with 5 ml of aqueous scintillant and the radioactivity 
retained on the filter determined using a scintillation 
counter. The remaining set of filters were placed in 
eppendorfs with 500 p1 of sample buffer (see section 
2.18.3.) and boiled for 20 min in a hot block, (Dri 
block, Cambridge, U.K.). The eppendorfs were allowed to 
cool and the filter removed. Insoluble material was 
pelleted by centrifugation at 11,600 g for 5 mm. A 
portion of the remaining soluble sample was then applied 
to a 10% SDS Polyacrylamide gel for electrophoresis. 
Molecular weight markers were also separated by SDS-PAGE 
at the same time. After electrophoresis the gel was 
stained, dried down and cut into 2 mm slices which were 
solubilised in 0.1 M NaOH and the radioactivity in each 
slice determined in aqueous scintillation fluid using a 
scintillation counter. 
2.28. Protein Kinase Assays. 
2.28.1. Buffers. 
The following buffers were used in the protein 
kinase assays. 
Buffer A. 22.2 mM MgCl2, 111 mM HEPES, 0.89 mM EGTA, 
1.09 mM CaCl2. The buffer was made at 2x concentration so 
that a free concentration of 100 pM Ca2+ was achieved 
when the buffer was diluted. 
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Buffer B. As for buffer A, minus Cad 2. 
Buffer C. 6 .iM Bovine cali'nodulin in buffer A. After 
dilution a concentration of 3 4M calmodulin was achieved. 
TCA/Na pyrophosphate/EDTA solution. 20 mM MaP?, 10 mM 
EDTA, 10% TCA. 
2.28.2. The cellulose disc assay for crude membrane 
fractions. 
15 .il of crude membrane resuspension was mixed with 
an equal volume of either buffer A, B or C. [ -32P] AT? 
was added (approx. 8 nM) , aliquots removed after 1 mm 
and spotted onto Whatman cellulose discs which had been 
pre-treated with 0.1 ml TCA/NaPP/EDTA solution. The 
filters were then washed overnight in a large volume of 
TCA/NaPP/EDTA solution. After removing the TCA/NaPP/EDTA 
solution, the discs were soaked in 25% (w/v) TCA for 20 
min and then transferred to boiling TCA/NaPP/EDTA for 15 
mm. After cooling for 30 min the discs were washed in 
acetone containing 2% (vlv) 1 M HC1 and air dried. 
Incorporated phosphate was estimated by Cerenkov counting 
of each disc in 5 ml d.H20. Blanks containing no protein, 
were also assayed. 
2.28.3. The phosphocellulose strip assay for solubilised 
membrane and column fractions. 
The solubilised membrane fractions or column 
fractions were mixed with an equal volume of either 
buffer A, B or C. [32p]  AT? at a final concentration of 
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either 8 nM or 1 p.M was added and aliquots were spotted 
onto 1 x 2 cm Whatman P81 phosphocellulose strips at the 
times indicated in the figure legends. The strips were 
then immediately placed into 75 mM phosphoric acid at 10 
ml/strip. Blanks were added last since desorption of AT? 
is time dependent. The strips were washed 3 times in 
phosphoric acid and then allowed to air dry. Incorporated 
phosphate was estimated by Cerenkov counting of each 
strip in 5 ml of d. H20. 
Samples for gel electrophoresis were prepared as 
described previously. After the gels had been coomassie 
stained and dried down they were exposed to Hyperfilm for 
upto 2 weeks at room temperature and then developed in a 
Gevamatic 60 autoradiograph developer. 
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CHAPTER 3. 
THE CHARACTERISATION OF [3H] VERAPANIL BINDING IN CRUDE 
MEMBRANE PREPARATIONS FROM MAIZE COLEOPTILES. 
3.1. Introduction. 
Radiolabelled drugs such as nifedipine, PN200-110 (a 
DHP) and verapamil have been used to identify and 
subsequently purify the voltage-dependent calcium channel 
from skeletal muscle T-tubule membranes, (Curtis & 
Catterall 1984; Borsotto et al., 1985). Various pieces of 
evidence outlined in the introduction to this thesis, 
suggest that calcium channels exist in plant cell 
membranes (Andrejauskas et al., 1985; Graziana et al., 
1987) . The first aim of this project was to detect 
calcium channel proteins in maize coleoptile tissue using 
[3H] verapamil and a related phenylalkylamine, [3H] 
desmethoxyverapamil (D888) 
The results presented in this chapter are:- 
Development of the verapamil binding assay and the 
subsequent detection of phenylalkylamine binding proteins 
in plant membranes using the assay. 
Determination of the specific binding constants of 
verapamil and D888 and estimates of binding 
protein/channel density. 
Estimation of the binding specificity of a variety of 
calcium channel antagonists. 
Localisation of binding sites according to tissue type 
and membrane type. 
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3.2. Principles of the binding assay. 
The principles behind the binding assay are 
presented here to define the terms used in this and the 
following results sections. 
Total binding refers to the amount of labelled 
calcium channel antagonist that binds to the membrane 
fractions. This is determined by adding labelled 
antagonist only to the membrane fractions. Under these 
circumstances the labelled antagonist binds to both high 
and low affinity binding sites. To distinguish between 
these, unlabelled antagonist is added to displace the 
labelled drug from any high affinity binding sites. The 
amount displaced depends on the concentration of the 
unlabelled antagonist and is known as specific binding, 
saturable binding or exchangeable binding. The term 
specific binding is used in this thesis. It should be 
noted that this term is not strictly accurate as the 
assay does not indicate anything about the specificity of 
the binding. However the term does distinguish between 
binding that is high affinity binding and weaker types of 
binding, whether saturable or not. Binding activity 
remaining at high concentrations of unlabelled drug is 
attributed to non-specific, non-saturable or non-
exchangeable binding. This comprises of low affinity 
binding and partitioning of labelled antagonist into 
membrane vesicles and spaces between vesicles. The term 
non-specific binding is used in this thesis. 
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3.3. Development of the [3H] verapamil binding assay. 
3.3.1. The centrifugation assay. 
Initial attempts to detect [3H] verapamil and [3H] 
D888 binding in crude membrane preparations from maize 
coleoptiles, were made using a centrifugation assay (Ray 
et al., 1977; Venis, 1985) . A brief description of the 
assay is presented here. Labelled antagonist was allowed 
to bind to crude membrane fractions in the presence or 
absence of unlabelled antagonist. The membranes were then 
separated from any unbound label by centrifugation and 
the resulting pellet rinsed to remove remaining liquid 
and excess label. The amount of bound label was 
determined by scintillation counting of the resuspended 
pellet. 
Fig.3.1. shows a typical displacement curve for E3HJ 
verapamil binding in crude membrane preparations from 
maize coleoptiles determined using the centrifugation 
assay. The graph indicates that at all the concentrations 
tested, the unlabelled verapamil was unable to 
significantly displace the labelled verapamil. At the 
highest concentration of unlabelled verapamil (100 .iM) 
non-specific binding comprised 70% of the total binding. 
Due to these high levels of non-specific binding, 
probably caused by the trapping of labelled antagonist 
within membrane vesicles at the pelleting stage of the 
assay, the centrifugation assay was not adopted as the 
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Fig.3.1. Displacement of [3H] verapamil by unlabelled 
verapamil measured using the centrifugation 
assay. 
[3H] verapamil was added to the crude maize coleoptile 
membrane fraction (0.4 mg/ml assay), to give a final 
concentration of 0.3 nM. Unlabelled verapamil was then 
added at the concentrations indicated. After incubation 
for 120 min at 200C the mixtures were peileted by 
centrifugation. The pellets were resuspended and the 
amount of radioactive label bound to the membrane 
determined by liquid scintillation counting. Total [3H] 
verapamil binding i.e. 100% was 2500 c.p.m. 
3.3.2. The filter assay. 
The filter assay, modified from Andrejauskas et al. 
(1985) , was then used to assay for [3H] verapamil binding 
to crude membrane fractions. In this method labelled 
antagonist was allowed to bind to crude membrane 
fractions in the presence or absence of unlabelled 
antagonist. The membranes were separated from any unbound 
label by filtration and the filters washed to remove any 
excess label. The label bound to the membrane was 
determined by liquid scintillation counting of the 
filters. This method gave a better distinction between 
specific and non-specific binding. This was probably 
because membrane vesicles which may trap any free label 
available, so increasing non-specific binding, do not 
form on the filters. Washing of the filters also appears 
to be more succesful in removing any free label present, 
compared to washing of the pellets in the centrifugation 
technique. 
Having achieved lower levels of non-specific binding 
with the filter method, the filter assay was subsequently 
chosen as the standard method for assaying [3H] verapamil 
and [3H] D888 binding in membrane preparations and used 
in all further experiments. Fig.3.3. shows a typical 
displacement curve for [3H] verapamil binding in crude 
membrane preparations using the filter assay method. 
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3.4. The kinetics of [3H] verapamil binding to maize 
coleoptile membranes. 
To ensure that {3H] verapamil binding had reached 
equilibrium, the kinetics of drug binding were 
investigated using the standard filter assay. 
Fig.3.2. shows the binding of [3H] verapamil at 
200C, pH 7.5 to crude membrane fractions and its 
displacement by 100 iM unlabelled verapamil. The graph 
indicates that binding of [3H] verapamil increases over 
time, with binding equilibrium being reached after 90 
mm. When 100 jiM unlabelled verapamil was added at the 
plateau phase, dissociation of bound verapamil occurred 
and was largely complete after a further 120 mm. 
As a consequence of these results, incubations of 
membrane fractions with [3H] verapamil were conducted for 
2 hours. 
3.5. [3H] verapamil and [3H1 D888 binding to maize 
coleoptile membranes. 
Binding curves for [3H] verapamil and [3H] D888 
were constructed using the standard binding assay. 
Fig.3.3. shows the displacement of [3H] verapamil by 
increasing concentrations of unlabelled verapamil. The 
graph indicates that the ainmount of displacement 
increases with increasing concentration of unlabelled 
drug. 100 iM unlabelled verapamil was able to displace 
the (3H] verapamil by 96%. The remaining 4% was 
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Fig.3.2. The kinetics of [3H] verapamil binding to maize 
coleoptile membrane fractions. 
Binding was initiated ( • ) , by the addition of [3H] 
verapamil (final concentration. 1.12 nN) to the 
incubation mixture containing membrane protein (0.38 
mg/500 p1 assay) . At the times indicated, 250 p1 samples 
were withdrawn and the amount of [3H] verapamil binding 
determined by the filter assay. Dissociation of [3H] 
verapamil binding ( Q ) , was initiated by the addition of 
100 pM unlabelled verapamil at the point indicated by '0.. 
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Fig.3.3. Displacement of [3H] verapamil by unlabelled 
verapamil measured using the filter assay. 
[3H] verapamil was added to the crude maize coleoptile 
membrane fraction (0.5 mg/500 i.il assay) to give a final 
concentration of 2.24 nM. Unlabelled verapamil was added 
at the concentrations indicated. The radioactivity bound 
to the membrane was determined using the standard filter 
assay. Total [3H] verapamil binding was 196 c.p.m. 
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The displacement of [3H] D888 by unlabelled D888 is 
shown in Fig3.4. The graph indicates that at low 
concentrations, the unlabelled D888 does not 
significantly displace the labelled D888. At 100 i.1M 
unlabelled D888 the amount of non-specific binding was 
50% of the total binding. It is also noticeable that the 
unlabelled D888 is unable to displace the labelled D888 
to the same levels as the unlabelled verapamil displaced 
the [3H] verapamil. These results indicate low affinity 
binding of D888 in maize coleoptile membranes. 
The graph also indicates an element of positive 
cooperativity in the region of the graph where low 
concentrations of D888 (10 8M) were used to displace [3H] 
D888 binding. Positive cooperativity occurs when the 
binding of one molecule of the drug facilitates the 
binding of subsequent molecules of the drug. This can 
happen because of a conformational change in the binding 
sites caused by the binding of the first molecule, which 
then alters the RD of the sites, (they become higher 
affinity or binding sites become revealed) , so allowing 
more molecules to bind. In this case it would appear that 
the addition of 10 8M - 10 7M unlabelled D888 facilitates 
the binding of more labelled D888, possibly by the above 
mechanism, which may have been induced by the slight rise 
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Fig.3.4. Displacement of [3H] D888 by unlabelled D888. 
[3H] D888 was added to the crude membrane fraction (0.5 
mg/500 il assay) , to give a final concentration of 2.3 
nN. Unlabelled D888 was added at the concentrations 
indicated. The amount of radioactivity bound to the 
membrane was determined using the standard filter assay. 
Total [3H] verapamil binding was 100 c.p.m. 
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3.6. Specific binding constants of verapamil & D888 and 
the estimation of binding protein density. 
Data from [3H] verapamil and [3H] D888 displacement 
experiments were transformed by the method of Scatchard 
(1949) , to give Scatchard plots. From these, the apparent 
dissociation constant (KD)  and the maximum number of 
binding sites (Bmax)  were calculated from the slope of 
the line of best fit and the intercept of the line on the 
x axis respectively. 
Fig.3.5. shows a typical Scatchard plot of [ii] 
verapamil binding to crude membrane preparations from 
maize coleoptiles. The Scatchard plot is linear which 
suggests that there is a single class of non-interacting 
binding sites. The apparent KD was 72 nM and the Bmax  was 
135 pmol/mg protein indicating a fairly high affinity 
binding site. 
A typical Scatchard plot of [3H] D888 binding to 
crude maize coleoptile membranes is shown in Fig.3.6. 
The Scatchard plot appears to be linear, suggesting a 
single class of D888 binding sites. It is possible that 
there may be another binding site, but in the absence of 
computerised line fitting is not detected using the least 
squares method to construct the line of best fit. Binding 
of D888 was of lower affinity compared to verapamil 
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Fig.3.5. Scatchard plot of [3H] verapamil binding to 
crude membrane fractions from maize coleoptiles. 
Data from [3H] verapamil displacement experiments was 
transformed to give a Scatchard plot. Least squares 
regression analysis was used to plot the line of best 
fit. The apparent KD was 72 nM and the Bmaxwas 135 
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Fig.3.6. Scatchard plot of [3H] D888 binding to crude 
membrane fractions from maize coleoptiles. 
Data from [3H] D888 displacement experiments was 
transformed to give a Scatchard plot. Least squares 
regression analysis was used to plot the line of best 
fit. The apparent KD was 579 nM and the Bmaxwas 220 
pmol/mg of protein. 
3.7. The displacement of [3H] verapamil and [3H] D888 by 
unlabelled calcium channel antagonists. 
In displacement experiments using skeletal muscle 
microsomes, calcium antagonists from one structural group 
were found to be able to displace calcium antagonists 
from another group, but not as well as those from the 
same series. These results suggested that there are 
separate binding sites for the different drugs and that 
these sites may be linked (Glossmann et al., 1982; 
Triggle et al., 1986) . To investigate whether separate 
calcium antagonist binding sites exist in plant 
membranes, the displacement of [3H] verapamil and [3H] 
D888 by unlabelled calcium channel antagonists was 
performed. 
3.7.1. [3H] verapamil displacement. 
Fig.3.7. shows the displacement of [3H] verapamil by 
unlabelled verapamil, D888, methoxyverapamil (]J600) and 
nifedipine. The graph shows that over the concentration 
range tested, only verapamil and D600 were able to 
appreciably displace [3H] verapamil binding in maize 
coleoptile membranes, with IC50 values of 100 nM and 700 
nM respectively. D888 competed poorly for the [3H] 
verapamil binding sites and had an IC50 value of 50 kiM. 
Nifedipine had little displacement effect even at iO 	H. 
3. 7.2. [3H] D888 displacement. 
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Fig.3.7. Displacement of [3H] verapamil by unlabelled 
calcium channel antagonists. 
Binding of [3H] verapamil to crude maize coleoptile 
membrane fractions was measured using the standard filter 
assay in the presence of either unlabelled verapamil () 
rnethoxyverapamil (0) , desmethoxyverapamil () or 
nifedipine () at the concentrations indicated. The value 
for total [3H] verapamil binding was 196 c.p.m. (250 f 
mol) . Non-specific binding, determined by the addition of 















9 8 7 6 5 4 
Unlabelled Channel antagonist.-Log(M) 
Fig.3.8. Displacement of [3H) D888 by unlabelled calcium 
channel antagonists. 
Binding of [3H] D888 to crude maize coleoptile membrane 
fractions was measured using the standard filter assay in 
the presence of either unlabelled verapamil (S) 
rnethoxyverapamil (0) or desmethoxyveraparnil () at the 
concentrations indicated. The value for total [3H] D888 
binding was 100 c.p.m. Non-specific binding, determined 
by the addition of 100 pm unlabelled D888 was 50 of the 
total. 
and verapamil is shown in Fig.3.8. In all cases 
displacement of the labelled antagonist from its binding 
sites was poor. Unlabelled D888 was able to displace 
approximately 50% of the labelled D888 at 10 	H. 
Unlabelled verapamil appeared to have no significant 
effect up to io- M, where it displaced approximately 30% 
of the [3H] D888 binding. D600 was able to displace [3H] 
D888 over the range of io- M - io 	H unlabelled D600, 
by approximately 50-70%. 
3.8. Localisation of [3H] verapamil binding sites 
according to tissue type and membrane type. 
3.8.1. Tissue type. 
[3H] verapamil binding studies were carried out 
using maize root and zucchini hypocotyl membranes, as 
well as maize coleoptile membranes. Figs.3.9 a & b. 
indicate the binding curve for [3H] verapamil in maize 
root tissue and the Scatchard plot derived from this 
data. For maize roots the RD was found to be 233 nM, 
which represents a relatively low affinity binding site 
compared to that found for maize coleoptiles. The 8max 
was found to be 165 pmol/mg protein (Table 3.1.). This is 
a comparatively high density of binding sites than found 
for maize coleoptile tissue. 
Figs.3.10 a- & b. show the binding curve and 
associated Scatchard plot for [3H] verapamil binding in 
zucchini hypocotyl tissue. The RD was found to be 114 nM 
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Fig.3.9.a. The displacement of [3H] verapamil by 
unlabelled verapamil in crude membrane 
fractions from maize roots. 
[ii] verapamil was added to crude maize root membrane 
fractions (0.4 mg/500 i.il assay) to give a final 
concentration of 2.24 nM. Unlabelled verapamil was added 
at the concentrations indicated. The amount of 
verapamil bound was measured using the standard filter 
assay. Total [3H] verapamil binding was 253 c.p.m. 
b. Scatchard plot of [3H] verapamil binding to 
crude membrane fractions from maize roots. 
Data from Fig.3.9.a. was transformed to give a Scatchard 
plot. Least squares regression analysis was used to plot 
the line of best fit. The apparent KD was 233 nM and the 
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Fig.3.10.a. The displacement of [3H] verapamil by 
unlabelled verapamil in crude membrane 
fractions from zucchini hypocotyls. 
[3H] verapamil was added to crude membrane fractions from 
zucchini hypocotyls (0.35 mg/500 iii assay) to give a 
final concentration of 2.24 nM. Unlabelled verapamil was 
added at the concentrations indicated. The amount of [3H] 
verapamil bound to the membrane was determined using the 
standard filter assay. Total E 3H] verapamil binding was 
189 c.p.xn. 
b. Scatchard plot of [3H] verapamil binding to 
crude membrane fractions from zucchini 
hypocotyls. 
Data from Fig.3.10.a. was transformed to give a Scatchard 
plot. Least squares regression analysis was used to plot 
the line of best fit. The apparent KD  was 114 nN and the 
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Tissue Type. 	Dissociation 	Maximum No. 	Reference. 
Constant. 	Binding sites. 
K 	tnM] . prnol/rng protein. 
Maize 	 72 	 135 	 * 
coleoptiles. 
Maize 	 233 	 165 	 * 
roots. 
Zucchini 	114 	 96 	 * 
hypocotyls. 
Zucchini 	102 60 Andrejauskas 
hypocotyls. et 	aJ..,1985. 
Rabbit 	 27 50 Galizzi 
Skeletal et 	al.,.1984. 
muscle. 
Guinea-Pig 	45 37 Goll 	et al., 
Skeletal (fmol) 1984. 
muscle. 
Rat cerebral 	93 	 435 	 Reynolds 
cortex. 	 et aJ..,1983. 
Table 3.1. [3H] verapamil binding in various plant and 
animal tissues. 
* denotes data obtained by the author. 
is comparable to that found by Andrejauskas et al. 
(1985) , who reported a KD of 102 nM and a Bmax of 60 
pmol/mg protein for zucchini hypocotyl membrane 
fractions. 
3.8.2. Membrane type. 
To investigate calcium channel localisation 
according to membrane type, preliminary studies were made 
utilising the phase partitioning of total membrane 
fractions according to the method of Yoshida et al. 
(1983) . During partitioning the plasma membrane 
preferentially moves into the upper polyethyleneglycol 
phase due surface properties and charge. It has been 
reported that only "right-side-out" sealed plasma 
membrane vesicles partition into the upper phase (Larsson 
et al., 1984). 
Plasma membrane enriched upper phase and residual 
membrane lower phase (containing ER, tonoplast and some 
plasma membrane) , were prepared and assayed for [3H] 
verapamil binding using the standard binding assay. The 
results indicated the general distribution of the calcium 
channel proteins according to membrane type. Table 3.2. 
summarises [3H] verapamil binding to the plasma membrane 
enriched fraction and residual membrane fraction from 
maize tissues. 
The results indicate that for all the tissues 
examined there is increased verapamil binding in the 
plasma membrane enriched upper phase compared to the 
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Tissue 
	 Verapamil bound (nmols!mg protein). 
Upper phase. 	Lower phase. 
Coleoptiles 	 15.7 	 1.25 
incl. leaf rolls. 
Coleoptiles 	 4.4 	 2.3 
excl. leaf rolls. 
Leaf rolls. 	 15.2 	 1.0 
Roots 	 4.9 	 2.5 
Table 3.2. [3H] verapamil binding to the plasma membrane 
enriched upper phase and the residual membrane 
lower phase, from various maize tissues. 
Plasma membrane was separated from the other membrane 
types using the two-phase method developed by Yoshida et 
al., 1983. Each phase was assayed for [3H] veraparnil 
binding using the standard filter assay. 
residual membrane lower phase. This suggests that there 
are more calcium channels in the plasma membrane compared 
to the other membrane types. 
The amount of verapamil bound by the plasma membrane 
enriched fraction also varies according to the tissue 
source the plasma membrane was derived from. Table 3.2. 
indicates that plasma membrane from leaf rolls only and 
from coleoptiles plus leaf roll, bound the most [3H] 
verapamil. Coleoptiles alone only bound a small amount of 
verapamil, suggesting that it is the leaf roll which 
actually binds the most [3HJ verapamil. This suggests 
that the plasma membrane from the leaf has more calcium 
channels than the coleoptile plasma membrane. Plasma 
membrane from root tissue also bound less verapamil than 
plasma membrane from leaf rolls. 
3.9. Discussion. 
Using the standard filter method to assay for [3H] 
verapamil binding, crude maize coleoptile membranes have 
been shown to bind verapamil. This binding is saturable 
and reversible. [3H] verapamil binding takes 2 hours to 
reach equilibrium at 200C, pH 7.5 and on addition of 100 
1.1M unlabelled verapamil the [3H] verapamil dissociates 
and binding levels off after a further 2 hours. These 
data can be compared to those obtained for verapamil 
binding to skeletal muscle microsomes and zucchini 
hypocotyl membranes, both of which also took 2 hours to 
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reach equilibrium (Goll et al., 1984a; Andrejauskas et 
al., 1985). 
Scatchard analysis of [3H] verapamil binding in 
crude maize coleoptile membrane fractions resulted in a 
linear plot, suggesting a single class of non-interacting 
binding sites. A KD of 72 nM and Bmax of 135 pmol/mg 
protein was obtained. The dissociation constant is 
similar to that obtained for [3H] verapamil binding in 
zucchini (KD = 102 nM, Bmax  = 60 pmol/mg protein), but is 
of lower affinity than that obtained for [3H] verapamil 
binding in skeletal muscle where the KD was 27 nM and the 
Bmax was 50 pmols/mg protein (Andrejauskas et al., 1985; 
Galizzi et al., 1984a) 
Scatchard plots of [3H] D888 binding indicated an 
apparent KD of 578 nM and a Bmax of 220 pmol/mg protein. 
This represents a lower affinity binding site compared to 
that found for verapamil. This data can be compared to a 
KD  of 85 nM and a Bmax of 120 pmol/mg protein obtained 
for D888 binding in carrot nuicrosomal membranes (Graziana 
et al., 1987) and a KD of 1.5 nM and a Bmax of 70 pmol/mg 
protein for D888 binding in skeletal muscle T-tubule 
membranes, (Goll et al., 1984b) . Both plant tissues 
appear to have a high density of D888 binding sites 
compared to skeletal muscle, but maize membranes appear 
to bind D888 with lower affinity compared to carrot 
microsome and skeletal muscle membranes. The plot 
possibly indicates the presence of 2 classes of low 
affinity binding sites for D888. If two sets of binding 
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sites for D888 do exist in maize coleoptile membranes, 
this is in contrast to the single class of D888 binding 
sites found in carrot microsome membranes and skeletal 
muscle t-tubule membranes. 
Displacement of [3H] verapamil and [3H] D888 by a 
range of unlabelled antagonists was carried out to 
investigate whether separate binding sites for the 
different calcium channel antagonists exist in plant 
membranes. Only D600 and verapamil could significantly 
displace [3H] verapamil over the concentration range 
tested. This suggests that D600 may be binding to the 
same or very similar sites as verapamil. D888 was less 
effective in displacing the [3H] verapamil. This was 
suprising as D888 is structurally closely related to 
verapamil i.e. another phenylalkylamine, and had been 
expected to bind to the same sites as verapamil. 
Nifedipine, which belongs to a different structural group 
than verapamil i.e. the dihydropyridines, also had very 
little displacement effect. This suggested that 
nifedipine was binding to a site distinct from that 
binding verapamil. Displacement of [3H] D888 by 
unlabelled D888, D600 and verapamil was extremely poor, 
despite all these drugs belonging to the same structural 
family. Only at the highest concentration tested was 
significant displacement of [3H] D888 observed and this 
was lower than that seen for the displacement of [3H] 
verapamil by the same concentration of unlabelled 
antagonist. On the whole, these results support the idea 
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that there are distinct binding sites for 
dihydropyridines and phenylalkylamine derivatives in 
plant membranes. It is possible that the different 
binding sites may represent different calcium channels 
which have differing sensitivities to the various 
antagonists. Alternatively, the separate binding sites 
for the different calcium channel antagonists may exist 
within a single channel. The latter situation has been 
found in animal tissues such as skeletal muscle. Both 
direct labelling and photoaffinity labelling experiments 
with a variety of channel antagonists have shown that 
there are distinct drug binding domains and that these 
binding sites are located on the a1 subunit of the 
purified calcium channel (Ferry & Glossmann, 1982a; 
Glossmann et al., 1984; Galizzi et al., 1984b; Goll et 
al., 1984a,b; Ferry et al., 1984a,b; Schmid et al., 
1986a,b; Striessnig et al., 1986a, 1987; Vaghy et a.2., 
1987) 
The [3H] veraparnil binding data found for the 
different tissue types examined in this research is 
summarised in Table 3.1. together with [3H] verapamil 
binding data obtained by other groups in both animal and 
plant tissue for comparison. The figures indicate that 
dissociation constants and maximum number of binding 
sites vary between different plant tissues and between 
plant and animal tissues. This suggests that the number 
of calcium channels in different tissues varies and 
indicates antagonist specificity according to tissue 
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type. However, the dissociation constants for plant and 
animal tissues presented here are all in the nanomolar 
range, which suggests that there is some degree of 
similarity in drug sensitivity between plant and animal 
calcium channel proteins. Animal tissues appear to have 
higher affinity binding sites than those found for plant 
tissue, possibly because more rapid responses are 
required in animal tissues like skeletal and cardiac 
muscle, than in plant tissues. On the other hand plant 
tissues appear to have higher densities of binding sites 
compared to animal tissue. For example, more channels 
appear to be found in maize root membranes compared to 
other plant tissues and to skeletal muscle membranes 
(Galizzi et al., 1984) . The apparently high density of 
calcium channels seen in maize roots rather than maize 
coleoptiles, may be found because the root is the major 
site of calcium uptake in the plant. 
From the results of [3H] verapamil binding to 
membrane fractions prepared by phase partitioning, more 
channels would appear to be found in the plasma membrane 
compared to organelle membranes. This suggests that there 
is subcellular localisation of verapamil binding calcium 
channels on plasma membrane in plants. This parallels 
work by Andrejauskas et al. (1985) , which also 
demonstrated [3H] verapamil binding sites to be primarily 
found in the plasma membrane with some sites in the ER 
and possibly the tonoplast. The results also indicate 
that binding of [3H] verapamil by plasma membrane varies 
01 
according to tissue type. Plasma membrane from 
coleoptiles plus leaf rolls bound the most verapamil and 
plasma membrane from roots bound the least. This 
contradicts data presented in section 3.8.1., where roots 
were shown to have more verapamil binding sites than 
coleoptiles including leaf rolls. However in those 
experiments verapamil binding to total membrane was 
examined, whereas the above comparisons reflect verapamil 
binding to plasma membrane only. 
When interpreting the data for [3H] verapamil 
binding to the plasma membrane enriched phase and the 
residual membrane phase, it must be taken into 
consideration that the purity of the plasma membrane in 
the upper phase was not checked by the use of membrane 
marker assays and contamination with other membranes may 
have occurred. However contamination of the plasma 
membrane enriched phase is generally considered to be low 
(Larsson, 1983) . It is also recognised that expressing 
the results on a mg protein basis may not give a useful 
estimate of the distribution of verapamil binding, as 
calcium channel density per unit surface area of membrane 
is probably the more appropriate parameter. However, 
expressing the results on a unit area basis would be 
diffcult as there are no means of calculating this. To 
make a better comparison of the localisation of calcium 
channels according to membrane type, pure membrane 
preparations would have to be obtained and [3H] verapamil 
binding examined for each membrane type. 
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CHAPTER 4. 
THE PARTIAL PURIFICATION OF A VERAPAMIL BINDING PROTEIN 
FROM MAIZE COIJEOPTILES. 
4.1. Introduction. 
The next aim of the project was to attempt to purify 
the verapamil binding protein from maize coleoptile 
membranes. This tissue was chosen as it had been found to 
be the richest source of high affinity verapamil binding 
sites and hence presumably, calcium channels. The 
Scatchard plot of [3H] verapamil binding in maize 
coleoptile membranes indicated that there was a single 
class of verapamil binding sites, which suggested that 
there may be only one verapamil binding protein. 
The voltage-dependent calcium channel has been 
purified from skeletal muscle using the specific binding 
of various calcium antagonist dihydropyridines to follow 
the course of purification. Two main methods have been 
used (Glossmann & Ferry, 1985). In the first method [3H] 
nitrendipine was mixed with T-tubule membranes to form a 
[3H] nitrendipine receptor complex. This complex was then 
solubilised with digitonin and purified 330 fold by a 
combination of lectin affinity chromatography, ion 
exchange chromatography and sedimentation through sucrose 
gradients (Curtis & Catterall, 1984) . In the second 
method, the dihydropyridine receptor was solubilised in 
CHAPS and then separated using anion exchange, lectin 
affinity and gel filtration chromatography, to give an 80 
fold purification of the dihydropyridine receptor. f 3H1 
(+)-PN 200-110 was used to detect the purified receptor 
by direct binding experiments after each purification 
step (Borsotto et al., 1985) . The second method has one 
major advantage over the first in that it does not rely 
on the formation and maintenance of a antagonist-receptor 
complex and therefore avoids potential problems related 
to the dissociation of the antagonist-receptor complex 
during purification. Using these methods, the structure 
of the skeletal muscle antagonist receptor was determined 
and it was shown to be a functional calcium channel 
(Curtis & Catterall, 1984,1985,1986; Borsotto et al., 
1985; Flockerzi et al., 1986a,b; Striessnig et al., 
1986b). The channel consists of 4/5 subunits, of which 
the cxi subunit is the main functional subunit and 
contains the drug receptor site (Takahashi et al., 1987) 
Thus by purification of the antagonist receptor the whole 
channel was purified. Working on this basis it was hoped 
to purify the verapamil binding protein and therefore the 
calcium channel from plant membranes. Taking a lead from 
published purification methods, attempts were made to 
solubilise the verapamil binding protein from maize 
coleoptile membranes and then to purify the solubilised 
protein using a similar combination of chromatography 
techniques as described for the purification of the 
dihydropyridine receptor from skeletal muscle. Due to the 
relatively low affinity of [3H] verapamil for its binding 
site in maize membranes, the production of a [3H] 
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verapamil receptor complex was not feasible. As a result, 
the procedure used to purify the verapamil binding 
protein was based largely on the second animal channel 
purification method, with the purified protein being 
detected by direct binding experiments with [3H] 
verapamil after each purification step. 
The development of the protocol adopted to 
solubilise and partially purify the verapamil binding 
protein from maize coleoptile membranes is presented in 
this chapter. 
4.2. Solubilisation of the Membrane Bound Verapamil 
Binding Protein. 
A pre-requisite for purifying membrane proteins by 
column chromatography, is that the protein in question 
can be solubilised in a non-denatured and relatively 
stable form. Experiments were therefore carried out to 
find the optimum conditions for solubilisation of the 
verapamil binding protein. The results of these 
investigations are presented in the following section. 
4.2.1. Optimisation of solubilisation. 
Preliminary experiments were carried out using a 
variety of detergents, to determine the optimum detergent 
type to solubilise the verapamil binding protein. These 
were Triton X-lOO, octyl-glucoside (non-ionic detergents) 
and CHAPS (a zwitterionic detergent) . Fig.4.1. shows the 


















Fig.4.1. Molecular stuctures of the detergents CHAPS, 
n-octyl glucoside and Triton x-lOO. 
The recovery of [3HJ verapamil binding activity 
after solubilisation, expressed as a percentage of [3H] 
verapamil binding activity initially found in crude 
membrane fractions, is summarised in Table 4.1. Recovery 
of activity after solubilisation with Triton X-100 and 
octyl glucoside was less than 1096 at all the 
concentrations investigated. The detergent CHAPS was more 
effective over the same concentration range. At 0.296 
CHAPS, 16% of [3H] verapamil binding activity was 
recovered. This increased to 4096 when the membrane 
fractions were solubilised in 0.3% CHAPS. A decline in 
binding activity was observed after solubilisation with 
0.5% and 1.0% CHAPS, with recoverys of 30% and 8% 
respectively. 
CHAPS was therefore selected as the detergent for 
further study because of its ability to solubilise the 
verapamil binding protein with relatively high levels of 
recovery of [3H] verapamil binding activity compared to 
the other detergents investigated. As 0.396 CHAPS had 
given the best recovery of binding activity, this 
concentration was used initially. 
The effects of 20% (w/v) sucrose or glycerol on 
solubilisation of the verapamil binding protein were 
investigated, as the addition of glycerol or sucrose to 
the solubilisation medium had been found to stabilise the 
solubilised nitrendipine receptor from rabbit skeletal 
muscle tubule membranes and had increased the yield of 
active receptor from 25% to approximately 71% (Borsotto 
Detergent 
concentration. 
Recovery of {3H] verapamil 
binding activity. 





0.2 96 	 1.5 
0.5 96 3.0 
1.0 6 	 5.0 
Octyl glucoside 
0.2 96 	 8.0 
0.5% - 
1.0% 	 - 
CHAPS 
0.2 96 16.0 
0.3 96 40.0 
0.5 96 30.0 
1.0 96 8.0 
Table 4.1. Solubilisation of [3H] verapamil binding 
activity using Triton x-100, octyl glucoside, 
Deca-10 and CHAPS. 
Crude maize coleoptile membrane fractions were 
solubilised in a buffer containing one of the above 
detergents at varying concentrations. After incubation 
for 60 min at 40C, the mixtures were centrifuged. The 
resulting supernatants were assayed for [3H] verapamil 
binding using the standard filter assay. 
et al., 1984). The results shown in Table 4.2. indicate 
that the recovery of [3H] verapamil binding activity was 
increased by the inclusion of 20% glycerol or 20% sucrose 
in the solubilisation buffer-. As 2096 sucrose gave the 
highest recovery of [3H] verapamil binding activity, this 
was added routinely to the solubilisation buffer in all 
further experiments. 
In the presence of 20% sucrose, the optimum 
concentration of CHAPS required to solubilise the 
verapamil binding protein was found to have increased. 
The graph shown in Fig 4.2. indicates that 0.5% CHAPS in 
solubilisation buffer gave the best recovery of verapamil 
binding activity. This equates with a protein:detergent 
ratio of 1:14 under the conditions used. 
In all subsequent solubilisation experiments, 0.5% 
CHAPS and 20% sucrose in 50 mM Tris, 50 mM Mops, pH7.5 at 
a 1:14 protein:detergent ratio was used to solubilise the 
verapamil binding protein. Using these conditions the 
recovery of verapamil binding activity after 
solubilisation was between 40-60%. The average 
purification of the verapamil binding protein achieved 
after solubilisation of the crude membrane preparation 
was 2.6 ± 0.53 (n=9) fold. Crude membrane preparations 
were always solubilised immediately, as recovery of 
binding activity after solubilisation of a previously 
frozen crude membrane preparation was only about 50% of 
that recovered after solubilisation of a fresh 
preparation. It should also be noted that when 
Solubilisation 
conditions. 
Recovery of [3H] verapamil 
binding activity. 
(96 of [3H] verapamil binding 
to crude membrane) 
0.396 CHAPS 	 8 
in 50 mM Tris 
50 mM Mops 
pH 7.5. 
0.396 CHAPS 	 36 
in 50 mM Tris 
50 mM Mops 
20% Glycerol 
pH 7.5. 
0.3% CHAPS 	 41 
in 50 mM Tris 
50 mM Mops 
20 96 Sucrose 
pH 7.5. 
Table 4.2. The effect of the inclusion of glycerol or 
sucrose on CHAPS solubilisation of verapamil 
binding activity. 
Crude maize coleoptile membrane fractions were 
solubilised in buffer containing 0.3% (5 mM) CHAPS ± 20% 
sucrose or glycerol. After incubation for 60 min at 40C 
the mixtures were centrifuged. The supernatants were 
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Fig.4.2. Determination of the optimum concentration 
required for CHAPS solubilisation of [3H] 
verapamil binding activity. 
Crude maize coleoptile membrane fractions were 
solubilised in buffer containing a range of CHAPS 
concentrations, plus 20% sucrose. After the standard 
solubilisation procedure, the supernatant and the 
residual pellet were assayed for [3H] verapamil binding 
using the standard filter assay. 
solubilised membrane fractions were frozen in liquid 
nitrogen and stored at -700C, recovery of binding was 
also reduced by about 50%. For this reason solubilised 
membrane fractions were kept at 40C and used within 
several hours, over which time the loss of binding 
activity was negligible. 
It was also observed that there was a high 
proportion (68% on average), of verapamil binding 
recovered in the insoluble protein fraction i.e. the 
pellet, at every concentration of CHAPS investigated. 
This activity may represent binding of [3H] verapamil to 
CHAPS insoluble binding sites or the entrapment of [3H] 
verapamil in vesicles during centrifugation. At high 
concentrations of CHAPS (1.0%, 2.0%, 3.0%) the percentage 
recovery of binding in the solubilised fraction decreases 
but remains high in the insoluble fraction. It may be 
possible that at these high concentrations of CHAPS the 
verapamil binding sites are denatured, so that even if 
they are still present in the supernatant they cannot 
bind verapamil. At the lower concentrations of CHAPS 
(0.1%-0.3%), there may not be enough CHAPS present to 
solubilise as many binding sites as 0.4%-0.5% CHAPS, thus 
more verapamil binding activity is seen in the pellet and 
less in the solubilised fraction. 
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4.2.2.[3H] verapamil binding in CHAPS solubilised 
membrane fractions. 
Using the standard [3H] verapamil binding assay, the 
binding characteristics of the labelled antagonist were 
examined in CHAPS solubilised membrane fractions. 
Fig.4.3. shows a typical displacement curve for [3H] 
verapamil binding in CHAPS solubilised membrane 
fractions. The graph is similar to that obtained for [3H] 
verapamil binding in crude membrane preparations. 
Increasing concentrations of unlabelled verapamil are 
able to displace more labelled verapamil. At 100 .iM 
unlabelled verapamil, [3H] verapamil is displaced by 
approximately 93%. The IC50 is about 700 nM and can be 
compared to the IC50 of 100 nM found in crude membrane 
preparations. 
Using this data, a Scatchard plot of [3H] verapamil 
binding in solubilised membrane fractions was constructed 
(Fig 4.4.). In the CHAPS solubilised preparation the KD 
was 158 nM and the Bmax was 78 pmol/xng protein. These 
values can be compared to those obtained for [3H] 
verapamil binding to crude membrane preparations, where 
the KD was 72 nM and the Bmax was 135 pmol/mg protein. In 
both cases the Scatchard plots were linear which suggests 
the presence of a single class of non-interacting binding 
sites. From the similarities in binding curves and 
Scatchard plots, it is concluded that the solubilised 
verapamil binding protein has similar properties to those 
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Unlabelled verapamil. -Log(M) 
Fig-4.3. Displacement of [3H] verapamil by unlabelled 
verapamil in CHAPS solubilised maize coleoptile 
membrane fractions. 
CHAPS solubilised membrane fractions (0.5 - 1.0 mg/500 iii 
assay) were incubated with [3H] verapamil to give a final 
concentration of 2.24 nM. Unlabelled verapamil was added 
at the concentrations indicated. The amount of bound [3H] 
verapamil was determined using the standard filter assay. 
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Fig.4.4. Scatchard plot of [3H] verapamil binding to 
CHAPS solubilised maize coleoptile membrane 
fractions. 
Data from Fig.4.2. was transformed to give a Scatchard 
plot. Least squares analysis was used to plot the line of 
best fit. The apparent KD was 158 nM and the Bmaxwas 
78 prnol/ing protein. 
of the membrane bound protein. However, it should be 
noted that [3H] verapamil binding to the solubilised 
protein is of slightly lower affinity compared to the 
membrane bound protein. A loss in binding capacity may be 
due to an adverse effect on the verapamil binding protein 
caused by the solubilisation procedure. This in turn may 
effect the subsequent purification steps. 
4.3. DEAE Ion Exchange Column Chromatography.. 
Following solubilisation of the verapamil binding 
protein from its membrane bound form, further 
purification of the verapamil binding protein was 
attempted using anion exchange column chromatography. 
DEAE anion exchange was selected as the first 
purification step for several reasons. 1. the solubilised 
sample volume was very large (approximately 20-30 ml) 
which prevented the easy use of gel filtration 
chromatography as a first step. 2. DEAE anion exchange 
provides an opportunity to remove large groups of 
negatively charged proteins and lipids, thereby removing 
a large component part that would bind verapamil in a 
non-specific manner. DEAE ion exchange was also chosen as 
the first step in the purification of the dihydropyridine 
receptor from rabbit skeletal muscle (Borsotto et al., 
1984) 
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4.3.1. Development of the elution protocol. 
The optimum conditions required for the elution of 
the verapamil binding protein were investigated in a 
number of pilot experiments using linear and step 
gradients of varying ionic strength. 
Fig.4.5. shows the elution profile of the DEAE 
column utilising a 0-0.5 M NaCl linear gradient. The 
graph indicates that a small amount of verapamil binding 
activity, with fairly low specific activity, was eluted 
from the column during loading of the sample and during 
the subsequent wash step. The major part of verapamil 
binding activity was eluted from the column over the 
first part of the gradient, upto approximately 0.2 M 
NaCl. Recovery of binding activity decreased as the 
gradient concentration increases, apart from a small rise 
in activity towards the end of the gradient (0.5 M NaCl).  
The major peak of verapamil binding activity was eluted 
with the major protein peak. 
In subsequent experiments the DEAE column was eluted 
stepwise with 0.1 M and 0.2 M NaCl. Fig.4.6. shows a 
typical elution profile using this protocol. The graph 
indicates that most of the verapamil binding activity is 
eluted from the column with 0.1 M NaCl and this binding 
activity has a relatively high specific binding activity. 
Approximately 16% of the binding activity initially 
loaded onto the column was recovered with this step, 
compared to only 4% with 0.2 M NaCl. Total recovery of 
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Fig.4.5. DEAE column elution profile using a 0 - 0.5 M 
NaCl linear gradient. 
Approx. 10 ml of solubilised membrane fraction was loaded 
onto a pre-equilibrated 4 x 1 cm DEAE column (1) . The 
column was washed with 10 ml of column buffer (2) . The 
verapamil binding activity was then eluted from the 
column using a linear gradient of 0 - 0.5 M NaCl in 
column buffer (3) . Fractions of 2 ml were collected and 
assayed for [3H] veraparnil binding. In a separate 
experiment, the NaCl gradient was determined by taking a 
conductivity reading for each fraction and for fractions 
containing a known concentration of NaCl. 
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Fig.4.6. DEAE column elution profile using a 0.1 M and 
0.2 M NaCl step gradient. 
Approx. 10 ml of solubilised membrane fraction was loaded 
onto a pre-equilibrated 4 x 1 cm DEAE column which was 
then washed with 10 ml of column buffer. The verapamil 
binding activity was eluted from the column using 0.1 M 
and 0.2 M NaCl steps, as indicated on the graph. 
Fractions of 1 ml were collected and assayed for [3HJ 
verapamil binding. 
binding activity was 2096 (before correction) , indicating 
a loss in binding activity of upto 80%. On average the 
loss in binding activity incurred over the duration of 
the DEAE column run was 42.5 ± 15% (n=7) . This accounts 
for a large proportion of the loss in activity observed 
here. In further experiments in which the loss of 
activity was measured, the figures for the overall 
recovery of binding activity have been corrected to take 
this loss into account. 
After elution from the DEAE column with 0.1 M NaCl, 
the verapamil binding protein was purified from the 
solubilised membrane preparation by just over 1 fold. (3 
fold purification from crude membrane fractions) . In 
similar experiments carried out using this protocol, it 
was often observed that recovery of verapamil binding 
activity, with a relatively high specific activity, was 
not always eluted with 0.1 M NaCl step. Bearing this in 
mind, it was decided to elute the verapamil binding 
protein from the DEAE column with 0.15 M NaCl. This was 
in order to elute as much verapamil binding activity as 
possible, while at the same time avoiding the dilution of 
the verapamil binding activity with proteins with no or 
very little binding activity. 
4.3.2. The final elution protocol. 
As a result of the above experiments, the 
solubilised verapamil binding protein was applied to the 
DEAE column and eluted with 0.15 M NaCl. This was carried 
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out routinely as the first chromatographic step in the 
purification of the verapamil binding protein. 
When the dihydropyridine receptor was purified from 
rabbit skeletal muscle it was found that the inclusion of 
a low percentage of detergent was necessary to obtain a 
good percentage recovery of binding activity. For this 
reason 0.1% CHAPS was included in the 0.15 M NaCl elution 
buffer used for the DEAE column (and in all column 
buffers used in the final purification protocol) . 20% 
sucrose was also present in the elution buffer to 
maintain the stability of the protein during 
purification. 
Using this method, the total fold purification of 
the veraparnil binding protein after solubilisation of the 
crude membrane fraction and subsequent fractionation on a 
DEAE column was on average 3.37 ± 1.41 (n=9) fold. 
Fractionation of the solubilised membrane preparation on 
a DEAE column gave an average fold purification of 2.25 ± 
1.28 (n=9). Recovery of binding activity after DEAE 
column chromatography of the solubilised fraction was 69 
± 42 % (n=9) of that initially loaded. Recovery of 
protein was 14.5 ± 2.3 mg or 31 ± 5.6 % (n=9). 
Although the purification factor achieved with the 
DEAE column was fairly low (2.25 ± 1.28 n=9), the DEAE 
step was retained in the purification procedure in order 
to remove components of the solubilised sample (lipid, 
protein, pigment complexes) , which would otherwise 
prevent the sucess of subsequent purification steps. 
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4.4. Gel Filtration Column Chromatography. 
Gel filtration column chromatography was employed 
for two reasons. 1. To purify further the verapamil 
binding protein found in the peak binding fractions 
eluted from the DEAE column. 2. To obtain an estimation 
of the molecular weight of the verapamil binding protein/ 
complex. 
In preliminary purification investigations, it had 
been noticed that decay of binding activity occurred over 
time. Therefore attempts were made to minimise 
denaturation of the verapamil binding protein by using a 
high flow rate gel filtration matrix. Sephacryl S300 and 
S400 were both examined chosen as Sephacryl gives higher 
flow rates than most other gel filtration matrices. 
Sephacryl S300 was used in initial experiments, but 
discarded in favour of 5400 in later (and in the final 
purification procedure), in an attempt to obtain a more 
accurate estimation of the molecular weight of the 
verapamil binding protein. 
4.4.1. Sephacryl 5300 experiments. 
DEAE fractions containing the highest verapamil 
binding activity were fractionated on a Sephacryl S300 
column. 
Fig.4.7.a. shows a typical S300 column elution 
profile. The graph indicates that the verapamil binding 
activity was eluted from the column as one main peak. The 
Fig.4.7.a.b.c. Sephacryl S300 column elution profiles. 
Approx. 0.5 ml of pooled peak veraparnil binding fractions 
from the DEAE column were loaded onto a pre-equilibrated 
Sephacryl S300 column. 
The column was eluted with 
column buffer. 
column buffer plus 1 M NaCl. 
column buffer plus 1 mM DTT. 
Fractions of 1 ml were collected and assayed for [3H] 
veraparnil binding. The void volume of the column was 
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elution position corresponds with the elution of the Blue 
Dextran 2000 from the column, indicating that the 
verapamil binding protein is eluted in the void volume of 
the column. This suggests that the verapamil binding 
protein or verapamil binding protein complex has a 
molecular weight of greater than 1.5 x 106  Daltons. 
To investigate whether the verapamil binding protein 
was being eluted from the column as a large aggregate, 
DEAE fractions were separated on S300 columns in the 
presence of 0.2 M, 1.0 H NaCl or 1 mM DTT in order to 
break up the potential aggregate. High salt was added to 
reduce protein/protein ionic interactions and DTT to 
break disulphide linkages between proteins. However, the 
inclusion of these substances in the elution buffer did 
not significantly alter the elution behaviour of the 
verapamil binding activity. In each case the verapamil 
binding activity was eluted in the void volume of the 
column. Figs. 4.7. b. & c. illustrate Sephacryl S300 
column elution profiles in the presence of 1 M NaCl and 1 
mM DTT. 
The average purification obtained after S300 
fractionation of peak DEAE fractions was 13 ± 7 fold 
(n=4) . The variation in purification may be attributed to 
the extent of purification achieved in earlier steps and 
may possibly depend on the presence of NaCl and DTT, but 
this was not investigated further. The recovery of 
binding activity from the column ranged from 29% to over 
100% of that originally applied to the column. 
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4.4.2. Sephacryl S400 experiments. 
The results obtained from the Sephacryl S300 
experiments suggested that the verapamil binding protein 
may be a large complex with a molecular weight of over 
1.5 x 106 Daltons. To investigate this further a 
Sephacryl S400 column, with a fractionation range of 2 x 
io - 8 x 106  Daltons, was employed. 
A typical S400 column elution profile is shown in 
Fig.4.8. The graph shows that the verapamil binding 
activity is eluted from the column in the void volume, as 
indicated by the Blue Dextran 2000. This suggests that 
the verapamil binding protein is larger than first 
thought and chrornatographs as a large aggregate with a 
molecular weight of over 8 million daltons. 
Phenyl Sepharose separation of the DEAE fraction 
prior to gel filtration fractionation, also had no effect 
on the elution behaviour of the verapamil binding 
protein, which still eluted in the void volume. 
Purification of the verapamil binding protein, after 
application of DEAE fractions containing peak verapamil 
binding activity to a Sephacryl S400 column, was on 
average 13.5 ± 8.17 fold (n=9). The average total 
purification i.e. the purification obtained from crude 
membrane, was 22.5 ± 9.59 fold (n=9) . Data from a number 
of experiments indicated that the recovery of binding 
activity in the pooled peak fraction was over 100% of 











Fig.4.8. Sephacryl S400 column elution profile. 
Approx. 2 ml of pooled peak verapainil binding fractions 
from the DEAE column were loaded onto a pre-equilibrated 
Sephacryl S400 column. The column was then eluted with 
column buffer. Fractions of 1 ml were collected and 
assayed for [3H] verapamil binding. The void volume of 
the column was determined separately using Blue Dextran 
2000 monitored at A280. 
binding activity, also seen in the S300 experiments, may 
be due to the removal of inhibitory binding proteins 
during purification and/or by the purification of other 
proteins which may promote veraparnil binding. Recovery of 
protein was 2.5 ± 1.0 mg or 16.1 ± 4.796 (n9). 
The figures quoted here have been adjusted for 
losses in activity which occurred due to freezing of the 
DEAE fraction prior to application to the S400 column and 
those losses incurred over the duration of the DEAE 
column run. On average the loss in activity due to 
freezing was 51 ± 10.8 96 (n=5). In some instances no 
activity appeared to be lost due to freezing. The average 
loss in activity over the duration of the DEAE column run 
was 42.5 ± 15% (n=7) , (see section 4.3.2.). (Adjustments 
were made for each individual experiment before the 
results were averaged) . Losses in binding activity 
during the S400 column run were negligible. 
4.5. Hydrophobic Interaction Column Chromatography. 
Following partial purification of the verapamil 
binding protein using ion exchange and gel filtration 
column chromatography, further purification was attempted 
using hydrophobic interaction chromatography (HIC) . This 
type of chromatography was chosen because it is known 
that calcium channels are hydrophobic in nature. Phenyl 
Sepharose CL-4B was chosen as the column matrix in 
preference to octyl Sepharose, as strong and weak 
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hydrophobic proteins can be eluted fairly easily from 
this matrix. 
In initial experiments phenyl Sepharose was used to 
separate fractions containing peak verapamil binding 
activity eluted from the DEAE column. Once suitable 
conditions for obtaining peak verapamil binding activity 
from the phenyl Sepharose column had been determined, 
fractions from the Sephacryl 3400 column were separated 
on phenyl Sepharose columns using similar conditions. 
The following section presents the development of 
the phenyl Sepharose column elution protocol and the 
purification of the verapamil binding protein from S400 
fractions achieved with the final optimum elution 
protocol. 
4.5.1. Development of the elution protocol. 
A number of elution protocols were utilised to 
optinise the conditions required for 1. Loading of the 
sample onto the column. 2. Washing of the column to 
remove non-specific binding proteins. 3. Elution of the 
verapamil binding protein with a high specific activity. 
Optimum conditions were investigated by varying the salt, 
calcium, detergent/sucrose concentration and buffer 
components of the load, wash and elution buffers. These 
changes alter the hydrophobicity of the aqueous 
environment of the column matrix and consequently qffect 
the behaviour of the verapamil binding protein and other 
proteins at the load, wash and elution steps. A balance 
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between the recovery of total binding activity and an 
increase in specific activity was looked for with each 
elution protocol, the aim being to obtain the verapamil 
binding protein in a fraction with high specific activity 
and most of the binding activity. (See Table 4.3.). 
The elution profiles for the different protocols 
investigated are shown in Fig.4.9. - Fig.4.13. 
Essentially three main buffers were used in the elution 
protocols. These were either 1. High salt, high Ca2+, 
high detergent & sucrose, Tris & Mops, referred to as 
high salt buffer. 2. Low salt, high Ca2+, detergent & 
sucrose, Tris & Mops, referred to as low salt buffer. 3. 
Low detergent & sucrose, high salt, higb. Ca2+,  Tris & 
Mops, referred to as low detergent/sucrose buffer. The 
sample was loaded onto the column and washed in one of 
the above buffers. The column was then eluted by the 
removal of salt, Ca2+ or Tris & Mops from the basic 
buffer, as indicated in the figures. These buffers are 
referred to as low salt elution buffer, low calcium 
elution buffer, minus Tris/Mops elution buffer. Minus 
Ca2+ elution buffer refers to an elution step of 
unbuffered EGTA only. 
Fig.4.9. illustrates the elution profile for the 
phenyl Sepharose column using protocol 1. Essentially 
this protocol involved loading and washing of the column 
in low salt buffer, followed by sequential elution with 
low calcium and minus Tris/Mops elution buffer. Total 
recovery of binding activity using this protocol was 90 
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Fig.4.9. Phenyl Sepharose column elution profile using 
protocol 1. 
Approx. 4 ml of pooled peak verapamil binding fractions 
from the DEAE column were adjusted to 1 mM Cad 2 and 
loaded onto a 4 x 1 cm phenyl Sepharose column which had 
been pre-equilibrated with low salt buffer. The column 
was then washed with low salt buffer (1) , followed by low 
Ca2 	buffer (2) , minus Tris/Mops buffer (3) , minus Ca2  
buffer (4) and d.H20 (5) . Fractions of 4 ml were 
collected and assayed for [3H] verapamil binding. 
An A280 trace was used to indicate protein elution from 
the column. Fractions were collected when the trace 
deviated from a basal level. Fractions containing no 
protein were not collected and are indicated by II on the 
graph. 
Table 4.3. Recovery of [3H] verapamil binding activity 
and specific activity for each phenyl 
Sepharose elution step. Protocol 1-5. 






% Total activity recovered indicates the activity 
recovered from the column as a percentage of that 
initially loaded. % Rec. indicates the recovery of [3H] 
verapamil binding activity for each elution step as a 
percentage of the total binding activity recovered from 
the column. SA indicates the specific activity of each 
elution step. D/S denotes detergent/sucrose. 
of that originally loaded onto the column. Of this 
activity, 71% was eluted from the column during the low 
salt loading and washing stage and had a relatively high 
- specific activity. Low calcium elution buffer followed by 
detergent/sucrose only elution, both eluted smaller 
amounts of binding activity, but of fairly high specific 
activity. No further elution of protein or binding 
activity was achieved with either minus Ca2+ buffer or 
H20. (Table 4.3.). 
Due to the high loss of binding activity under low 
salt loading conditions, the inclusion of high salt in 
the loading and washing steps was investigated in 
protocol 2. In summary, following the high salt load and 
wash, the column was eluted with low salt, low Ca2+ and 
minus Tris/Mops elution buffers (Fig.4.10.). Using this 
protocol 32% of the binding activity initially loaded 
onto the column was recovered. The graph indicates that 
in the presence of salt a high proportion of the 
verapamil binding activity remained bound to the column. 
Only 2% of the total binding activity recovered was 
washed off the column at this stage. (Table 4.3.). After 
low salt elution very little binding activity eluted from 
the column. Low Ca2+  eluted a small amount of activity 
but with high specific activity. However, the majority of 
the verapamil binding activity with relatively high 
specific activity was eluted with minus Tris/Mops elution 
buffer. Very little activity or protein was eluted after 
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Fig.4.10. Phenyl Sepharose column elution profile using 
protocol 2. 
Approx. 4 ml of pooled peak verapamil binding fractions 
from the DEAE column were adjusted to 1 M (NH4)2SO4 and 1 
mM Cad 2 and loaded onto a 4 x 1 cm phenyl Sepharose 
column which had been pre-equilibrated high salt buffer. 
The column was then washed with high salt buffer (1) 
followed by low salt buffer (2) , low Ca2 buffer (3) 
minus Tris/Mops buffer (4) , minus Ca2 buffer (5) and 
d.H20 (6) . Fractions of 4 ml were collected and assayed 
for [3H] verapamil binding. An A280 trace was used to 
indicate protein elution from the column. Fractions were 
collected when the trace deviated from a basal level. 
Fractions containing no protein were not collected and 
are indicated by II on the graph. 
(Fig.4.10., Table 4.3.). The main conclusion drawn from 
the use of this protocol was that the presence of high 
salt improves the loading of the sample. 
In further investigations into the optimum loading, 
washing and elution conditions, the effects of low 
detergent & sucrose concentration, were examined. 
(Protocol 3., Fig.4.11.). In summary the sample was 
loaded in high salt followed by elution with low salt, 
minus Tris/Mops buffer (to give low detergent/sucrose 
only) and minus Tris/Mops buffer (to give high detergent 
sucrose only) . With this protocol 83% of the activity 
initially loaded onto the column was recovered. 50% of 
this activity with relatively high specific activity was 
eluted immediately in the load and wash step. (Fig.4.11., 
Table.4.3.). Low salt led to the elution of a very small 
amount of binding with low specific activity. The 
remaining activity was eluted with low detergent/sucrose 
only and high detergent/sucrose only elution buffer. The 
latter elution step had the highest specific activity. 
(Table.4.3J. The conclusions from this protocol were 
that loading the sample in low detergent/sucrose does not 
promote the binding of the sample to the column matrix 
and minus Tris/Mops (low detergent/sucrose) elution 
followed by minus Tris/Mops (high detergent/sucrose) 
elution gives good recovery of the veraparnil binding 
protein with high specific activity. 
As a result protocol 4 used high salt, high 
detergent/sucrose loading conditions, followed by elution 
123 
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Fig.4.11. Phenyl Sepharose column elution profile using 
protocol 3. 
Approx. 4 ml of pooled peak verapamil binding fractions 
from the DEAE column were adjusted to 1 M (NH4)2SO4 and 1 
mM Cad 2 and loaded onto a 4 x 1 cm phenyl Sepharose 
column which had been pre-equilibrated with low 
detergent/sucrose buffer. The column was then washed with 
the same buffer (1) , followed by low salt buffer (2) 
minus Tris/Mops (low detergent/sucrose) buffer (3) and 
minus Tris/Mops (high detergent/sucrose) buffer (4k. 
Fractions of 4 ml were collected and assayed for [ H] 
verapamil binding. 
An A230 trace was used to indicate protein elution from 
the column. Fractions were collected when the trace 
deviated from a basal level. Fractions containing no 
protein were not collected and are indicated by // on the 
graph. 
with low salt (which should elute a high proportion of 
the protein according to previous protocols) , minus 
Tris/Mops (low detergent/sucrose) and minus Tris/Mops 
(high detergent/sucrose). (Fig.4.12.). 3596 of the 
activity initially loaded was recovered using this 
protocol. The graph indicates that the sample loaded 
sucessfully onto the column, with only 14% of the total 
activity recovered lost at this stage. Low salt led to 
the elution of a large proportion of the protein 
(Fig.4.12.) , and a small amount of activity (Table.4.3.) 
Elution with minus Tris/Mops (low detergent/sucrose) 
included to cause the elution of a relatively large 
amount of verapamil binding activity with high specific 
activity, failed to do so in this case; a small amount of 
binding activity with low specific activity was eluted 
from the column. However, use of minus Tris/Mops (high 
detergent/sucrose) resulted in the elution of the 
majority of the binding activity with high specific 
activity. (Table.4.3.). 
From these investigations the following conclusions 
were drawn. 
Successful loading of the verapamil binding activity 
onto the column requires the presence of high salt and a 
high concentration of detergent & sucrose. 
If the sample is loaded under these conditions, most 










Fig.4.12. Phenyl -Sepharose column elution profile using 
protocol 4. 
Approx. 4rnl of pooled peak verapamil binding fractions 
from the DEAE column were adjusted to 1 M (NH4)2SO4 and 1 
mM CaC12 and loaded onto a 4 x 1 cm phenyl Sepharose 
column which had been pre-equilibrated with high salt 
buffer. The column was then washed with the same buffer 
(1) , followed by low salt buffer (2) , minus Tris/Mops 
(low detergent/sucrose) buffer (3) and minus Tris/Mops 
(high detergent/sucrose) buffer A4). Fractions of 4 ml 
were collected and assayed for [ H] veraparnil binding. 
An A280 trace was used to indicate protein elution from 
the column. Fractions were collected when the trace 
deviated from a basal level. Fractions containing no 
protein were not collected and are indicated by 1/ on the 
graph. 
A small but significant amount of veraparnil binding 
protein with high specific activity is eluted by lowering 
the calcium concentration in the elution buffer. 
The majority of the binding protein with high specific 
activity is eluted upon removal of the buffer component 
of the elution step i.e. with high detergent/sucrose 
only. 
These conclusions led to the design of the final 
elution protocol which was, loading and washing in high 
salt buffer followed by sequential elution with low salt, 
low Ca2 and high detergent/sucrose only. 
4.5.2. The final elution protocol. 
Fig.4.13. illustrates a typical phenyl Sepharose 
elution profile using the final protocol to separate 
pooled S400 fractions containing peak verapamil activity. 
Total recovery of binding activity from the column was 
46% of that originally loaded. During loading and washing 
a small amount of binding with low specific activity was 
eluted from the column. The lowering of salt and calcium 
led to the elution of 39% and 10% of the binding activity 
respectively with relatively high specific activity. 
Elution with high detergent/sucrose only led to the 
elution of 34% of the total binding activity with the 
highest specific activity. (Table.4.3.). 
Data from eight experiments utilising the final 
elution protocol indicated that the average fold 
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Fig.4.13 Phenyl Sepharose column elution profile using 
the final elution protocol (protocol 5). 
Approx. 4ml of pooled peak verapamil binding fractions 
from the Sephacryl S400 column were adjusted to 1 M 
(NH4)2SO4 and 1 mM CaC12 and loaded onto a 2 x 1 cm 
phenyl Sepharose column which had been pre-equilibrated 
with high salt buffer. The column was then washed with 
upto 18 ml of high salt buffer and then eluted with 18 ml 
each of low salt buffer, low Ca2+ buffer and minus 
Tris/Mops buffer. Fractions of 2ml were collected and the 
first four 2 ml fractions of each elution step were 
assayed for [3H] verapamil binding. 
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phenyl sepharose fractionation of the S400 fraction, was 
4 ± 1.58 (n=8) . Total fold purification i.e. after all 
the purification steps, was 39 ± 15.6 (n=8) and recovery 
of protein was 0.27 ± 0.09% (n=8) of that in the initial 
crude membrane preparation. This was equivalent to an 
average of 0.14 ± 0.019 (n=8) mg of protein found in the 
peak phenyl Sepharose fraction. The figures have been 
adjusted for losses in activity incurred earlier in the 
purification. Losses in binding activity during the 
phenyl Sepharose column run were negligible. 
4.6. Lectin Affinity Column Chromatography. 
Lectin affinity chromatography, which purifies 
glycoproteins, was used in the purification of the 
skeletal muscle calcium channel by taking advantage of 
the glycoprotein nature of the channel. Following this 
precedent set in the animal system, the purification of 
the verapamil binding protein from solubilised membrane 
fractions and DEAE fractions, was also attempted using 
both wheat germ lectin (coupled to agarose) and Con-A 
Sepharose. 
This section outlines some of the approaches taken 
to purify the verapamil binding protein and to 
characterise its possible sugar specific residues using 
lectin affinity chromatography. 
Solubilised membrane fractions were applied to Con-A 
Sepharose and wheat germ lectin (WGA). Fig.4.14. and 
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Fig.4.15. illustrate the elution profiles for the Con-A 
and wheat germ lectin columns respectively. 
Using the Con-A Sepharose column, 6196 of the binding 
activity initially loaded onto the column was recovered. 
Of the total activity recovered from the column, 72% was 
eluted in the load supernatant, together with the major 
protein peak (fraction 1.). In the susequent wash step a 
further 18% of the total recoverable activity was eluted 
from the column (fraction 2.). Elution of the column with 
0.1 N, 0.3 M and 0.4 M a-methyl mannoside resulted in no 
recovery of activity (fraction 1,3,4.). 0.2 M and 0.5 M 
a-methyl inannoside eluted 6% and 3% of the verapamil 
binding activity from the column respectively (fraction 
2,5.). No purification of the verapamil binding protein 
was achieved using Con-A sepharose. This result suggests 
that the verapamil binding protein does not have the 
specific sugar residues (a-D-mannopyranosyl, a-D-
glucopyranosyl and sterically related residues) , to 
interact with Con-A lectin. 
Using the wheat germ lectin column, 88% of the 
binding activity initially loaded onto the column was 
recovered. 81% of the total activity recovered from the 
column was eluted in the load SN and was eluted with the 
major protein peak (fraction 1.). 10% of total binding 
activity was eluted from the column in the following wash 
step (fraction 2.) and approximately 3% of total binding 
activity was eluted with 100 mM n-acetyl-glucosarnine 
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Fig.4.14. Con-A Sepharose elution profile. 
Approx. 1 ml of solubilised membrane fraction was applied 
to the Con-A Sepharose which had been washed with Con-A 
column buffer. The Con-A plus sample were incubated for 
2 h at 40C and then centrifuged. The supernatant, 
referred to as the load supernatant (LSN) was removed and 
assayed for [3H] verapamil binding (fraction 1) . The Con-
A was washed with Con-A column buffer and centrifuged. 
The wash supernatants (WSN) were pooled and assayed for 
[3H] verapainil binding (fraction 2) . The Con-A was then 
sequentially eluted with 1 ml each of 0.1 M, 0.2 M, 0.3 
M, 0.4 M, 0.5 M a-methyl mannoside in Con-A column 
buffer. The supernatants from each elution step (ESN) 
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Fig.4.15. Wheat Germ Agarose column elution profile. 
Approx. 1 nil of solubiljsed membrane fraction was applied 
to the Wheat Germ Agarose which had been washed in column 
buffer. The WGA plus sample were incubated for 2 h at 40C 
and then centrifuged. The WGA was washed and then eluted 
with 100 mM n-acetyl-D-glucosamine in column buffer. The 
load supernatant (fraction 1) , wash supernatant (fraction 
2 and elution supernatant (fraction 3) were assayed for 
H] verapamil binding. 
protein was not achieved with wheat germ lectin. The 
results suggest that the verapamil binding protein does 
not have the specific sugar residues (N-acetyl-
glucosaminyl residues) , to interact with wheat germ 
lectin. 
With both Con-A and WGA, incubation of the protein 
sample with the matrix for up to 24 hours at 40C, did not 
alter the elution behaviour of the verapamil binding 
activity, i.e. the major part of the verapamil binding 
activity eluted in the load SN. 
Approximately 60% and 80% of the activity initially 
loaded was recovered from the Con-A and WGA columns 
respectively. This suggests that a proportion of the 
loaded activity remains bound to the column and/or the 
binding protein may have lost its activity during the 
experiment. 
Using WGA and Con-A, the greater part of the 
verapamil binding activity recovered in total from the 
lectin columns was eluted from the column immediately 
(during loading of the sample and the subsequent wash 
steps) . This indicates that the verapamil binding protein 
may not be a glycoprotein or has sugar residues which do 
not interact with Con-A or WGA. Other lectin types need 
to be tested to confirm this. Alternatively, the 
verapamil binding protein may be a glycoprotein but 
during the earlier stages of purification the appropriate 
sugar residues, which would allow interaction of the 
protein with the lectin, have been removed. 
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As the purification achieved was negligible and 
because verapamil binding activity was not retained by 
Con-A or WGA, lectin affinity chromatography was not used 
in the purification of the verapamil binding protein. 
4.7. SDS Polyacrylamide Gel Electrophoresis. 
After each purification step, (solubilisation,DEAE, 
gel filtration and phenyl Sepharose columns), the 
proteins contained in the different fractions were 
analysed by gel electrophoresis under reducing 
conditions. 
Fig.4.16. shows a 10% SDS polyacrylamide gel of the 
purification steps. The gel has been stained with 
Coomassie blue, followed by silver staining. Lane 1 shows 
the protein content of the solubilised CHAPS extract. The 
heavy staining of this lane indicates the presence of 
many proteins. 
After fractionation of the solubilised extract on a 
DEAE column, the DEAE fractions with peak verapamil 
binding activity still have many other proteins 
associated with the verapamil binding protein, (lane 2) 
The slightly less dense staining of the lane suggests 
that a small proportion of the associated proteins have 
been removed by this step, which corresponds to the low 
fold purification (average 2 fold) , achieved after DEAE 
fractionation of the solubilised sample. 
Lane 3 indicates the protein content of the S400 
fraction containing peak verapamil binding activity. 
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Fig.4.16. SDS PAGE of [3H] verapamil binding fractions 
from maize coleoptile membranes at different 
stages of purification. 
Lane 1, CHAPS solubilised membrane extract (5 pg of 
protein); Lane 2, pooled peak verapamil binding DEAE 
fraction (5 pg of protein); Lane 3, pooled peak 
verapamil binding Sephacryl S400 fraction (5 pg of 
protein) ; Lane 4, Sephacryl S400 fraction with no 
verapamil binding activity (5 pg of protein) ; Lane 5, 
minus Tris/Nops (high detergent/sucrose) fraction from 
the phenyl Sepharose column (1 pg of protein) . The 
proteins were visualised by staining the gel with 
Coomassie blue and silver. 
Substantially more of the associated proteins have been 
removed after this step, which reflects the average 
purification of approx. 13 fold found after fractionation 
of S400 fractionation of the DEAE sample. 
Lane 4 shows the protein content of an S400 major 
protein fraction containing no verapamil binding activity 
for comparison. It is noticeable that the band of Mr 
169,000 is absent in the protein profile of this 
fraction, together with some bands of lower molecular 
weight. 
The final purification step, lane 5, contains four 
stained bands of Mr 169,000, Mr 100,000, Mr 70,000 and Mr 
66,000. The large reduction in the number of proteins 
present in the peak binding fraction after the final 
purification step, suggests that there has been extensive 
purification of the verapamil binding protein. The bands 
of Mr 169,000 and 70,000 appear to become enriched during 
the purification and their enrichment follows the 
increase of specific binding activity of [3H] verapamil. 
The band of Mr 169,000 was found to be absent from the 
protein profiles of inactive fractions (lane 4) , but 
present in active fractions. This suggests that this 
protein may be essential for the binding of verapamil. 
Indeed, it may be the verapamil binding protein/receptor 
and be part of a plant calcium channel. Could any of the 
other protein bands in the final fraction be the 
verapamil binding protein? The band of Mr 100,000 is 
considered to be a contaminant protein, as this protein 
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was observed in both verapamil binding and non-verapamil 
binding fractions from the Sephacryl 5400 column and the 
breakthrough fractions from the DEAE column. The protein 
of Mr 70,000 may also be a contaminant, as a protein of 
equivalent molecular weight was observed in some of the 
non-verapamil binding fractions of the Sephacryl 5400 
elution profile. The band of Mr 66,000 is also discounted 
as being the verapamil binding protein or part of a 
calcium channel, as this band is a staining artefact from 
keratin, frequently observed even in unloaded gel slots 
and reported by others (Ochs, 1983) 
On the basis of these observations, the protein of 
Mr 169,000 is suggested to contain the verapamil binding 
site. It is also possible that the Mr 70,000 band may 
bind verapamil or perhaps be an associated channel 
protein. The band of Mr 169,000 is thought to be the more 
likely candidate for the verapamil binding protein, as 
this polypeptide is comparable in size to the a1 subunit 
of the L-type calcium channel from skeletal muscle, which 
has a molecular weight of 155-200 kDa (Glossmann & 
Streissnig, 1988) and contains the receptor sites for 
dihydropyridines and phenylalkylamines (Striessnig et al, 
1986,1987) 
There are no comparable calcium channel subunits in 
skeletal muscle, of molecular weight similar to the band 
of Mr 70,000 observed here. However, on this basis alone, 
the Mr 70,000 band cannot be discounted as a channel 
137 
subunit, as plant calcium channels may have different 
sized subunits compared to their animal counterparts. 
4.8. The Purification Procedure: Summary and Discussion. 
The putative verapamil binding protein was partially 
purified using a combination of detergent solubilisation, 
ion exchange, gel filtration and hydrophobic interaction 
column chromatography. In summary the purification 
protocol was as follows. The membrane bound verapamil 
binding protein was solubilised using 0.5% CHAPS and 20% 
sucrose in buffer at a protein detergent ratio of 1:14 
(w/w). The solubilised verapamil binding protein was then 
subjected to DEAE ion exchange chromatography and the 
verapamil binding protein eluted from the column with 
0.15 M NaCl in column buffer. Fractions containing 
verapamil binding activity were further fractionated on a 
Sephacryl S400 column. Peak verapamil binding fractions, 
eluting in the void volume of this column, were then 
applied to a phenyl Sepharose column in high salt buffer. 
The column was eluted with low salt, low Ca2+  and minus 
Tris/Mops elution buffer, with the verapamil binding 
protein being eluted in the Tris/Mops elution buffer. The 
proteins from the final purified fraction were then 
separated by gel electrophoresis. This revealed four 
stained bands, one of which (Mr 169,000) was proposed to 
be the putative verapamil binding protein. 
The purification protocol used in the research 
presented in this thesis, can be compared to that 
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employed to purify the dihydropyridine-sensitive, 
voltage-dependent (L-type) calcium channel from skeletal 
muscle. One of the main differences in the methodology 
adopted to purify the verapamil binding protein and that 
used to purify the dihydropyridine receptor, was the 
absence of lectin affinity chromatography in the final 
verapamil binding protein purification protocol. Lectin 
affinity chromatography was very successful in the 
purification of the dihydropyridine receptor, because 
although the receptor subunit (ai) was not itself a 
glycoprotein, it was associated with glycosylated channel 
proteins and so could be purified. (Using wheat germ 
lectin the dihydropyridine receptor/skeletal muscle 
calcium channel was purified 38.2 fold (Borsotto et al, 
1985)) . The use of lectins was attempted, but the 
verapamil binding protein in solubilised maize coleoptile 
membrane preparations and DEAE fractions did not adhere 
successfully to Con-A Sepharose or Wheat germ lectin 
columns. This suggested that the verapamil binding 
protein was not a glycoprotein. If the putative verapamil 
binding protein is directly comparable to the a1 subunit 
of the skeletal muscle calcium channel, this might be 
expected. As no purification of the verapamil binding 
protein was achieved using WGA or Con-A Sepharose, lectin 
affinity chromatography was not employed in the 
purification protocol. 
Table 4.4. summarises the average purification data 
obtained using the final purification protocol. It is 
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PURIFICATION RECOVERY OF ACTIVITY. PROTEIN. SPECIFIC FOLD PURIFICATION. 
C.P.N. 39. STEP. TOTAL STEP. ACTIVITY. 
STEP TOTAL. STEP. TOTAL. 
CRUDE 226853 100 100 65 100 100 5793 - - 
?URNE. ± 	64618 ± 	5.5 11625 
HAFS 324070 297 297 57 119 119 19242 2.62 2,62 
OTRACT. 1264626 ± 	58.5 1 	58.5 ±14.6 ± 	19,2 ±1.2 ±6295 ±0.53 ±0.53 
DEAf. 113954 69,3 111 14.5 30.9 30.6 9960 2.25 3.37 
1 	31165 1 	41.7 ± 	52.6 1 	2.3 ± 	5.6 ± 	6.0 ± 3510 ±1.28 ± 	1.61 
SOD. 59040 106 74,2 2.5 16.1 5.0 51291 13.5 22.5 
1 	17569 ± 	68.0 ± 	39.6 ± 	1.0 ± 	6.7 1 	1.6 ±15925 ±1.17 ±9.59 
FIENYL 6228 21.2 6.6 0.09 5.97 0.2 94053 3,95 .36.3 
HAROSE. ± 	2156 ± 	15.6 1 	3.7 ± 	0.03 ± 	1.28 ± 	'J.Oó ± 19568 ± 	1.58 ± 	16.2 
Table 4.4. Averaged values for the recovery of binding 
activity, recovery of protein, specific 
activity and fold purification obtained using 
the final purification protocol. 
Values shown for crude membrane, CHAPS extract, DEAE and 
S400 are ± SE (n=9) . Values for phenyl Sepharose are ± SE 
(n=7). 
noticeable that there is variation in the degree of 
purification of the verapamil binding protein within a 
single stage of the procedure. The reasons for this 
variation probably lies in differences in the specific 
activity of the starting material and the degree of 
purification obtained in the previous purification steps. 
The activity of the crude membrane may vary according to 
how well the tissue was homogenised. Up to 50% of the 
plasma membrane can be lost with the cell walls during 
homogenisation and centrifugation (Hall, 1983) . Therefore 
if the homogenisation procedure is not totally uniform 
between experiments, the amount of activity will vary 
between preparations. Activity of the solubilised 
verapamil binding protein may also vary because although 
the tissue is solubilised at a strict protein:detergent 
ratio, variation in activity may occur if the preceeding 
homogenisation step has resulted in more or less membrane 
protein being available for solubilisation. 
Data from a number of ion exchange separations of 
the solubilised membrane fraction, indicated that where 
solubilisation of the crude membrane extract resulted in 
a significant purification of verapamil binding activity, 
the fold purification after DEAE column chromatography 
tended to be very low. This is probably because the 
solubilisation and DEAE steps are removing similar 
proteins, so that if most of these non-verapamil binding 
proteins are removed during solubilisation of the crude 
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membrane preparation, very few will be left to be removed 
by the DEAE column, thus resulting in low purification 
after ion exchange. Similarly where solubilisation of the 
crude membrane fraction has been poor, resulting in low 
purification after this step, the fold purification after 
the DEAE column tended to be higher. Therefore depending 
on the specific activity of the crude membrane and degree 
of purification of verapamil binding activity during 
solubilisation, the overall purification of the verapamil 
binding protein after ion exchange will vary between 
experiments. The average fold purification values 
obtained after solubilisation of the membrane bound 
receptor and DEAE fractionation of the solubilised 
verapamil binding protein were 2.62 ± 0.53 fold (n9) and 
2.25 ± 1.28 fold (n=9) respectively. 
S400 fractionation of DEAE fractions containing peak 
verapamil binding activity also gave variable amounts of 
purification depending on the sucess of the previous 
steps. However the S400 column consistently resulted in 
the highest purification of the verapamil binding protein 
compared to the other steps of the protocol. On average 
13.5 ± 8.1 fold (n=9) purification was achieved with this 
step. Separation of the S400 fraction on a phenyl 
Sepharose column resulted in an average 3.96 ± 1.58 fold 
(n=7) purification of the verapamil binding protein. 
C 
It therefore appears that the sucAess  of all the 
steps of the purification procedure are dependent on each 
other and all of them appear to be necessary for the 
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partial purification of the verapamil binding protein, 
despite the fact that the level of purification achieved 
maybe low after individual columns. 
Table 4.4. also indicates that there is variation in 
the recovery of binding activity within a single stage of 
the protocol. The figures have been adjusted for losses 
in activity due to freezing of the sample during the 
purification and decay of activity over time. This means 
that the observed variation is due to factors other than 
denaturation of the binding activity by freezing and over 
time. One explanation may be that some of the binding 
activity cannot be eluted and is therefore lost on the 
column. 
Loss of binding activity over the duration of the 
purification protocol occurred mainly at the DEAE stage 
of the purification procedure. On average this loss was 
42.5 ± 15 (n=7) . The observed variation in the decay of 
activity is probably a reflection of the degree of 
purification achieved during solubilisation eg: if 
purification after solubilisation has been poor, more 
proteases may be present in the sample than if the 
solubilisation had resulted in a better purification. 
This may lead to increased loss in binding activity due 
to protease action. Denaturation of the verapamil binding 
protein does occur during purification, despite attempts 
to stabilise the protein by the inclusion of 20% sucrose 
in all the column buffers. In a similar fashion, 
exogenous lipid or glycerol were used to limit receptor 
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denaturation in the purification of the dihydropyridine 
receptor from skeletal muscle. 
Using the final purification procedure, the average 
total purification i.e. after all the columns, of the 
verapamil binding protein was 36.3 ± 16.2 fold (n=7) . In 
one experiment the total purification was as great as 121 
fold. (Table.4.5.a.). However this figure is probably an 
over estimate due to the innacuracies involved in 
measuring the very low levels of protein remaining in the 
final phenyl Sepharose fraction. The average purification 
figures quoted are probably more representative of the 
purifications that can actually be achieved using the 
final protocol. (Table.4.4. & Table.4.5.b.) 
From SDS gel electrophoresis of fractions from the 
final purification step, a protein of Mr 169,000 is 
proposed as the putative verapamil binding protein. The 
gels indicate only one possible associated subunit, not 
four subunits as seen in gels of purified calcium 
channels from skeletal muscle (run under reducing 
conditions) . This suggests either that this method may 
not purify the whole channel, or that the structure of 
the plant calcium channel is different compared to 
animals. No absolute identification of the stained bands 
has been made, although attempts to do so using 
photoaffinity labelling and [3H] verapamil binding to 
western blots of purified fractions were made. These 
attempts are described later in this thesis. To check 








mm 7:600 100 56 100 1302 
CHAPS 
TRACT. 
32240 64 25 46 1705 1 
D€AE. 10304 14 4 7 2576 2 
SOO 23800 32 0,24 0.42 99166 76 
PriYI_ 1264 1.7 0,008 0.014 158000 121 
Table 4.5.a. Values for the best purification achieved 
using the final purification protocol. 
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PURIFICATION RECOVERY Of ACTIVITY. PROTEIN. SPECIFIC FOLD PURIFICATION. 
STEP. C.P.M. ig. ACTIVITY. 
cMI)E 102853 100 13 100 739 
CHAPS 
TRACT. 
345032 335 15 115 22288 3 
AE 58580 57 2.6 20 2158 3 
flO 37028 36 '132 2.3 115712 15 
Y1.. 
SEPIOSE. 
2285 ,2 0.016 ID.11 142750 18.68 
Table 4.5.b. Typical purification values obtained using 
the final purification protocol. 
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the channel, would require the protein to be 
reconstituted into lipid bilayers and tested for channel 
activity by patch clamping, which was outside the scope 
of this thesis. 
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CHAPTER 5. 
IDENTIFICATION AND VISUALISATION OF THE VERAPAMIL BINDING 
PROTEIN FROM MAIZE COLEOPTILES. 
5.1. Introduction. 
Two methods were employed to visualise a verapamil 
binding protein (or possibly proteins) in maize 
coleoptile membrane preparations and to verify whether 
the proposed protein of 169 kDa is the verapamil binding 
protein in plant membranes. 1. Photoaffinity labelling of 
the membrane bound and partially purified putative 
verapamil binding protein using the tritiated arylazido 
phenylalkylamine [3H] LU49888, an azido analog of D888. 
2. [3H] verapamil binding to western blots of crude 
membrane fractions and to fractions after each stage of 
purification. 
The results of these investigations are shown in the 
following section. 
5.2. Photoaffinity labelling using [N-methyl-3H] LU49888. 
5.2.1. [N-methyl-3H] LU49888 binding in crude membrane 
preparations from maize coleoptiles. 
In initial experiments utilising [3H] LU49888, the 
binding characteristics of the drug to maize coleoptile 
membrane fractions were investigated. The binding assay 
used to detect [3H] LU49888 binding in crude membrane 
fractions, was essentially the same as that used for [3H] 
verapamil binding. 
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Fig.5.1. illustrates [3H] LU 49888 binding in crude 
membrane fractions. The graph shows that there is a much 
higher amount of non-specific binding compared to 
specific binding at all the concentrations of [3H1 LU 
49888 examined. This is in contrast to [3H] verapamil 
binding where non-specific binding only makes up about 4% 
of the total binding, but similar to D888 binding 
experiments where non-specific binding was approximately 
50% of total binding. It is possible that the higher 
element of non-specific binding encountered here results 
from the azido group present in [3H) LU 49888, which may 
cause the drug to bind to proteins other than just 
specific phenylalkylamine binding proteins. Differences 
in the binding characteristics between [3H] verapamil and 
[3H] LU49888 may also be expected, as LU49888 is 
structurally slightly different. It should also be noted 
that the binding assay for LU 49888 has not been 
optimised for this particular drug, which may account for 
some of the differences observed. 
5.2.2. Photoaffinity labelling of the phenylalkylamine 
binding protein(s) from maize coleoptile membrane 
preparations. 
A variety of experiments were conducted in an 
attempt to identify the verapamil binding protein(s) 
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Free 3H LU49888 (nM). 
Fig.5.1. Binding of [3H] LU 49888 to crude membrane 
fractions from maize coleoptiles. 
[3H] LU 49888 was incubated with crude membrane fractions 
(0.5 mg/500 3.11 assay) for 2 h at 200C in the dark, at the 
concentrations indicated (total binding) . Non-specific 
binding (A) , was determined in parallel samples 
containing 100 3.1N unlabelled D888 and was subtracted from 
total binding to give specific binding () 
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purified membrane fractions by SDS PAGE. The methods 
employed were essentially the same as those used by Ferry 
et al. (1984b) . In particular it was hoped to determine 
whether the 169 kDa protein seen on SDS polyacrylamide 
gels was the verapamil binding protein as proposed 
earlier in this thesis. 
Membrane fractions were incubated with [3H] LU 49888 
and irradiated with UV light. This activiates the azido 
group which forms a covalent link with specific proteins. 
The labelled samples were then separated by gel 
electrophoresis, fixed and stained with Coomassie blue. 
Initially the gel was incubated in EN3HANCE, dried down 
and then autoradiographed. However, no bound [3H] LU 
49888 was observed, possibly because inadequate 
quantities of bound radioactivity were loaded onto the 
gel initially, which prevented detection of the binding 
proteins. Tritium is also difficult to detect by 
autoradiography. Following the failure of this method, 
the dried down gel was then cut into slices and the 
radioactivity incorporated into each slice determined by 
scintillation counting, as this is more sensitive than 
autoradiography. Fig.5.2. & Fig.5.3. show labelling of 
proteins from crude membrane and DEAE fractions after 
separation by SDS PAGE, using this method. 
Fig.5.2. indicates that a protein of apparent 
molecular weight 30 kDa is photolabelled with [3H] LU 
49888 in crude membrane fractions. No other proteins 
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Fig.5.2. Photoaffinity labelling of crude maize 
coleoptile membrane fractions using 
[3H] LU 49888 (method 1) 
Crude membrane fractions (0.5-1.0 rng/100-200 pl were 
incubated with a final concentration of 18 nM [ H] LU 
49888 (total binding) . Non-specific binding was 
determined by incubating membrane with [3H] LU 49888 plus 
100 i.1M of unlabelled D888. Specific binding (shown on 
this graph) was determined by subtracting non-specific 
binding from total binding. After incubation for 2 h at 
200C in the dark, the samples were photolabelled and 
separated by SDS PAGE. The gel lanes were cut into 2 mm 
slices, solubilised in alkali and the radioactivity 
incorporated into each slice determined by scintillation 
counting. The figure shows the results from the top of 
the gel (slice no.1) . The arrows indicate the position of 
the molecular weight markers. 
possibilities exist as to the identity of the labelled 30 
kDa protein: It maybe a subunit of a plant membrane 
calcium channel, which can bind phenylalkylamines. 
Subunits of a similar size have been found to be part of 
the L-type calcium channel from skeletal muscle, but they 
do not contain drug binding sites; it may be a 
proteolytic fragment of the 169 kDa peptide, which has 
been labelled by the [3H] LU 49888. However one may 
expect to see more fragments if this were the case; it 
may represent a low affinity phenylalkylamine binding 
site which is unrelated to the calcium channel drug 
binding sites. This type of binding has been identified 
in work with various animal tissues where [3H] 
nitrendipine plus high intensity UV irradiation 
identified components with low Mr (20,000 to 50,000) 
(Campbell et al., 1983; Home et al., 1984). 
The same photoaffinity technique was applied to DEAE 
fractions. (Fig.5.3.). The graph indicates that the 
labelling is fairly widespread, making it difficult to 
identify any definite peaks of [3H] LU 49888 
incorporation. The area of high incorpration at the top 
of the gel is probably due to contamination from the 
stacking gel which tended to accumulate protein and 
label. It is possible that there may a peak of [3H] LU 
49888 incorporation corresponding to a protein of approx. 
molecular weight 48 kDa, but apart from this the 
incorporation of label is found to some extent in every 
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Fig.5.3. Photoaffinity labelling of DEAE fractions 
containing peak verapamil binding activity, 
using [3H] LU 49888. 
DEAE fractions (0.1-0.5 mg/100-200 iil were incubated 
with a final concentration of 18 nM [ H] LU 49888 (total 
binding 0). Non-specific binding was determined in 
samples containing [3H] LU 49888 plus 100 iM unlabelled 
D888 (0). After incubation for 2 h at 200C in the dark, 
the samples were photolabelled and separated by SDS PAGE. 
The gel lanes were cut into 2 mm slices, solubilised in 
alkali and the radioactivity incorporated into each slice 
determined by scintillation counting. The figure shows 
the results from the top of the gel (slice 1) . The arrows 
indicate the position of the molecular weight markers. 
binding protein has fragmented during the photolabelling 
process, as reported for [3H] LU 49888 labelling of the 
skeletal muscle calcium channel (Striessnig et al., 
1987) , or that the label has bound to any protein it has 
come into contact with during irradiation. Fragmentation 
of the phenylalkylamine binding protein is possible as no 
protease inhibitors are present at any stage of the 
purification or during photolabelling. However in the 
results presented here it is difficult to identify 
definite proteolytic fragments, as the incorporation of 
label appears to occur throughout the sample with no 
obvious peaks of incorporation. This type of labelling 
was also observed when 3400 fractions were photolabelled 
with [3H] LU 49888. 
To reduce the amount of non-specific binding by the 
[3H] LU 49888 to the membrane fractions and allow clearer 
labelling of any phenylalkylamine binding proteins, 
irradiation was performed after filtration and washing of 
the sample. (Method 2.27.2.). [3H] LU 49888 is a highly 
reactive species, which, once it is activated by UV light 
appears to bind to any proteins in its vicinity, 
regardless of specificity. By irradiating the proteins 
plus label on the filter rather than the protein plus 
label in solution, it was hoped to remove some of the 
non-specific binding element by the filtering process and 
nature of the assay. When the incorporation of label by 
the irradiated filters was determined by scintillation 
counting, the results indicated that non-specific binding 
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was reduced to approximately 40-50% of the total binding 
compared to 70-80% of total binding obtained when the 
sample plus label was irradiated and then filtered. 
Despite the apparent reduction in non-specific binding, 
this element was still a substantial part of the total 
[3H] LU 49888 binding when the incorporation of 
radioactivity was determined in gel slices. The gel 
slices also indicated that there was no incorporation of 
label into specific polypeptides extracted from the 
filters. The high amount of non-specific binding plus the 
likely loss of labelled proteins during extraction (not 
all the labelled proteins will have been extracted from 
the filter) , prevented the identification of any labelled 
polypeptides in the gel slices. 
5.3. [3H] verapamil binding to Western blots of crude 
membrane fractions and to fractions containing the 
partially purified putative verapamil binding protein. 
An alternative strategy was adopted to detect 
verapamil binding proteins. After separation on SDS PAGE, 
the proteins in crude membrane fractions and partially 
purified verapamil binding fractions were then 
transferred to nitrocellulose paper and incubated in [3H] 
verapamil. [3H] verapamil binding to the separated 
proteins was detected by autoradiography of the 
nitrocellulose blot. 
Three methods were used to investigate [3H] 
verapamil binding to the separated protein fractions. 
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(Method 2.24) . Transfer of the proteins was essentially 
the same in all three methods. 
In the first method the proteins were transfered to 
nitrocellulose paper, washed with Tween 20 and incubated 
in [3H] verapamil. The Tween 20 was present to site 
saturate the blot. The blot was then washed, air dried 
and sprayed with EN3HANCE prior to autoradiography. On 
development of the autoradiograph, no localisation of 
[3H] verapamil binding was evident. Instead the label 
appeared to be found all over the blot, suggesting that 
the Tween 20 had not been sucessful in site saturating 
the blotted proteins, so allowing the verapamil to bind 
indiscriminately to any proteins present. 
In an attempt to alleviate this indiscriminate 
binding of [3H] verapamil to the blot, a second method 
was adopted in which the blot was incubated in 10 	M 
nifedipine followed by [3}j]  verapamil. Nifedipine was 
used because it was known from earlier experiments that 
verapamil is unable to displace nifedipine and that 
nifedipine does not appear to bind to the same site as 
verapamil. Because of this, nifedipine should be an 
effective agent to site saturate the blotted proteins. No 
localised bands of [3H]verapamil binding were detected in 
any of the fractions (crude, solubilised, DEAE, S400 and 
phenyl Sepharose) , although non-specific binding was 
reduced using this method. 
In the two methods described above, binding of [3H] 
verapamil to denatured proteins was measured. Because the 
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proteins were denatured and therefore conformationally 
changed, this was a possible reason for the proteins not 
binding [3H] verapamil. In the third method, the proteins 
were first renatured by incubation of the- gels in buffer 
containing 0.196 CHAPS prior to Western blotting. 0.196 
CHAPS was present throughout the whole experiment to keep 
the proteins renatured. The renatured proteins were then 
transferred to nylon membranes, incubated in nifedipine 
and then [3H] verapamil, as before. Autoradiographs of 
the nylon membranes indicated that again no binding of 
[31-] verapamil to specific proteins had occurred, despite 
renaturation of the proteins. 
5.4. Discussion. 
In summary, the verapamil binding protein was not 
detected by either photoaffinity labelling of membrane 
fractions prior to SDS PAGE or by [3H] verapamil overlay 
procedures on nitrocellulose blots. Thus no further 
evidence was found to support the proposal that the 169 
kDa protein found in partially purified preparations is 
the verapamil/phenylalkylamine binding protein. 
Futher work is needed to investigate photoaffinity 
labelling of phenylalkylamine binding proteins in maize 
coleoptile membrane preparations and in fractions 
containing the partially purified verapamil binding 
activity. The major problem with the photoaffinity 
labelling appears to be the amount of non-specific 
binding of [3H] LU 49888 to the membrane and purified 
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fractions. The use of carrot microsomal membrane 
fractions might overcome this problem as they bind D888 
with higher affinity than maize membranes and with 
greater distinction between specific binding and non-
specific binding (Graziana et al., 1987). As [3H] LU 
49888 is an azido analog of D888, use of the 
photoaffinity label may be more sucessful in carrot 
membranes. 
[3H] verapamil binding to western blots of SDS gel 
separated fractions also proved to be unsucessful. Using 
this technique, no specific phenylalkylamine/verapamil 
binding proteins were detected. It is possible that 
verapamil may not bind tightly enough to the blotted 
proteins and the label is removed during the washing of 
the blot. [3H] verapamil may also fail to bind to the 
blotted proteins because during purification components 
vital to the binding of verapamil have been removed. 
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CHAPTER 6. 
THE PRELIMINARY CHARACTERISATION OF THE PUTATIVE 
VERAPANIL BINDING PROTEIN. 
6.1. Introduction. 
The calcium channel has been sucessfully identified 
using [3H] verapamil. However, photoaffinity labelling 
and [3H] verapamil overlays failed to identify the 
verapamil binding subunit(s) of the channel. Other 
techniques were therefore used to further characterise 
the verapamil binding protein and associated components. 
L-type calcium channels from skeletal muscle have 
three glycosylated subunits, a2, 	and 5 (Glossmann & 
Streissnig, 1988) . The a., subunit, which contains the 
drug receptor sites, has glycosylation sites but no 
attached carbohydrate. The 13 subunit is also not 
glycosylated. These calcium channels are also known to be 
regulated by phosphorylation. The 165 kDa polypeptide (a1  
subunit) of the L-Type channel has been reported to act 
as a substrate for cAMP-dependent and calcium calinodulin-
dependent protein kinases and can undergo multiple 
phosphorylation at distinct sites by these enzymes 
(O'Callahan, 1988) . As well as these characteristics, 
calcium ions are thought to pass through the calcium 
channel by binding to divalent cation binding sites 
within the channel pore (Hess & Tsien, 1984) . From 
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studies of the amino acid sequence of the a1 subunit of 
the L-Type calcium channel, regions resembling areas of 
calcium binding proteins have been detected and 
electrophysiological and biochemical data suggests that 
there are at least two divalent cation binding sites in 
the channel (Tanabe et al., 1987) 
This chapter outlines the results from preliminary 
experiments carried out to investigate whether the 
verapamil binding protein and associated components from 
plant membranes are; 1. glycoprotein in nature. 
2. regulated by phosphorylation. 3. calcium binding 
proteins. 
6.2. The Possible Glycoprotein Nature of the Putative 
Verapamil Binding Protein. 
Binding of Con-A to proteins immobilised on 
nitrocellulose paper. 
Earlier work using lectin affinity chromatography 
indicated that the putative verapamil binding protein may 
not be a glycoprotein. To investigate further the 
possibility of the verapamil binding protein being 
glycosylated, an experiment was performed where the 
purified fractions from each column step in the 
purification protocol were separated by SDS gel 
electrophoresis. The separated proteins were then 
transferred to nitrocellulose paper by western blotting 
and incubated in peroxidase linked Con-A. The binding of 
Con-A to the immobilised proteins was detected by assay 
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for peroxidase activity, with purple bands indicating the 
presence of glycosylated proteins. 
Fig.6.1. shows the binding of Con-A to proteins 
immobilised on nitrocellulose paper. The lectin is seen 
to bind to a large number of bands in the DEAE fraction, 
including a band of Mr 169,000. This suggests that the 
putative verapamil binding protein may be glycosylated, 
although the specificity of detection is questionable. 
Binding of the lectin to proteins from the later stages 
of the purification (S400 and phenyl Sepharose) was not 
detected. 
6.3. Is the Putative Verapamil Binding Protein a Calcium 
Binding Protein? 
Binding of 45Ca2" to proteins immobilised onto 
nitrocellulose paper. 
To investigate whether the putative verapamil 
binding protein or other associated proteins in fractions 
from the final purification steps, were able to bind 
calcium, nitrocellulose blots of the separated proteins 
were overlayed with 45Ca2+ and the blots 
autoradiographed. The results suggest that the putative 
verapamil binding protein does not bind calcium and that 
there are no detectable associated calcium binding 













Fig.6.1. Binding of Con-A to peak verapamil binding DEAE 
fractions separated by SDS PAGE and 
blotted onto nitrocellulose paper. 
Lane 1.Silver stained SDS PAGE separation of a DEAE 
fraction containing peak verapamil binding activity. 
Lane 2. Binding of Con-A to the separated proteins 
immobilised on nitrocellulose.The dark bands indicate the 
presence of glycosylated proteins. 
6.4. The possible control of plant calcium channels by 
phosphorylation. 
Is the putative verapamil binding protein phosphoryla ted 
by endogenous protein kinase (s)? 
To investigate the possible role of phosphorylation 
in the regulation of plant calcium channels, 
phosphorylation of the putative verapamil binding protein 
was studied. These investigations focus on the 
phosphorylation activity of an endogenous kinase(s) which 
appears to co-purify with the verapamil binding protein. 
The activity of exogenous kinases such as cAMP-dependent 
and calcium cairnodulin-dependent protein kinases was not 
studied. 
In initial experiments, endogenous kinase activity 
was detected in crude membrane, DEAE and S400 purified 
verapamil binding fractions. Table.6.1. shows kinase 
activity in these different fractions as ATP incorporated 
in fmol/pg protein after 1 minute. The increase in 
activity over the blank suggests that phosphorylation has 
taken place. After each purification step the specific 
activity decreases, which suggests that a kinase may not 
co-purify with the putative verapamil binding protein or 
that the substrates for the kinase are being lost as 
purification procedes. 
Fig.6.2. indicates protein kinase activity over time 
in DEAE fractions containing peak verapamil binding 
activity in the absence and presence of calcium. The 
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Condition. 	Phosphate incorporated (fmo1/ig of protein). 
	
Crude 	 DEAE 	 S400 
membrane. 	fraction, 	fraction. 
-Ca2 	 6.7 	 6.3 	 2.1 
+Ca2 	 155.0 	 5.9 	 2.3 
+Ca2 	 29.5 	 5.9 	 2.6 
& CAM 
Blank 	 0.3 	 1.4 	 1.4 
(no protein) 
Table 6.1. Endogenous protein kinase activity in crude 
membrane and column fractions containing peak 
verapamil binding activity. 
Crude membrane or column fractions were incubated in an 
equal volume of buffer A (+Ca2 ) , buffer B (-Ca2 	or 
buffer C (Ca2+  plus Calmodulin) . 8 nM ATP was added and 
after 1 min the phosphate incorporated was measured using 
the cellulose disc assay (crude membrane) or the 






1 	 5 	 10 
Time (mm). 
Fig.6.2. Endogenous protein kinase activity in DEAE 
fractions containing peak verapamil binding 
activity. 
15 p.1 of DEAE fraction was mixed with an equal volume of 
buffer A (+Ca2) , (S ) or buffer B (-Ca2 ), ( 	). 
8 nN [ -32P] ATP was added and at the time 
points indicated phosphate incorporation was measured 
using the phosphocellulose strip assay. 
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similarity between the graphs suggests that there is 
little or no calcium dependence of phosphorylation. At 
the minute time point, kinase activity in the presence of 
calcium and calmodulin was not significantly different to 
that seen in the presence of calcium alone, suggesting 
that kinase activity was also not calcium/calinodulin-
dependent (Table.6.1.). The graphs show a peak in 
phosphate incorporation at 1 minute. Thereafter there is 
a rapid decline in incorporation to a plateau after about 
5 mm. The turnover of label suggests that protein 
phosphatase activity may also be present. The decline of 
phosphate incorporation may therefore represent the 
balance between kinase and phosphatase or the action of 
the phosphatase alone after depletion of the substrate. 
To investigate this, phosphorylation assays were 
conducted in the presence of pM ATP concentrations 
instead of nM ATP concentrations (as used initially) , to 
prevent substrate depletion, plus or minus sodium 
fluoride, a phosphatase inhibitor. 
In the presence of a higher concentration of ATP, 
phosphate incorporation remains high after 1 mm 
(Fig.6.3.). This suggests that kinase activity is not 
limited by the substrate. The final plateau level 
probably represents a balance between kinase and 
phosphatase activity. 
The inclusion of sodium fluoride in the assay 
mixture would be expected to cause an increase in 










Fig.6.3. Endogenous protein kinase activity in DEAE 
fractions containing peak verapamil binding 
activity, measured in the presence of 10 mM 
sodium fluoride and 1 pM ATP. 
15 p1 of DEAE fraction was mixed with an equal volume of 
buffer A (+Ca2 ), plus 1 pM ATP (fl-) or 1 pM ATP and 10 
nM NaF1 (--) . At the time points indicated 
incorporation of phosphate was measured using the 
phosphocellulose strip assay. 
fluoride. However this is not seen in the graph, which 
suggests instead that the sodium fluoride is having a 
non-specific inhibitory effect. The effect of sodium 
fluoride on kinase activity was not examined. 
Autoradiography of phosphorylated partially purified 
verapamil binding fractions suggests that the putative 
verapamil binding protein is not phosphorylated by the 
endogenous protein kinase. Other proteins in the 
solubilised and DEAE fractions appear to be 
phosphorylated (Fig.6.4.). Phenyl Sepharose and S400 
fractions were not anlaysed. 
6.5. Discussion. 
Results from the Con-A blot experiment suggest that 
the verapamil binding protein may be glycosylated. Con-A 
binding was only detected to proteins from the DEAE 
fraction and not to proteins from later stages of the 
purification. This was probably due to insufficient 
levels of purified protein (total protein) being blotted 
onto the nitrocellulose paper. Alternatively, the 
specific sugar residues required for binding of Con-A may 
have been lost during purification. This might also 
explain why lectin affinity chromatography was not 
sucessful in purifying the verapamil binding protein. 
At present it is difficult to draw any firm conclusions 
about the glycoprotein nature of the putative verapamil 
binding protein from plant membranes, especially as the 










Fig.6.4. Autoradiograph of a phosphorylated solubilised 
membrane fraction and peak veraparnil 
binding DEAE fraction. 
Solubilised membrane fractions and DEAE fractions 
containing peak verapamil binding activity were incubated 
in buffer A (+Ca2 ) and 8 nM ATP for 1 mm. Samples were 
then prepared and separated by SDS PAGE. The gel was then 
stained with Coomassie blue, dried and autoradiographed. 
Calcium binding by the verapamil binding protein 
and/or any associated channel proteins was not detected. 
If the plant calcium channel is similar to the skeletal 
muscle T-tubule channel, then perhaps one might expect 
calcium binding proteins to be found. However, although 
the channel needs to be specific for calcium ions, (a 
specificity apparently achieved by the channel binding 
calcium) , the binding and release of calcium is probably 
so rapid that it cannot be detected by the 45Ca2+ overlay 
technique. Further studies are required to verify the 
calcium binding capacity of the putative verapamil 
binding protein and associated proteins before any 
conclusions can be drawn about this character of plant 
calcium channels. 
Several conclusions can be drawn from the 
preliminary phosphorylation studies. 1. There is 
endogenous kinase activity in the partially purified 
verapamil binding fractions, but probably not in the 
final purified fraction, although low protein levels make 
this difficult to judge properly. 2. The endogenous 
kinases(s) does not appear to phosphorylate the putative 
verapamil binding protein, although it does appear to 
phosphorylate other proteins present in the partially 
purified fractions. It is possible that phosphorylation 
of the verapamil binding protein is not detected because 
it has been phosphorylated already. Further work to 
clarify the situation in respect to phosphorylation of 
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the veraparnil binding protein needs to be carried out 




7.1. The Experimental Approach: Problems and Criticisms. 
7.1.1. Using [31i3 verapamil as a marker for calcium 
channels. 
Calcium channel antagonists such as nifedipine and 
verapamil are extremely useful in the study of calcium 
channels as they bind to specific receptors located 
within the calcium channel itself. Radiolabelled forms of 
the drugs can therefore be used to specifically label 
calcium channel proteins and provide a relatively easy 
method for calcium channel detection and identification. 
The labelled channel antagonists have also be/ used in the 
purification of the drug binding subunit by either 
purification of an antagonist-channel complex (Curtis & 
Catterall, 1984) or by direct binding assay after each 
purification step (Borsotto et al., 1985). Using these 
methods the receptors for both the dihydropyridine and 
phenylalkylamine calcium antagonists plus their 
associated subunits, i.e. the whole calcium channel have 
been purified from skeletal muscle. 
In this research the calcium channel antagonist [3H] 
verapamil was used to detect and subsequently purify a 
verapamil binding protein (presumably the calcium 
channel) , from maize coleoptile tissue. Using a filter 
assay, [3H] verapamil binding was detected in crude 
membrane fractions prepared from maize coleoptiles, maize 
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roots and zucchini hypocotyls. Binding constants for [3H] 
verapamil were of slightly lower affinity than those 
obtained in animal tissue. The results of the [3H] 
verapamil binding experiments suggested that calcium 
channels were present in plant tissues, assuming the 
antagonist was behaving in the same way as it would in 
animal tissue. In this thesis no experiments were 
performed to show whether verapamil causes the blockade 
of the calcium movement into a cell. However, recently 
the phenylalkylamine D888 has been shown to inhibit 
45Ca2+ influx into carrot protoplasts (Graziana et al., 
1987) . It is interesting to note that although verapamil 
and other phenylalkylamines have nanomolar binding 
constants in vitro, rnicromolar to rnillimolar 
concentrations are required to produce inhibitory effects 
on calcium metabolism in tissue or whole plant 
experiments. This indicates a discrepancy between in 
vitro and in vivo concentrations required to obtain 
verapamil effects. However higher concentrations of 
verapamil are probably necessary to cause inhibition in 
intact tissues, as much of the drug may be sequestered or 
access to the binding sites may be restricted. In this 
respect, verapamil is thought to bind to the inner mouth 
of the calcium channel, having gained access to the sites 
while the channel was open (Hescheler et al., 1982) 
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7.1.2. Purification of the verapamil binding protein. 
Partial purification of the verapamil binding 
protein was achieved using detergent solubilisation of 
the membrane bound protein(s) , followed by ion exchange, 
gel filtration and hydrophobic interaction 
chromatography. SDS polyacrylamide gel electrophoresis of 
the purified fractions indicated the presence of two 
major polypeptides of molecular weights 169 kDa and 70 
kDa. The 169 kDa polypeptide was favoured to be the 
verapamil binding protein for two main reasons. 1. The 
169 kDa band was found to be absent in non-verapamil 
binding purified fractions. 2. The 169 kDa band is very 
similar in size to the a, subunit of the L-type calcium 
channel (155-200 kDa) , which is known to contain the 
phenylalkylamine and dihydropyridine receptor sites 
(Striessnig et al., 1986b, 1987) 
The verapamil binding subunit could not be further 
accurately identified despite the use of either 
photoaffinity labelling or [3H] verapamil overlay 
techniques. 
7.2. The need for calcium channels in plants. 
In animal cells a large calcium concentration 
gradient exists across the plasma membrane, but the 
permeability of the plasma membrane to calcium is 
relatively low. Therefore if calcium channels situated on 
the plasma membrane (and possibly the endoplasmic 
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reticulum) open, large quantities of calcium ions move 
rapidly into the cell, down the steep calcium 
concentration gradient. As a result there is a transient 
rise in cytoplasmic calcium concentration which can be 
used as a signal to trigger a cellular response. Calcium 
channels therefore provide the means for rapid but 
controlled entry of calcium ions into the cytoplasm, so 
allowing the modulation of calcium dependent processes. 
A similar situation appears to exist in plant cells, 
which maintain a low cytosolic calcium concentration 
against a high concentration of calcium in the apoplast. 
Controlled entry of calcium via a channel has the same 
potential to act as a signal or a second messenger. 
Calcium channels have a central role in this type of 
signalling system, but there is only limited evidence for 
their existence in plants. In a number of studies, 
calcium channel antagonists have been shown to bind to 
various plant membranes. For example, verapamil binding 
has been demonstrated in zucchini hypocotyl and maize 
coleoptile membranes by the author and others 
(Andrejauskas et al., 1985) Binding of nitrendipine to 
pea seedling membranes has been shown by Hetherington & 
Trewavas (1984) and recently D888 has been demonstrated 
to block 45Ca2+  influx into carrot protoplasts (Graziana 
et al., 1987). Calcium channel antagonists have also been 
used to inhibit various developmental events in plants. 
For example, cytokinin-induced bud formation is inhibited 
by D600 and verapamil (Saunders & Hepler, 1983) 
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metaphase is inhibited by D600 (Hepler, 1985) , polarised 
growth in Micrasterias is inhibited by verapamil 
(Lehtonen, 1984) and tip growth of pollen tubes is 
inhibited by nifedipine (Reiss & Herth, 1985) 
As well as these inhibitor studies, the similarity 
in size of the putative verapamil binding protein (169 
kDa) found in this research, compared to the main 
functional subunit of the voltage-dependent calcium 
channel from skeletal muscle (155-200 kDa) , (Striessnig 
et al., 1986a) , is yet another piece of evidence to 
suggest that calcium channels exist in plant cells. 
7.3. What are the functions of plant calcium channels? 
Calcium channel antagonist studies suggest that 
calcium channels are important in the co-ordinated growth 
and development of plants. Once calcium moves inside the 
cell via the calcium channel, the calcium concentration 
can vary spatially and temporally. These variations 
result in calcium concentration gradients and localised 
areas of calcium which appear to influence the 
development pattern of the cell. Brownlee & Wood, (1986) 
demonstrated the presence of a longitudinal gradient of 
cytosolic calcium in the rhizoid cells of Fucus serratus. 
Their results suggested that Ca2 enters the rhizoid tip 
through calcium channels. They postulated that this 
gradient was important to cell polarity and growth of the 
cell. Ca2+ gradients have also been found in other tip 
growing cells, for example Lily pollen tubes (Reiss & 
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Herth 1985) . Saunders (1986) has shown that calcium 
channels are involved in the establishment of a gradient 
in Funaria which determines the subsequent growth 
pattern. In electrophysiological studies and the use of 
Fura-2 AM, cytokinin has been demonstrated to induce an 
increase of inward calcium current along the length of 
Funaria cells, which results in a high free calcium zone 
at the distal ends of the cell i.e. the presumptive bud 
site. From these results it was postulated that cytokinin 
activates plasma membrane located calcium channels that 
subsequently create a zone of high calcium at the site of 
the new bud. This study indicates that calcium channels 
may be involved in the localised development of plant 
cells. Localised influx of calcium via the calcium 
channel may also provide the cell with spatial and 
positional information for cytoskeletal assembly and 
structure (Brawley & Robinson, 1985) 
The processes described above tend to require the 
presence of calcium for several hours before a response 
is induced. Calcium channels therefore, may be involved 
in maintaining elevated calcium levels in plant cells. As 
well as these 'slow' responses, the presence of calcium 
channels helps to explain more transient changes or 
'fast' responses. Such responses include chloroplast 
movement in Mougeotia which is a light-dependent, 
calcium-mediated response (Wagner et al., 1984), red-
light dependent germination of Onoclea spores (Wayne & 
Hepler, 1984) and the action potential dependent increase 
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of cytoplasmic calcium concentration in Chara which 
inhibits cytoplasmic streaming (Williamson & Ashley, 
1982) 
7.4. Properties of Plant Calcium Channels. 
As there is limited data on calcium channels in 
plants, it is difficult to make generalisations about 
their properties. In particular, whether there are 
families of calcium channels, whether they are localised 
according to membrane type and how they are controlled, 
i.e. are they voltage-dependent and/or receptor operated? 
In animal cells families of calcium channels have 
been distinguished on the basis of their differing 
sensitivities to various calcium channel antagonists 
(Glossmann et al., 1982) . It is possible that the 
differential binding characteristics of verapamil, D888, 
1J600 and nifedipine seen in this research, may reflect 
different families of channels, each sensitive to a 
different antagonist. Nifedipine for example, was unable 
to displace verapamil in this research and did not 
inhibit 45Ca2 influx into carrot protoplasts (Graziana 
et al., 1987). However nifedipine has been shown to 
affect pollen tube growth (Reiss & Herth, 1985) and Fucus 
zygote polarity (Brownlee & Puisford, 1988) 
The cellular location of calcium channels in plants 
has not been rigorously examined. Preliminary data 
presented in this thesis indicates increased verapamil 
binding (and therefore presumably calcium channels) in. 
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plasma membrane enriched fractions compared to fractions 
containing the other membrane types. This parallels work 
by Andrejauskas et al. (1985) , which also indicated high 
verapamil binding in plasma membrane fractions, with 
slightly less in fractions of endoplasmic reticulum and 
tonoplast. These results suggest that plant calcium 
channels are localised according to membrane type. It is 
possible that channel sensitivity to channel antagonists 
may vary according to their location, which might be a 
useful tool to identify and purify the various channel 
types from different membranes. 
In animal cells calcium channels open either when 
the membrane is depolarised (voltage-dependent channels) 
or when a ligand binds to the channel (receptor-operated 
channels). Whilst the requirements for the opening and 
closing of plant calcium channels are not definitely 
known, there is evidence for voltage-dependent ion 
channels in plant cells, in particular the tonoplast 
(Hedrich & Neher, 1987; Hedrich & Schroeder, 1988) 
indicating that change in membrane potential can be used 
to control ion entry. Other pieces of evidence also point 
to the existence of voltage-dependent calcium channels in 
plants; a calcium action potential has been demonstrated 
in Chara, which is thought to trigger the opening of 
calcium channels thereby increasing the cytoplasmic 
calcium concentration (Williamson & Ashley, 1982) 
calcium flux into corn root tissue was found to increase 
as . a result of actions which depolarised the membrane 
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(Rincon & Hanson, 1986) . At present there is little firm 
evidence for receptor-operated channels in plant cells. 
7.5. Future Work. 
Information about calcium channels in plants is 
limited. As this discussion indicates, there are many 
questions that still remain to be answered. In general 
terms these questions cover all aspects of calcium 
channel behaviour and control. More specifically the 
research presented in this thesis needs to be taken 
further and some of the findings investigated in more 
depth. This would include making a definite 
identification of the 169 kDa protein which is proposed 
to be the verapamil binding protein. This may involve 
further photoafinity labelling experiments, although so 
far these have been unsucessful. 
Further verification that we are dealing with a 
calcium channel protein may come from antibody studies, 
although it has been shown that monoclonal and polyclonal 
antibodies developed for dihydropyridine and 
phenylalkylamine receptors from skeletal muscle do not 
cross react with plant membranes. However antibodies, 
raised to the 169 kDa protein, could be used to 
demonstrate the presence of channel proteins by the 
inhibition of 45Ca2 influx into protoplasts. The 
antibodies could also be used to demonstrate the location 
and clustering of channels in histochemical studies, 
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which could then be related to calcium influx by the use 
of dyes and ratio imaging technology. 
A molecular approach could also be taken to 
elucidate the identity of the 169 kDa protein. The 
protein could be sequenced and compared to that of a 
known calcium channel; the sequence for the a1 subunit of 
the voltage-dependent calcium channel from skeletal 
muscle has already been determined (Tanabe et al., 1987) 
Ultimately to determine if the putative verapamil 
binding protein is a functional channel, the protein 
could be reconstituted into lipid bilayers and then patch 
clamped. Depolarisation of the membrane and the addition 
of calcium channel antagonists would determine if the 
protein is a functional channel. One drawback to this 
approach, is that for the isolated verapamil binding 
protein to act as a functional channel may require the 
presence of its' associated subunits (assuming that the 
plant calcium channel does consist of a number of 
subunits). 
The control and regulation of plant calcium channels 
is an extremely interesting area for further research. 
Animal calcium channels are known to be regulated by 
cAMP-dependent and Ca2 calmodulin-dependent protein 
kinases and possibly protein kinase C (O'Callahan, 1988) 
Phosphorylation may also be important in the regulation 
of plant calcium channels and to investigate this an 
electrophysiologjcal and/or biochemical approach could be 
taken. As in the animal channel work, the activity of 
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exogenous protein kinases on the purified antagonist 
binding protein could be studied, as a continuation of 
the studies made on the endogenous kinase activity 
presented in this thesis. 
Possibly one of the main ways to discover more about 
plant calcium channels will be by patch clamping. This 
technique has been sucessfully applied to plant 
protoplasts and has helped to elucidate more about the 
mechanisms of ion transport (Hedrich et al., 1987) . Using 
patch clamping the properties of a single channel, such 
as ionic selectivity, conductance, kinetics and 
modulation by chemicals and drugs can be studied. Using a 
combination of patch clamping and for example 
intracellular calcium dyes, it might be possible to 
determine whether calcium does enter the cell via the 
calcium channel or is released from intracellular stores 
in response to external stimuli. So far there have been 
no reports of plasma membrane calcium channels found by 
patch clamping, (although there may only be very few per 
cell which might make them very difficult to find) 
However patch clamping has identified two types of 
calcium-dependent ion channels in the vacuolar membrane, 
which might conceivably be calcium channels. Patch 
clamping is a powerful technique for ion channel study 
and may provide, in combination with biochemical and 
molecular biological techniques, the way forward in plant 
calcium channel research. 
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aie necessary for sillooth-, cardiac- and skeletal-muscle 
contraction iul(t For secretory pi'OcCSSCS [7 91. Ca2 '-
channel antagonists are a group of drugs (used to treat 
cardiovascular disorders) of' which there are three main 
structurally unrelated types. These are the diliydro-
pyriduies, e.g. niledipinc, the phenylalkylamiies, e.g. 
verapanlil. and the henzotliiazipines, e.g. diltiaicm 
[It). 111. These compounds hind to specific receptors 
located in the Ca channel. The radioactive forms of the 
channel antagonists can he used to label specifically 
the Ca'-cliannel proteins, so providing a means of' 
Ca'-channel detection and idenlification [12,131. 
Experimental evidence Suggests that ('ii channels do 
exist in plant cells [6,14,0  17 ("a- '-chtnneI 111Iauoi1ists 
have been (lemonsi rated to disrupt a ii urn her of' plant  
Functions [16 IKf. Nifedipine and erapaillil hate heeul 
shown to bind specifically to plant nieillbrancs in 11110 
flY 211. More recently. \;uioLis pIienl;dkylnnines have 
been sfiovv a to inliuhu t 	'Ui 2 	nfl us into carrot ( /)(nu its 
)(I1,0141) protoplasts 	?] ..\ d:i'ect relationship has bee 
established heistecu nienubruie binding constants for 
range ol pilenvlulkvlainiles and the ability of the drug 
to ullubut ('i!  uptake ]221. 
Here ste preeei ii;iia i';r ['}--!]vcr:ipamii haiding 
niai,e /ea uiuii.s ) coleoptile membranes and describe 
method for the solubulization and partial purihcation c 
the 	era pa ni il-binding protein I'roni iiti iie coleoptil 
nieni bra ic prepa rations. 
\i\'F1':In..is AND METHODS 
Plant material 
N1u/e (Zea niai,r cv. Leader) seeds. From the Nitmn 
Institute of Agricultural Botany, Cambridge, U.K. 
were grown in Illoist verniictihte in the dark at 25 '( 
Aker 5 days the coleoptiles, including the leaf' rolls, wet 
harvested and collected on ice. 
Chemicals 
[A'-nu'!/lu'I- 2 FI]VerapLunil hydrochloride, vs ith a specifi 
radioactivity of 68.8 ('i/mniol. was obtained roil) Ne 
England N ucica r, Bedford, NIA U.S.A. Li nlabelle 
+ / -- )-verapainii hydrochloride was ohtuncd Fror 
Sigma. All other chemicals were of the highest grad 
available, obtained From various sources. 
Preparation of crude membrane fractions 
All pi'eparat is e procedures vs crc carried out at 4 °( 
unless stated otller\sise. Freshly harvested tissue vvii 
chopped vs oh a razor hlatle and then homogenized i 
(2 vol. per g fueslu v'eight) St) uiist-l'ris/3 nlvi-FIYI' 
hufler, adjusted to p1! 7.5 vs iii 110. The Ilomogenat 
vsiis then titieted ttuoiiglu one li\ei' of iulon cloth an 
centrifuged at 4)tttt) g for 20 win. The pellet was discarde 
,\tiici,tii'ii, 	ti',,t 	It (. 	t''l'ieiti 	erie 	ill Lui, 	ti t. 	p't'etIli IC tic Illlrre . 	( ii \t'S 	U i 	Jlt.IiIidtiip\ tiIiii It: iti 	Ir [III Ili ill IjuIftIIrc' 
'.Iltptirihuie; P,\()., t)lIOtCF\tIIiiilt('- IL't CtCLiFII'tiIL' ,l, , it I. diiliiritiieiuirt. C till A. C'irLaii,I\aiIi A t(',, iiitiitsiiirii c'ii'.i,ii)i ('.r'iiLCIItiIiiifl 










Ii I )Ittxc&, tl \ \xui 	intl .\ .1 lixeixiL 
;III(I 	111, 	 1 Hill lilt 	IL i l'iiiiilii(eit 	il 	Ill))) 	Hi 
WIS non \iC(&Iiiitl Hw erililL' iiieitilti,iiie pellet. \'liiCIl \\i 
rcipeiuteit In 	)) Ili\l-1 I i 	T1I III \Ni\iii11' huller. adjn'.ieil 
IN 1 7 5 .i(Ii K III lfl)iiLi a )ilU'/ I elltiii lliiilii)CenI/er 
))ItIl))Ii)Ii4)t) III Ilic cr)i)t( I1l(Il)l)riII1 1rit.tiiiii 
('i titti_ 	iiitiii(i,iiit. 	Ill (:t)r  :it Itii 	\(IC 	iiit_'iiIilCit 	ii 	1 
	
ti ii,(Ic et !.irll I ill it 	1 	.1 H / \ I. ill ii 	', H / 
i \ 14 '211' 	1 NucroNci 51) Iil\l- I ii' ,/')) iiii- rip' 
I)IlItLi'. 	iiliii'ici.I iii 	)ll 75 \\iiIi  I 1(1. (tic 10uiiiii 	flu ice 
and then kxIIIII1lIgVd lilt I It at lfl)ihi)t,'. hue restulinuii 
ii 	I tt liii tilt Itile 	it Ii hi Ii 	I 	pi ti ci ifi. 
\'crutpaiiiil-hiinlitig :isst 
lii tile slandald i'aiIi \ I I I It.cl allaind \\ as added ii [lie 
u_nate )uiu_'IuuIlriiue ieLIi,peIiitLI1, 'iltuihilu/ctI tiuendur:unc 
li;ie)iinu 	ii & iiuuuuuuu (Hicilitli. iii )ii&C Ii linalcolicclikilliml 
til 2.24 uui. I iiuIihe)Icul 'erapaiuuul ill tulle; c&Hhulfluli&l\ 
t¼1_'lc then itl&Ie&l i ICL(iiiieil It) Ii tu;i;iI i'i\ \iiliilili, ii 
cn)I,,( ,'Iuei an iiuctuttlitii )LetiOt( Ill 12)) null at 20 
liii.' icicIiiii \\IL .iOItr)&.tl li', [lie addition of .I IIII iii ie' 
cult) wuIu huller ciililaiiiilie I)),, (wv) 
5)) ni 	1 it,,, adjusicd lo 1111 7.5 	u_uiti 11(1. 'I he uluixilire 
'iis 	i Ill iii&2t,li;il&_lv 	I'll ter cii 	undcl 	v:ucullltii 	iti;uuuili 
Iii I Ina it (j), U Ii ci' (pi ci, CII it_ti V 1 iii 0.3 II L)  )ill- 
Owl I'll 	lt_i.I 21i. \'licli LiliiI)iIi/Cil tIIicililtu \\eie  
it f\IilIiti'u.' IntiltililICI 	iuiu;i. 	I lit. Iliti' 
i.ie uii'liei( titice Vitli 41111ill ice )_'t)l(t VIIti hiultet . 	I lie 
iluitililiL_)i\ui\ ieiiint.&) iii tile tu()ei tu_l (Iu_ieitutulue&t Iu 
lit;iui&I 	LLiitiiIliiii)il 	i_i)llIlIii(. 	l'Jttu 	pi.citlt 	tiIii,tIuiLi 	\'i' 
tleieu uiuinett 	lIit.'uuliiitlu_i 	;iIuijte \t iiti I)))) t\I Iititilette1t 
u_et:itInttil and 	u' 	sult,ir:icieti 	in 
((thillu iii) liniiu i' i\u'iitiiIil;ultuL! I 'ii 	ci a pa lii) iiit( 	In 
vi 	C the 	()t.'el lii.. binding ut III J\ I_u a pa lull 
I':lrjIll 1)11!  Iii&'IiIIi)ll of III) 	%(l':l)Illl)il-ttiulltllg lrlItilL 
l)l',, l/-I)in-(c1 i))ll-cxcllIIIlg). uI)rt))llatogra)hl. Stitiitui- 
tiieui nicilihuliuie ti;iciiuuit (coin appmv 	1)1) p reIu \u.cil_iIii 
of Ii's)ic \\i 	tOitteul (ill to it e(tliuuiiit (4)) an x III u_ni) 
of 	I)l.'\I-I)u-Gel 	\ (I)ii>-Ruu.t(_ V ticti had Fueen 
eq iii ti hi a I ed V itt Column bullet' containing 50 iii i- I i 
50 liI\l Mops. 2)) 	SliCrOse. I).)',, 	(i 11\S. 	p11 7.5 
(utpi'led tu. (Ii I h( 'I). Ilie ratio (it si ulipte to 111:11 11X Vas 
5:? (x/v). Alter linit_IllIg A Aw simple. (tie cudtuniti xxix 
5 	ISI1C(l 	"till an C() III t Sot iiiiiu_ (it I_it Iulttlt huller. 1? utii&)ii 
\viih) I). t 5 \i-r"Ji( •t in l,iitllIlIil killer )ieIu.Ietl the xerap;iinit-
tuluixliic aWky in (lie tuixi i( nd ill 	tie etnitie. I tiN Su_ix 
collected. puniltuns \xci'c asspal ilitceit) ni xcripaituul 
hutittitie. and lie cIlIate lIlt_li ijuiut.'h tinier, in tittuitt N, 
UIIC) siiT'C(l at 	il) 	( nniil rcitlliie&I for liii ilier ptiui- 
ti_i lit iii 
1ephacr I 	--I(I)) gil filtration. \ Sepltiers't S--I)))) 
ctiltnttui I 	iili it heit volume (i) 31X S lilt) 55 its Ci)lflIihi'uleit 
5511)1 CiiIlHHlt huller 	Ii II tltisv title of ((5 lit/inn). 	1 lie 
pl)Li-l)L'\l.hliui-(iel traction 12 nih 	xxix lieitIt'tl nut (it Ilic 
ciituuiuiu and u_Iillcil xxuili ctl&iiiuii luillet . 	I iICOilL (I IIII 
etch) xxeue collected. and port nis xxeieissixed tin 
SCripiltlT(-I1il1&lHli. iclivul). l'racti ii xxilu lie luieliexi 
Imnidniui at. I lxii S xi, ete pooled. 
Ihiti I-.(phi:irc( hlSllrtIi4l-iilItrlu.iliI 'lii'ui,:iiti-
graili. l'uuIeil liit_linnx lui lii.' SepIiicit t_uluiuuui 
xx ccc nmdc I \t xxi) Ii t expect ii I N Ill • S( I 	;i nil I inst 
xxtili 	iixpt'cl 	u, 	1 _ 	t,. 	I lu 	xxeic 	(tiauhtl till 	lit 	a 
iuIutnuti Won I Ii u_tnt id IdietI'St.'1iliuniise ('I .411  
II'llilliiit_ii) ui_ti lit ltcti eptuliliuIcil xxuilu i))u._tluuiuuii 
SuiliunieL 1)1 huller eouutiillullL! 5)) fiSt- I 'is))) uitxi-rxio1-is 
21) 	xnctu xc. 11 I ',, CHAPS, . I si-( Nil 	I) I uui\i' 
('u('I, MI 75  )aljlisicd xxith 	1(1) ftniller .11 ,'\liei 
xxuxtiunu suuli I)ullet 	I. Ilue u_'oltntutt xxuseluieit xxiilt l 	nil 
cut_lu ttl 	lie ltiltiixxuiiti series iii luuullers; 11. 5() tOt- tin! 
5)) iitxt-Mutps,2)I ''. 	slieruise/() I,, 	(1 i.\b'S/)) I 	iou 
('l( I. 	I 75 (uiliuistctt xxiilt IRA): C. 5)) liStIli,, / 
50 iui\t-slitps/Ii,, 	suiernse/l). I, 	('IIAPS, 	p11 7 
(t&liiusied ciili I I C Ii. i) 	()  I 	(}l,,\PS/2)), xliel'uuxe, 
Ill 	lIuui(llliSiet_I I'uuciiotis (2 1111) su_Cie e&utlecie(i and I till 
xuiuipl&..s \\ei  I. 	lS.l\u2uI for 	Set iIitill 	Illtu(tlli,1!. 
Sl)S/i' \(;l: 
Suuiuplxx \eue ticuualuutett Hi 2.3,, (xxx) SI)S,'tI)", 
(x /s I 	itlxceitil . u2 5 nix;- I nix, 11(1 	(pi I (i.Si/5 	(s/s 
,tu tiic'L;ulli , lt_'lluiiill )t i))uitiuu at 05'(' and seplti)eu.t 
lt i'\(l on II)', 	I puil\uci)Iauttl_Ie u_iels, using 
tic hiiltu..'i x\.iu.'Hl of I ueiuiiiili 1211. (icli st_etc slaincil 
xxiili 	sits ci 	1 211. 	Muileu.uulai '111155 	uitutkeis 	tilt)HiIetl 
li'nuu Supuii;i sscue: Iui\niui (200,0;1), /1 )!iIiciuuxill;uu. 
1 (i L I)u)_ phtxpIinr lie h (92 Ma), )i)_ hun inc 'el 11111 
uthltuuitii )0( LI )t ) aiuui eirhottuc auilu)itrtsc (ii k 1)ii. 
I'roleiii lItterillilultiun 
Ill), 	55,15 	Cal iICuI 	tiull 	liv 	it uitinli(iell 	I)iuu.Iltuiil 	1 2S1 
lIt_i liiiul_ xx ii Ii l)ii S Iii S) 1. 111 ii it I 111111 i 	as il xl ii 1_I ii 
lI'..Sl if. I S \Nl) I)I('I L(L.(I()N 
I'iui&lics of I I  iii traillillil iliulililig to ILiii/e cI)l1))I)IiIc 
mcitibranu,  
N.liii,_ 	ttIeil))ile 	iiueutuluttiucs 	Icr it_Ic 	and 	('I lAPS 
xiluhili/t'tl) t)uuit \u_iljHHIl illi 5l))lrutllc tilinllcr_ and 
Iluis hiluillul1_' is i'exeriihte. IluiHtunp cqunhiht'iunui is t.tctieul 
ulieu appiov 120 hut ('up. I). \\'lien I)))) /151 IllilulLelteul 
xcripuuulil is ,l(tilCtt Ii lilt.! pIuleuui. dissociation of 
huutiut sxuiiuutiil is iuitduuctl and is largely i'olilplchc illici' 
a 1111111cr IN nut. Situuitii' kuuietut_ dulu fiuxe hecn loilInt 
100 juxi Un)nlwlkud vcrnpctinti 
60 	120 	180 	240 
1 111w (111111) 
lig. 	I. bi,uu'Ii&' 	ii 	I I Itr:l1nlItIiI 	Iiiui&Iiit 	iitt_liic 	IiiiIli 
lllu')tlt)r lilt' II :i&'i 44)5 
11111 	t&ix 	uiiuiuuicI 	l)\ 	itltlituoll 	ni II IIxcttlxlilit 
liii ('tilt I t 11\11 Ii tue iili'iiliuliuul itli\lnit_ itllI,liiliuli' 
lilt 	I'l ,It lii 	II ii 	itt' 	SIll) pI 	ixu\ x,iuuuuci. 	\i 111c 
11111c, uiu,I It .tu.t_I, 25II111 xi nu des xx i_Ic 	Itt it itt Ii It_i) mid 
iii 	111 1! 	unit iult'ihtl 	xt'u.Iutll 
I Ii _, 	lit, 	Ii' 	1111)11 Itt1 	ii 	utlilil iii 	it) IllIi 	xi- 
\ellupiilitl 







































log f Unlabelled Ca' -chanrel anlagoiiisj (M) 
 
20 	 100 	 200 
Voi ai,ariiul Onuunil ( pniO(/ni(j of i)(oIeii 
I' ig. 2. Displacement of II llier1ipanlil by unl.ihellcil ('a'-
channel antagonists 
liiitjiiiii iI 11 Ij\ei'ipiiiiiil to 11101/C ciileoplile iiieiiihriiic 
Iriiclions was measured tinder equilihimin coiicljIjuiii. 0 
p11 7.5 mid 2() °C. in the presence of eiher unluhcll:J 
s'eriipinul ( ). n1clliox\'veritpiiuil (0),desnielhov-
ser.upuuiil (L I or niledipitie (A) ill (lie eoiicciilrilions 
I III CO (Cu! Total vei 0 O iiii hi oh iiu ut I iou I add ion ol 
unlabelled compounds was 250 thud, and niiui'spccific 
hi uiu(i iui I uheterni uncut h 	the addition ol 	((((ii i ii a h'l 
verapaniil % us 4,, of lie ROut. 
I or both i ucchi n (Coil rgct te, ('ionr/Jila pepo ) membranes 
Mid skeletal-muscle micrcisomcs [20,261. 
01 the drugs tested for displacement of [H]verapaniil, 
only verapamil and methoxyverapamil were able to 
apprciahly displace [ii l]verapamil binding in maize 
colcoplile nicin bra ties, with 1C, values of' 100 nM and 
700 nst respectively (Fig. 2). Desinelhoxyverapauiuil 
eonipeteuj poorly, even though it is closely related to 
vera pa mi I and has an IC.,,, value of about 50 //51. 
Ni led pine, which is of a different structural class, had 
little effect, even at lOb /151. These results suggest that 
there are specific binding sites for the different Ca' - 
channel antagonists within it channel. 
Figs. 3(u) and 3(b) show Sca tehard plots for ['H] 
verapamil binding in crude and CHAPS-soluhilized 
menibra lie fractions. For crude membrane fractions they 
indicated it K of 72 mu and of B 	(binding-site con- 
centration) of' 135 pniol/rng of protein. In the ('[IA PS-
soluhiliied preparation the K1 was 158 nsi and the 
Th prnol/mg of protein. In both eases (lie plots are 
linear, suggesting the presence ola single class of binding 
sites. The similarities in dissociation conshanls suggest 
that the solubilized verapanul-binding protein has pro-
perties similar to those of lie uiiciiihr;ine-hotiiul protein. 
Scatcliird plots were also constructed or II] 
verapam 1 binding 10 crude mciii bra tie prep r;i liii 115 
from uiiuize roots and tticcliini Ii) pocois Is. 	ieldiiig 
linear plots in both eases Iresults not slio. n). Maize 
roots were hound to li,m'.e it K, uI 2.1,1 nu for seripnnml 
binding and it L3 	of 165 p11101/lug of protein. A K1  
Hg. 3. Scaichuard plots oil IlIerapainiI binding in (a) crude and 
(.i) soluubihited muuii.e t'mulemupiile uuucnuhrane l'raciimuiis 
l..cusu-squ,iies reuressioil uiuIvsis uuas used to plol (lie line 
til best hi. 
of I 14 rust and it lI,, of 96 pniolrng OF protein was 
obtained or inecluni iuetuihu- uie fractions, u.s lueli (.0111- 
a" ou:ub!', -,%ilh 	 obtained pres iously for 
zucehuu, 	u.s her e the A 1 was 102 nra and Ille ll 
60 pinol hug oh pro tein [20]. It is Iiolieeable that (he 
dissoeiatiini L'oustauits obtained for plait crude 
iieuiibruuic Iractions are of it lower affinity than those 
obtauied 'or skeletal-muscle mierosonie preparations, 
for u.s hich the A was 43 TiM and the B 	44 piiiol/nig 
of protein [261). The concentration of verapaniil- binding 
si1es also tends to he greater for plant (issues. 
Partial purification of the serapaiuiil-binding protein 
file sci tpiinil-Iiiuidiiig protein was partially purified 
('rum maize coleoptile membranes by using anion-
exchange and gel-liltration chromatography. I'ollou.s ed hi 
phenyl-Sepharose hydrophobic-interaction ehiromato-
graphy. Lectun-aflinity chromatography was attempted, 
hut veraparnil-binding proteins in soluhili7ed maize 
coleoptile uieuiubrane preparations and DEA E- I3io-(jcl 
Fractions dud not adhere to Con A Sepharose or to 
wheat-germ- eeti ii col urn us. The phcuiyl -Sepharose 
column was used in order to take advantage of the 
hydrophobic nature of the Ca' channel, 
Af'ter initial studies u.s thi it variety of' delergenls, the 
verapamih-hiuudiig sites were optimally soluhilized by 
0,5,, ClI.'\PS at it proleiui/delcrgcnt ratio of I: 14 
(w/M. The iuuclllsiolu of -10",,sucrose during solubiliitt- 
(ion inipros eih t lie 'iiabihi i 	ot' (lie sohuihihized veripiiuiuih- 
binding protein. Under these condulions the recovery of 
era pit nuul - hi ihiui 	si Ics %% its a pprox .50,. 
1 he soluhuhized receptor was then subjected 10 DEAF_ 
liio-(;Cl 
- 
Ili1.(eh Iiulon-e\chimiiLie clirouiiitoguiphmy. VcrmpaiuiiI. 
bunihtni,u ICtuu.lt 	u.sas eluted u.sihhi ((IS st-Na('l in coluuiiiu 
huller. 
 
111C iutchitsuini oh ((.1 	('I l,\PS in the ehiitiou 
butler \u.iis build to he uiecessar for successful elution of 
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Fraction no 
11g. 4. Illiti ion prolile for the S&phacrI S-40H1 cciliimn 
II00ii)ii5 (inn the I)FAF-l)jii-Get ion-exchange cotiiiiin (2 nil) were loaded 	ii to the coliii,iii ( 1. 5 ciii 	22 cm) of SephicI)t S-400  Mid etmiteit as described in the Materials and methods section. The I mitt fractions 	ere assicd hir vertipamnil binding 
The mimd solmime of lie eimltmmn 	as determined separately sith tIme E)exinmmi 2000 
lie clegmec () '])III i lieu  I I( ) i It) hm I mmcd a ei aged ibm mit .1 I(dii 
(varying from I to 7 fold, or reasons dial arc not cleat). 
Recovery of bmdiit activity ranged froiti 2)) to 5(1,. 
Aitiimigii tile pnrrlcmtoti factor mctneed ssith time 
I)I:.\ k-I3mo-(ei eoliminn is fairly low it appeared a be a 
I1CceSStrv step iii order that the subsequent purification 
steps should be successful. 
Fractimins coimtitmtmmng \erap;mmnib-hindimig activity eltited 
from the DF\ F-Rio-Gel column were further fraction-
ated on it Sephacryl S-40() column. A typical elutiott 
profile is shos a in Fig. 4. The recovery of binding 
activity was more than 100",of that loaded on to the 
column, perhaps heea use of removal of proteins inhibi-
tory to hindm nh'. lime recovery of binding activity was 
74 	of thu initially in the sol uhiiiied membrane extract. 
The degree of purification achieved with the gel-filtration 
step was 76-fold (Ta He I). The vera painil- binding protein 
was eluted in the void volume, suggesting that it chroma-
(ogra plied as a hi rge aggregate with i t  itmislecu Ia r mass 
of more than 8000 k Dii. the presence of I st-NaC'l or 
I nlM-Dfl mu the column huller had no effect on the 
eltition hcIm inur. 
Verapaniil-him(liig fractions trout the Sephacryf S-400 
column were then applied to it phenyl-Sepha rose column. 
Fig. 5 shows a typical elution profile from the column. 
Tue profile indicates that verapanmil-hinding activity is 
efuted partly by huller II, and pat tly h' huller I), the 
latter fraction teluted with 0.1 	Cl IAPS/20 	sucrose), 
having the higher specific activity.  The recovery of 
veraparnil_hinding activity from the phenvf-Sepharose 
column (huller I) fraction) sas 20, and oerall recovery 
as less tItan 4, of the initial acti'itv in the ('I lAPS-
smiltihifi/cll nmcmimhiane extract. 
After each ptmrihicittion step. the proteins contained in 
the dmlleremmt fractions \erc mum;ml)sed by SI)S/I1AG[ 
(Fig. 6). 'I lie fuitml pnrdicitton step tms 	hmmmrstaiict t 
hands oil! 169000. 100000 711000 and 66()ttO(I:i. 6. 
lane 5). Silcr staining mit tIme gel indicated it hand mit 
11 	169000 v, hitch 5itS enriched In the flnaf verapamil- 
rAi 	C 
I 
12 	 18 0 
Fraction no 
Fig. 5. l';Iiii hut profile fur the plietivi-Sepharose colurmin 
Pouted fractions front the Scpimacrvt S-40)) cotoitmn ssere 
imdtiisted to I 'm-(Nt I )SO and t msi-('a(l, and loaded on 
to ttie p)iciiI-Sepliarose cottuumi, which tmd previously 
been equilibrated with It) column volumes of Butler 1. 
Numerous ehmitmon protocols were esalmm;miet. Time following 
cttmtmon series c'ave the best recovery of verapamil-hinding 
acimvmt. 'vVlmen sample loading was complete, the column 
was washed si tb up to 18 nil of hu)Fcr -I, and then eltmted 
with 18 nil each of' butlers B. C and I) (urrows). Fractions 
(2 nit) were collected, mud tIme first four 2 nil Fractions of 
each eltitmomm step iscre assil)cd for verapamnil binding. 
hmim&tiini fruit mitt (hp, i1i (u. lm ic 5, see arrow). This baud 
wits abscmmt limmrmm tIme protein prIilcs ol inactive fractions 
(Jig 6. home 4). A Itroteim) of 11, 11(11()))0 \sims observed 
tim mu mmglu liii tIme scm a jim ii ml- hi mmdi mg and mmliii - 'eta iii mi I-
bmmmdimmu iriicitolms frommi the Sep)ttmcrvl S-400 coluinmi and 
tIme hiemIthrumttahi (itctmmnis t'rmnu the I)F\F-IIio-Gei 
culummnm. \ piuiemmm uI eilimmvmIcmit i/ 	70000. was obserscd 














1lI!IliCi)I(llI lilt 'CI f)liIIlll-hIlilllllL! protcill 110111 111111/C 
Table I. PiIriticllliun of the erapiniiI-huiiiJing protein 
VerlipIllilil 	hound Pioiin 
Purification Specific P11111 IC 11100 
Iep )e.p.iil.) 	1..) rug) I',) ieirrty (fold) 
(II\PS 	Lire1 3224)) 	I)))) 25 I)))) I 305 1. 
Dl1.\0tijtt-6ct 10III) 12 4 l(> 2525 2 
Scpil;Icryi 	S-441() 218M 	74 024 ft 	18 99160 76 
Pllenvl-Seplill rose 1 204 4 )fIXk ((032 158000 121 
Molecular 





tig. 6. 	t)S/I'(;t. 1)1 erapaniiI-tiinding fraction from 111111/1 
CtiIt.oi)iiI& membranes III itilfertiii 	:1(4CM of 
l.Iit1C I, (1 l,\l1S-oIiihili,ed eSlitci (5 /llg,  of pI'oleiiI)l Line 
pooled I)IAtl-ltItt-(jeI Iruclroti (5 ue of prolelli): line 
pooled Sephllcryl S-400 Irlictron (5 tg of proteil): 
iiiie 4. SupIrlicryl S-40() lF,tCtIt)il itli flo seilipaillil- 
iirittiig IteiI\ ly 45 ag 	[rtl(eIrI): kine 5. huller I) Irlictioll 
Irtlili tile l)llCIi\ I-Se jtliIiFO'4C ctiliiiiiii ( I 	ig of proieiil). 
The If , -109000 eoinpttilcnt of the veripiiiiil-bindm 
protein ill 111111/C eoleoptile iiieitih)rlilIes found in till 
present studs is eonipllrable 	itli the major subunit (1 
.11 14200)) iottiid litr tile dtli'o.lropyridmc receptor if 
rabbit skeletal ililiSele 1111(1 to the pol peptide of 'ui 
651)()) 11)01111 for tile phtenyhalkvliniine receptor (also if 
rabbit skeletal muscle) [28 101. If the (i' chllillilel hal 
been conser ed during e olittion, uric would expect t 
see if similarity in the si/c of the channel pol peptides if 
pllult 111111 ilililIllil tissues. Moiiocfu>iial 111111 poiyclona 
anti bodies ha e been developed 'or di hydropyrid I tie am 
plleiivlalkvluiriiiie receptors 10111 skeletal iiiitsehe [31 .32J 
I lowever. these antibodies (to not cross-react wtih plan 
ineiiibraiies (NI I .a,dunski, personal eoinnlunieatlon) 
0 hUh suggests some structural dillerenees hcteen thu 
receptors Ill IrlIllits 11(1(1 101111)11k. 
lurdier o 01k 	5 needed to deterlilfile 55 hietlier tb 
11111101 baud of 'il 169011)) obtluned from the p;irtiahl 
ltI1Ik'I 	1111/C Ct icopiile 	0eil1i10iC prel11t11u111115 	1 
mdccii the pliL'il\ lalkyfimniie receptor in plants. 
u';le ktlllssledL'e (\Sh )('rt'operiitvc ,'\\vlirds ill Seienc 
111112 llrlgtileerlllg) sitdeiitslrip 5uPP01( lot 	If. J It. by thu 
SI,ICI1LC 111111 lirgitreci ing ReSClite)l ('oltilciL 
Sepillieryl S-40() elution profile (Fig. 6. lane 4). The blind 
at 66000 11 is a staining artefact frequently observed 
even in unloaded SI)S/ PA (iF slots and rcported by 
others [27]. on this basis the protein of 51 169000 is the 
most likely candidate to contain the verapainil- biii(iing 
site. 
The gel SUggestS that there has been extensive puri-
fication of' the veriipamil-hinding protein. Ilowever, the 
purification actor. I 20-fold (Table 	), is higher than 
might he anticipated from a simple calculation of the 
abundance of' the protein in the initial CHAPS extract. 
Despite Care, we have found the binding-site activity to 
he unstable during purification. This instability, com-
bined with potential illiccnrlieies in iilc:isiirilig low ieels 
of protein, probably accounts for this. 
Co investigate the possible glycoprotein nature of the 
verapamil-hundino protein, gels of the post-l)NAF-Bio- 
(id 	era pani I I-hi ndi iig fraction were blot ted oil to nitro- 
cellulose paper and incubmed 	itli peroxldltse-hnked 
('on A. The hcctni was seen to hind to tIle Kind of 
51 	6900) and to other prolcilis preselit in this l)F\l- 
Bin-Gel purified fraction. stiecestlile that the .11-1(19004) 
Conlponellf is II glycoprotein. Binding of the ler'iii to tJie 
ha tci 'a ltgcM of the 1)11111 11.11 t liii \ 	it) ohi It led. pt tssi hI 
M\1119 to instiflictent lcels of the purified protein. 
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